>KH358001.1 Sequence 183 from patent US 9493750
TTGACTATCCT
>KH358000.1 Sequence 182 from patent US 9493750
TTGACCATCCT
>KH357999.1 Sequence 181 from patent US 9493750
TTGACTATCCT
>KH357998.1 Sequence 180 from patent US 9493750
TTGACGATCCT
>KH357997.1 Sequence 179 from patent US 9493750
TTGACCATCCT
>KH357996.1 Sequence 178 from patent US 9493750
TTGACAATCCT
>KH356198.1 Sequence 2 from patent US 9493460
DTATAGCTATA
>LX251234.1 WO 2017111166-A/13: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
GTGTTTGTGGG
>LX246172.1 JP 2017093459-A/51: DISEASE RESISTANT PLANTS
ATGAACTCCAC
>LX246171.1 JP 2017093459-A/50: DISEASE RESISTANT PLANTS
CTTTTGTTGTT
>LX246168.1 JP 2017093459-A/47: DISEASE RESISTANT PLANTS
CTTCCCATAGA
>LX246167.1 JP 2017093459-A/46: DISEASE RESISTANT PLANTS
AGAGGATTAGT
>LX246164.1 JP 2017093459-A/43: DISEASE RESISTANT PLANTS
AGCGATAGAAG
>LX246159.1 JP 2017093459-A/38: DISEASE RESISTANT PLANTS
ATCAGTGTGAA
>LX246156.1 JP 2017093459-A/35: DISEASE RESISTANT PLANTS
AAGCAATCTAC
>LX246152.1 JP 2017093459-A/31: DISEASE RESISTANT PLANTS
ACTGGGCTGAT
>LX246151.1 JP 2017093459-A/30: DISEASE RESISTANT PLANTS
GGAAATCAAGA
>LX246144.1 JP 2017093459-A/23: DISEASE RESISTANT PLANTS
GTCAACCTTCC
>LX246143.1 JP 2017093459-A/22: DISEASE RESISTANT PLANTS
GGAAGATCATA
>LX246140.1 JP 2017093459-A/19: DISEASE RESISTANT PLANTS
CGTGGAAAGTA
>LX246139.1 JP 2017093459-A/18: DISEASE RESISTANT PLANTS
CTCATCTTGTT
>LX246136.1 JP 2017093459-A/15: DISEASE RESISTANT PLANTS
AATGGTTGGAG
>LX246135.1 JP 2017093459-A/14: DISEASE RESISTANT PLANTS
GCGAGAACACA
>LX244942.1 JP 2017104109-A/322: RNAse H-Based Assays Utilizing Modified RNA Monomers
ACTGGACCTGA
>LX244612.1 JP 2017104108-A/322: RNAse H-Based Assays Utilizing Modified RNA Monomers
ACTGGACCTGA
>LX155763.1 JP 2017510301-A/6: Melting Curve Analysis using PNA Probe, Method and Kit for Analyzing Nucleotide Polymorphism using Melting Curve Analysis
TTGGGCGGGCC
>LX155762.1 JP 2017510301-A/5: Melting Curve Analysis using PNA Probe, Method and Kit for Analyzing Nucleotide Polymorphism using Melting Curve Analysis
TTGGGCGGGCC
>LX155761.1 JP 2017510301-A/4: Melting Curve Analysis using PNA Probe, Method and Kit for Analyzing Nucleotide Polymorphism using Melting Curve Analysis
TTGGGCGGGCC
>LX155760.1 JP 2017510301-A/3: Melting Curve Analysis using PNA Probe, Method and Kit for Analyzing Nucleotide Polymorphism using Melting Curve Analysis
TTGGGCGGGCC
>LX155279.1 JP 2017510277-A/104: Ureohydrolases as dominant selectable markers in yeast
GTTATTTAATG
>LX155275.1 JP 2017510277-A/100: Ureohydrolases as dominant selectable markers in yeast
AATAATTTTCT
>LX155266.1 JP 2017510277-A/91: Ureohydrolases as dominant selectable markers in yeast
TATTTATTACC
>LX155258.1 JP 2017510277-A/83: Ureohydrolases as dominant selectable markers in yeast
ATCTATGTCGG
>LX155238.1 JP 2017510277-A/63: Ureohydrolases as dominant selectable markers in yeast
GGTAGCCAAAT
>LX155217.1 JP 2017510277-A/42: Ureohydrolases as dominant selectable markers in yeast
CACATCCATAA
>LX155210.1 JP 2017510277-A/35: Ureohydrolases as dominant selectable markers in yeast
GTTCCGGCGCG
>LX155180.1 JP 2017510277-A/5: Ureohydrolases as dominant selectable markers in yeast
TCTGTAAATAA
>LX154278.1 JP 2017509872-A/10: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
CAATCTCATCC
>LX154277.1 JP 2017509872-A/9: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
TCTTTATGCTG
>LX154276.1 JP 2017509872-A/8: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
GCTGTCTATTG
>LX154275.1 JP 2017509872-A/7: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
ATATACAAGCG
>LX154274.1 JP 2017509872-A/6: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
GCATTGTTACT
>LX154273.1 JP 2017509872-A/5: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
TTTCTTGCTTC
>LX154272.1 JP 2017509872-A/4: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
ACAATTCTTCG
>LX154271.1 JP 2017509872-A/3: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
GTTTAATTGCG
>LX154270.1 JP 2017509872-A/2: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
GAATTTCCTCG
>LX154269.1 JP 2017509872-A/1: HIGH-THROUGHPUT AND HIGHLY MULTIPLEXED IMAGING WITH PROGRAMMABLE NUCLEIC ACID PROBES
CATCTAAAGCC
>LX154261.1 JP 2017510247-A/15: Universal controls for sequencing assays
GGAATCGATAT
>LX155285.1 JP 2017510277-A/110: Ureohydrolases as dominant selectable markers in yeast
GTCGGGCTCAT
>LX155284.1 JP 2017510277-A/109: Ureohydrolases as dominant selectable markers in yeast
CATAACCCGAA
>LX152368.1 JP 2017510871-A/11: SYSTEMS AND METHODS FOR USE OF KNOWN ALLELES IN READ MAPPING
TTGGATATGGG
>LX153005.1 JP 2017511121-A/97: TARGETED SEQUENCING AND UID FILTERING
GCCAGCACCAG
>LX145841.1 JP 2017506074-A/3: APTAMER CONSTRUCT
ACGTATACTAT
>LX145839.1 JP 2017506074-A/1: APTAMER CONSTRUCT
ACGTATACTAT
>LX095636.1 WO 2017057540-A/12: Nucleic derivatives having immunostimulatory activity
AACGTCAGGAA
>LX095209.1 JP 2017070299-A/30: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTTGCTNA
>LX095208.1 JP 2017070299-A/29: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ANTCGTTGCTA
>LX095206.1 JP 2017070299-A/27: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTTGCTNA
>LX095205.1 JP 2017070299-A/26: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ANTCGTTGCTA
>LX095197.1 JP 2017070299-A/18: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTNTGCTA
>LX095196.1 JP 2017070299-A/17: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTNTGCTA
>LX095193.1 JP 2017070299-A/14: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGNTTGCTA
>LX095192.1 JP 2017070299-A/13: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGNTTGCTA
>LX095189.1 JP 2017070299-A/10: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTNTGCTA
>LX095188.1 JP 2017070299-A/9: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGNTTGCTA
>LX095187.1 JP 2017070299-A/8: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCNGTTGCTA
>LX095186.1 JP 2017070299-A/7: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTTGCTNA
>LX095185.1 JP 2017070299-A/6: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ANTCGTTGCTA
>LX095184.1 JP 2017070299-A/5: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGTNTGCTA
>LX095183.1 JP 2017070299-A/4: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCGNTTGCTA
>LX095182.1 JP 2017070299-A/3: MODIFICATIONS FOR ANTISENSE COMPOUNDS
ATCNGTTGCTA
>LX095179.1 JP 2017077244-A/51: OPTIMIZATION OF MULTIGENE ANALYSIS OF TUMOR SAMPLES
ACAGAAAGACA
>LX095039.1 JP 2017070296-A/8: COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
ACTACRGTCAA
>LX095038.1 JP 2017070296-A/7: COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
CGTACKAAGAG
>LX088606.1 JP 2017068521-A/7: DEVICE AND SYSTEM FOR EXTRACTION OF NOVEL TRANSCRIPTOME
ACCGAGTGTAG
>LX087732.1 JP 2017070241-A/39: Primer, method, and kit for detecting influenza A virus
GTGAACACAAA
>MS797032.1 Sequence 461 from Patent WO2017009400
GRTVDGTVVSD
>MS657917.1 Sequence 164 from Patent EP3129477
GCCAGGTGTCC
>MS657909.1 Sequence 156 from Patent EP3129477
GTCAGCTGCAA
>MS657908.1 Sequence 155 from Patent EP3129477
GACACCTGGCC
>MS657907.1 Sequence 154 from Patent EP3129477
CCCACCTGCAG
>MS657906.1 Sequence 153 from Patent EP3129477
CCCAGCTGCCT
>MS657905.1 Sequence 152 from Patent EP3129477
CCCAGCTGCAC
>MS657904.1 Sequence 151 from Patent EP3129477
GGCAGCTGGGG
>MS657901.1 Sequence 148 from Patent EP3129477
ATTTCTAAGTA
>MS657900.1 Sequence 147 from Patent EP3129477
ACTCCCAGGAA
>MS657886.1 Sequence 133 from Patent EP3129477
CAAGGGCCAGG
>MS657882.1 Sequence 129 from Patent EP3129477
TTTTGTGGCTA
>MS657881.1 Sequence 128 from Patent EP3129477
CTCTGTGGCTT
>MS657863.1 Sequence 110 from Patent EP3129477
AACCTCTCCAG
>MS657859.1 Sequence 106 from Patent EP3129477
TGGCTTTTCCC
>MS657838.1 Sequence 85 from Patent EP3129477
CCGGAAGCACC
>MS657837.1 Sequence 84 from Patent EP3129477
CATAGTTTATG
>MS657836.1 Sequence 83 from Patent EP3129477
AAATGTTTATT
>MS657835.1 Sequence 82 from Patent EP3129477
TCAAATCCACT
>MS657832.1 Sequence 79 from Patent EP3129477
GCCGGAAGCAC
>MS657827.1 Sequence 74 from Patent EP3129477
CCAAGGGCAGG
>MS657822.1 Sequence 69 from Patent EP3129477
ACAGGAAGCCT
>MS657821.1 Sequence 68 from Patent EP3129477
AGAGGAAGGCG
>MS657820.1 Sequence 67 from Patent EP3129477
AGAGGAAATGG
>MS657819.1 Sequence 66 from Patent EP3129477
GTGCTTCCGGC
>MS657811.1 Sequence 58 from Patent EP3129477
CTCTCATGGGC
>MS657810.1 Sequence 57 from Patent EP3129477
CTCCCCAAGGA
>MS657809.1 Sequence 56 from Patent EP3129477
CTCCCCTGAGC
>MS657808.1 Sequence 55 from Patent EP3129477
CCCTCCAGGGG
>MS657807.1 Sequence 54 from Patent EP3129477
ACGAGGGAGGG
>MS657806.1 Sequence 53 from Patent EP3129477
GGGAGGGAGCC
>MS657805.1 Sequence 52 from Patent EP3129477
TGGAGGGAAGG
>MS657804.1 Sequence 51 from Patent EP3129477
GGGAGGGAGGG
>MS657803.1 Sequence 50 from Patent EP3129477
GGGAGGGAAGG
>MS657793.1 Sequence 40 from Patent EP3129477
CCCACGTGAAC
>MS789140.1 Sequence 5 from Patent EP3175244
TCCCTGATCCA
>MS787682.1 Sequence 30 from Patent EP3124607
AGAATACTTTT
>MS786622.1 Sequence 1 from Patent EP3124606
TATTAGGACCA
>MS652263.1 Sequence 29 from Patent EP3137606
GTCCCTTCTTC
>MS652259.1 Sequence 25 from Patent EP3137606
GTTTCGTTCGA
>MS652255.1 Sequence 21 from Patent EP3137606
GCTCCCTTTCT
>MS652264.1 Sequence 30 from Patent EP3137606
GCCCTCCCTGA
>MS652260.1 Sequence 26 from Patent EP3137606
GTTGCGTTCTA
>MS652256.1 Sequence 22 from Patent EP3137606
AGTCTTTTCTT
>MS652261.1 Sequence 27 from Patent EP3137606
GTTCTCGTCTC
>MS652257.1 Sequence 23 from Patent EP3137606
AGGCTTTCTTT
>MS652262.1 Sequence 28 from Patent EP3137606
GGCCGACCTAC
>MS652258.1 Sequence 24 from Patent EP3137606
GCGCTCTCTTC
>MS652252.1 Sequence 18 from Patent EP3137606
GCGTTCCTTCT
>MS652248.1 Sequence 14 from Patent EP3137606
GCGCCTTTCTT
>MS652244.1 Sequence 10 from Patent EP3137606
CTTTTGTTCTC
>MS652240.1 Sequence 6 from Patent EP3137606
GCGCTTCTCTT
>MS652236.1 Sequence 2 from Patent EP3137606
AGCTTCTTCTT
>MS652253.1 Sequence 19 from Patent EP3137606
GGGTCGTTTTT
>MS652249.1 Sequence 15 from Patent EP3137606
GTCCTTGCTTC
>MS652245.1 Sequence 11 from Patent EP3137606
CTTCTTCTTTC
>MS652241.1 Sequence 7 from Patent EP3137606
TTTTTTCTCTT
>MS652237.1 Sequence 3 from Patent EP3137606
GGTCTTATTTG
>MS652254.1 Sequence 20 from Patent EP3137606
GCGCCGATTTT
>MS652250.1 Sequence 16 from Patent EP3137606
CTTCCTTCTTC
>MS652246.1 Sequence 12 from Patent EP3137606
GTTCTTGTTTC
>MS652242.1 Sequence 8 from Patent EP3137606
GTTTTCTTTCT
>MS652238.1 Sequence 4 from Patent EP3137606
GGTGTTCATTT
>MS652251.1 Sequence 17 from Patent EP3137606
GCCTCTTTTCC
>MS652247.1 Sequence 13 from Patent EP3137606
CGGTTTCGTTT
>MS652243.1 Sequence 9 from Patent EP3137606
GTTCTCTTCTC
>MS652239.1 Sequence 5 from Patent EP3137606
TTCTTTCTTTT
>MS652235.1 Sequence 1 from Patent EP3137606
GTTCTTTCTTT
>MS651914.1 Sequence 1425 from Patent EP3137118
GNGGAAGNNNA
>MS651902.1 Sequence 1413 from Patent EP3137118
GNGGAAGNNNA
>MS651900.1 Sequence 1411 from Patent EP3137118
GNGGAAGNNNA
>MS651898.1 Sequence 1409 from Patent EP3137118
GNGGAAGNNNA
>MS651896.1 Sequence 1407 from Patent EP3137118
GNGGAAGNNNA
>MS999664.1 Sequence 2 from Patent EP3147364
TTGGGGGGTAC
>MS996386.1 Sequence 12 from Patent EP3157572
TTTTGCTTTTT
>MS996388.1 Sequence 14 from Patent EP3157572
AAAAAGCAAAA
>MS647347.1 Sequence 10 from Patent EP3137479
GTGGAAGGCGG
>MS647341.1 Sequence 4 from Patent EP3137479
GTTAGGGTTAG
>MS647339.1 Sequence 2 from Patent EP3137479
CTAACCCTAAC
>MS995379.1 Sequence 1 from Patent EP3158089
AAANAAANAAA
>MS995068.1 Sequence 6 from Patent EP3126511
TTGGGCGGGCC
>MS995067.1 Sequence 5 from Patent EP3126511
TTGGGCGGGCC
>MS995066.1 Sequence 4 from Patent EP3126511
TTGGGCGGGCC
>MS995065.1 Sequence 3 from Patent EP3126511
TTGGGCGGGCC
>MS991366.1 Sequence 27 from Patent EP3158065
TGGAGGAGACA
>MS637255.1 Sequence 357 from Patent EP3115059
GGGTTTTTGGG
>MS637245.1 Sequence 346 from Patent EP3115059
GGTTTTTTTGG
>MS954792.1 Sequence 2 from Patent WO2017034970
AGATCGGAAGA
>MS954791.1 Sequence 1 from Patent WO2017034970
AGATCGGAAGA
>MS946423.1 Sequence 7 from Patent WO2017035319
TAAGCACTTTG
>MS631995.1 Sequence 8 from Patent EP3168766
TATCATCTTTG
>MS942316.1 Sequence 6 from Patent EP3177722
CAAACACCGAC
>MS942315.1 Sequence 5 from Patent EP3177722
ACAACACCAGC
>MS942314.1 Sequence 4 from Patent EP3177722
ACAACACCAGC
>MS941839.1 Sequence 11 from Patent EP3117214
GGCTTTAGATG
>MS941838.1 Sequence 10 from Patent EP3117214
CAATCTCATCC
>MS941837.1 Sequence 9 from Patent EP3117214
TCTTTATGCTG
>MS941836.1 Sequence 8 from Patent EP3117214
GCTGTCTATTG
>MS941835.1 Sequence 7 from Patent EP3117214
ATATACAAGCG
>MS941834.1 Sequence 6 from Patent EP3117214
GCATTGTTACT
>MS941833.1 Sequence 5 from Patent EP3117214
TTTCTTGCTTC
>MS941832.1 Sequence 4 from Patent EP3117214
ACAATTCTTCG
>MS941831.1 Sequence 3 from Patent EP3117214
GTTTAATTGCG
>MS941830.1 Sequence 2 from Patent EP3117214
GAATTTCCTCG
>MS941829.1 Sequence 1 from Patent EP3117214
CATCTAAAGCC
>MS941083.1 Sequence 1156 from Patent EP3116889
AGGATTAGCGC
>MS941082.1 Sequence 1155 from Patent EP3116889
CCACCAGAACT
>MS941081.1 Sequence 1154 from Patent EP3116889
TTAGCGTCATT
>MS941080.1 Sequence 1153 from Patent EP3116889
GTAATGGGAAA
>MS941079.1 Sequence 1152 from Patent EP3116889
CCTGAGAGTCC
>MS941078.1 Sequence 1151 from Patent EP3116889
TCATATATTCA
>MS941077.1 Sequence 1150 from Patent EP3116889
ATTATCATTGC
>MS941076.1 Sequence 1149 from Patent EP3116889
GTGAGGCGGTC
>MS941075.1 Sequence 1148 from Patent EP3116889
ATAAAAGGGTA
>MS941074.1 Sequence 1147 from Patent EP3116889
ATTTTTTCATT
>MS941073.1 Sequence 1146 from Patent EP3116889
GAGATAGACCG
>MS941072.1 Sequence 1145 from Patent EP3116889
ATGGAAACAGT
>MS941071.1 Sequence 1144 from Patent EP3116889
TATTGACGGTA
>MS941070.1 Sequence 1143 from Patent EP3116889
ATAGTAGTAGG
>MS941069.1 Sequence 1142 from Patent EP3116889
ACATCACTTTT
>MS941068.1 Sequence 1141 from Patent EP3116889
TTGATGATATT
>MS941067.1 Sequence 1140 from Patent EP3116889
CATTAAATTGA
>MS941066.1 Sequence 1139 from Patent EP3116889
TATCTAAAAAC
>MS941065.1 Sequence 1138 from Patent EP3116889
TTTGCTAAAGC
>MS941064.1 Sequence 1137 from Patent EP3116889
GGGAACGGACA
>MS941063.1 Sequence 1136 from Patent EP3116889
GAAGATGATTT
>MS941062.1 Sequence 1135 from Patent EP3116889
CAGAGCCACTA
>MS941061.1 Sequence 1134 from Patent EP3116889
GCGCCATTCCA
>MS941060.1 Sequence 1133 from Patent EP3116889
CAAAATTATGA
>MS940363.1 Sequence 436 from Patent EP3116889
AGGATTAGCGC
>MS940362.1 Sequence 435 from Patent EP3116889
ATTTTTTCATT
>MS940361.1 Sequence 434 from Patent EP3116889
CCACCAGAACT
>MS940360.1 Sequence 433 from Patent EP3116889
TTAGCGTCATT
>MS940359.1 Sequence 432 from Patent EP3116889
GTAATGGGAAA
>MS940358.1 Sequence 431 from Patent EP3116889
GAGATAGACCG
>MS940357.1 Sequence 430 from Patent EP3116889
CCTGAGAGTCC
>MS940356.1 Sequence 429 from Patent EP3116889
TCATATATTCA
>MS940355.1 Sequence 428 from Patent EP3116889
ATTATCATTGC
>MS940354.1 Sequence 427 from Patent EP3116889
ATGGAAACAGT
>MS940353.1 Sequence 426 from Patent EP3116889
GTGAGGCGGTC
>MS940352.1 Sequence 425 from Patent EP3116889
ATAAAAGGGTA
>MS940351.1 Sequence 424 from Patent EP3116889
TATTGACGGTA
>MS940350.1 Sequence 423 from Patent EP3116889
ATAGTAGTAGG
>MS940349.1 Sequence 422 from Patent EP3116889
ACATCACTTTT
>MS940348.1 Sequence 421 from Patent EP3116889
TTGATGATATT
>MS940347.1 Sequence 420 from Patent EP3116889
CATTAAATTGA
>MS940346.1 Sequence 419 from Patent EP3116889
TATCTAAAAAC
>MS940345.1 Sequence 418 from Patent EP3116889
TTTGCTAAAGC
>MS940344.1 Sequence 417 from Patent EP3116889
GGGAACGGACA
>MS940343.1 Sequence 416 from Patent EP3116889
GAAGATGATTT
>MS940342.1 Sequence 415 from Patent EP3116889
CAGAGCCACTA
>MS940341.1 Sequence 414 from Patent EP3116889
GCGCCATTCCA
>MS940340.1 Sequence 413 from Patent EP3116889
CAAAATTATGA
>MS687507.1 Sequence 62 from Patent EP3135775
TGAACAAGGCT
>MS835684.1 Sequence 46 from Patent EP3112465
TCATAAGNRBA
>MS912653.1 Sequence 345 from Patent WO2017021541
GTTCGGATAAA
>MS912593.1 Sequence 285 from Patent WO2017021541
TGTATTGTTAG
>MS912585.1 Sequence 277 from Patent WO2017021541
GCTCAGTTGTC
>MS912630.1 Sequence 322 from Patent WO2017021541
TAGCGGAGATT
>MS912643.1 Sequence 335 from Patent WO2017021541
GTCCGGATAAG
>MS912603.1 Sequence 295 from Patent WO2017021541
TTGATTGTTAA
>MS910723.1 Sequence 2 from Patent WO2017062343
TAAGGAGGTGA
>MS994120.1 Sequence 116 from Patent EP3159409
CGCCGCCATTT
>MS993958.1 Sequence 12 from Patent EP3157573
TTTTGCTTTTT
>MS993960.1 Sequence 14 from Patent EP3157573
AAAAAGCAAAA
>MS994119.1 Sequence 115 from Patent EP3159409
TCTGTTAGCCA
>MS987319.1 Sequence 83 from Patent EP3118208
TACCCGGTACT
>MS941327.1 Sequence 1400 from Patent EP3116889
GGCCTTGATTT
>MS941323.1 Sequence 1396 from Patent EP3116889
ACCCGTCGGTT
>MS941319.1 Sequence 1392 from Patent EP3116889
ATTTGGGGCAA
>MS941315.1 Sequence 1388 from Patent EP3116889
GCTGGTAATGT
>MS941311.1 Sequence 1384 from Patent EP3116889
TTTAACGTCAA
>MS941307.1 Sequence 1380 from Patent EP3116889
TAAATGAATGC
>MS941328.1 Sequence 1401 from Patent EP3116889
GCCCGTATAGC
>MS941324.1 Sequence 1397 from Patent EP3116889
AAGTTTATTAT
>MS941320.1 Sequence 1393 from Patent EP3116889
AGCCTTTATAT
>MS941316.1 Sequence 1389 from Patent EP3116889
CTGACCTGAAA
>MS941312.1 Sequence 1385 from Patent EP3116889
ACGACGGCCAA
>MS941308.1 Sequence 1381 from Patent EP3116889
TGCGGAACAAG
>MS941325.1 Sequence 1398 from Patent EP3116889
CCAGTAGCAAT
>MS941321.1 Sequence 1394 from Patent EP3116889
AGCTATTTTCC
>MS941317.1 Sequence 1390 from Patent EP3116889
CCTGCAACAAT
>MS941313.1 Sequence 1386 from Patent EP3116889
CCTGTAGCAGC
>MS941309.1 Sequence 1382 from Patent EP3116889
AGCTTTCCGTT
>MS941305.1 Sequence 1378 from Patent EP3116889
TTTGAATACCA
>MS941326.1 Sequence 1399 from Patent EP3116889
TCAAAATCATG
>MS941322.1 Sequence 1395 from Patent EP3116889
AATATTTAACC
>MS941318.1 Sequence 1391 from Patent EP3116889
CACTAACAAGA
>MS941314.1 Sequence 1387 from Patent EP3116889
GATTAAAGGCT
>MS941310.1 Sequence 1383 from Patent EP3116889
GGTTGATATAG
>MS941306.1 Sequence 1379 from Patent EP3116889
AAACGTACATT
>MS940836.1 Sequence 909 from Patent EP3116889
AATTAACCGAC
>MS940832.1 Sequence 905 from Patent EP3116889
AATCAAGTTTT
>MS940828.1 Sequence 901 from Patent EP3116889
TCTACAAAGAG
>MS940824.1 Sequence 897 from Patent EP3116889
AGTTGGCAATG
>MS940820.1 Sequence 893 from Patent EP3116889
AGAACCGCCAG
>MS940816.1 Sequence 889 from Patent EP3116889
GTTTACCAGTA
>MS940837.1 Sequence 910 from Patent EP3116889
GAAAAGGTGGG
>MS940833.1 Sequence 906 from Patent EP3116889
TTTGCCCGATT
>MS940829.1 Sequence 902 from Patent EP3116889
CACCCTCAGGC
>MS940825.1 Sequence 898 from Patent EP3116889
ACGTTAATATG
>MS940821.1 Sequence 894 from Patent EP3116889
GCAGAGGCGAA
>MS940817.1 Sequence 890 from Patent EP3116889
AATTGCGAATC
>MS940838.1 Sequence 911 from Patent EP3116889
GGAGGGAAGAA
>MS940834.1 Sequence 907 from Patent EP3116889
GTGGGAACAGT
>MS940830.1 Sequence 903 from Patent EP3116889
TATTTACATAT
>MS940826.1 Sequence 899 from Patent EP3116889
GTCATACATAA
>MS940822.1 Sequence 895 from Patent EP3116889
AGCTTTCAGAC
>MS940818.1 Sequence 891 from Patent EP3116889
ATACTTCTGAA
>MS940835.1 Sequence 908 from Patent EP3116889
TCAAGAGAAGC
>MS940831.1 Sequence 904 from Patent EP3116889
CAAGGATAAGG
>MS940827.1 Sequence 900 from Patent EP3116889
AAATACCGAAC
>MS940823.1 Sequence 896 from Patent EP3116889
TTTCTGTATCG
>MS940819.1 Sequence 892 from Patent EP3116889
TTCTGGTGCGG
>MS940815.1 Sequence 888 from Patent EP3116889
AATTACATTTA
>MS824957.1 Sequence 9 from Patent WO2017085175
CCANNNNNTGG
>MS824984.1 Sequence 36 from Patent WO2017085175
CCACCAGGTGG
>MS908796.1 Sequence 7 from Patent WO2017060457
ATAGTTGACAC
>MS904723.1 Sequence 346 from Patent EP3138577
GGTTTTTTTGG
>MS870368.1 Sequence 366 from Patent EP3173092
GGGTTTTTGGG
>MS870357.1 Sequence 355 from Patent EP3173092
GGTTTTTTTGG
>MS842508.1 Sequence 7 from Patent EP3130682
AGCATTTCCGT
>MS841845.1 Sequence 3 from Patent WO2017013103
AGCCACAAAGA
>MS841844.1 Sequence 2 from Patent WO2017013103
AGCTACAATGA
>MS841843.1 Sequence 1 from Patent WO2017013103
AGCTACAGTGA
>MS821573.1 Sequence 5 from Patent WO2017089520
ATGTGACCTAT
>MS788345.1 Sequence 5 from Patent EP3175001
TCCCTGATCCA
>MS890225.1 Sequence 9 from Patent WO2017059122
AGAGAAAGAAA
>MS890220.1 Sequence 4 from Patent WO2017059122
TTTCTTTCTCT
>MS999993.1 Sequence 5 from Patent WO2016207124
ATTGTAGCGTA
>MS999990.1 Sequence 2 from Patent WO2016207124
GGGGACTTTCC
>MS939929.1 Sequence 2 from Patent EP3116889
TTATCTACATA
>MS904733.1 Sequence 357 from Patent EP3138577
GGGTTTTTGGG
>MS883839.1 Sequence 48 from Patent EP3155101
ACTCTTTCCCT
>MS883838.1 Sequence 47 from Patent EP3155101
ACTCTTTCCCC
>MS883837.1 Sequence 46 from Patent EP3155101
ACTCTTTCCCA
>MS883831.1 Sequence 40 from Patent EP3155101
ACGAAACACCG
>MS835664.1 Sequence 26 from Patent EP3112465
WTNTTATGNTM
>MS838361.1 Sequence 3 from Patent WO2017013102
AGCCACAAAGA
>MS838360.1 Sequence 2 from Patent WO2017013102
AGCTACAATGA
>MS838359.1 Sequence 1 from Patent WO2017013102
AGCTACAGTGA
>MS835655.1 Sequence 17 from Patent EP3112465
YGATGGCNNTA
>MS813242.1 Sequence 33 from Patent EP3093661
GAAACCCAGCA
>MS813239.1 Sequence 30 from Patent EP3093661
CAGACTCCGGT
>MS813238.1 Sequence 29 from Patent EP3093661
GGAATGAAGGA
>MS813236.1 Sequence 27 from Patent EP3093661
AGCTGCTTTTG
>MS813235.1 Sequence 26 from Patent EP3093661
GGATTCCGTTG
>MS813233.1 Sequence 24 from Patent EP3093661
CCCCTATCACG
>MS813232.1 Sequence 23 from Patent EP3093661
ATTAGCATTAA
>MS813230.1 Sequence 21 from Patent EP3093661
AACCCATGGAA
>MS813229.1 Sequence 20 from Patent EP3093661
TTCAGTTCTCA
>MS813227.1 Sequence 18 from Patent EP3093661
CCATCTTTACC
>MS813226.1 Sequence 17 from Patent EP3093661
AGACAGTGTTA
>MS813224.1 Sequence 15 from Patent EP3093661
TCACAAGTTAG
>MS813223.1 Sequence 14 from Patent EP3093661
GGTCTCAGGGA
>MS813221.1 Sequence 12 from Patent EP3093661
TCAGACCGAGA
>MS813220.1 Sequence 11 from Patent EP3093661
CAAGTGCAATG
>MS813217.1 Sequence 8 from Patent EP3093661
TGACTACAACT
>MS811907.1 Sequence 37 from Patent EP3143141
AGTTCAGCGAC
>MS811906.1 Sequence 36 from Patent EP3143141
ACACGTTGTTC
>MS811905.1 Sequence 35 from Patent EP3143141
CCTCCGAGGGA
>MS811904.1 Sequence 34 from Patent EP3143141
TTTACAAGTGC
>MS811903.1 Sequence 33 from Patent EP3143141
ATGTTGTCCAT
>MS811902.1 Sequence 32 from Patent EP3143141
TGTTGTCCATT
>MS811901.1 Sequence 31 from Patent EP3143141
GTTGTCCATTA
>MS811900.1 Sequence 30 from Patent EP3143141
TTGTCCATTAC
>MS811899.1 Sequence 29 from Patent EP3143141
TGTCCATTACC
>MS811898.1 Sequence 28 from Patent EP3143141
TCCATTACCCC
>MS811897.1 Sequence 27 from Patent EP3143141
CCATTACCCCT
>MS811896.1 Sequence 26 from Patent EP3143141
CATTACCCCTC
>MS811895.1 Sequence 25 from Patent EP3143141
GTCCATTACCC
>MS811894.1 Sequence 24 from Patent EP3143141
GGATGCATGAG
>MS811893.1 Sequence 23 from Patent EP3143141
ATGCATGAGCC
>MS811892.1 Sequence 22 from Patent EP3143141
CTTTCGTTCGC
>MS811891.1 Sequence 21 from Patent EP3143141
GCCCGAGATCC
>MS811890.1 Sequence 20 from Patent EP3143141
CGTGTGGCAAC
>MS811889.1 Sequence 19 from Patent EP3143141
CGTGAACGAAG
>MS811888.1 Sequence 18 from Patent EP3143141
CATGGATGTCC
>MS811887.1 Sequence 17 from Patent EP3143141
TCGGATCTGTG
>MS811886.1 Sequence 16 from Patent EP3143141
AAGGTCTGCAT
>MS811885.1 Sequence 15 from Patent EP3143141
ATACTGTCCAA
>MS811884.1 Sequence 14 from Patent EP3143141
GGCAATTCCAT
>MS811883.1 Sequence 13 from Patent EP3143141
CCATCAAGTTT
>MS811882.1 Sequence 12 from Patent EP3143141
TCCTTTTATTC
>MS811881.1 Sequence 11 from Patent EP3143141
TCAAGTTTTCC
>LX058223.1 JP 2013544816-A/62: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTGACGTTCTT
>LX058221.1 JP 2013544816-A/60: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTGACGTTCT
>LX058218.1 JP 2013544816-A/57: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTTGACGTTC
>LX058217.1 JP 2013544816-A/56: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTGACGTTCT
>LX058210.1 JP 2013544816-A/49: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTGTCGTTCTT
>LX058208.1 JP 2013544816-A/47: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTGTCGTTCT
>LX058205.1 JP 2013544816-A/44: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTTGTCGTTC
>LX058202.1 JP 2013544816-A/41: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTGTCGTTCT
>LX058188.1 JP 2013544816-A/27: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
TCTGTCGTTCT
>LX058187.1 JP 2013544816-A/26: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
TCTGTCGTTCT
>LX058176.1 JP 2013544816-A/15: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTCTGTCGTTA
>LX058174.1 JP 2013544816-A/13: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
TCTGACGTTCT
>LX058173.1 JP 2013544816-A/12: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
TCTGACGTTCT
>LX058171.1 JP 2013544816-A/10: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTTGTCGTTC
>LX058169.1 JP 2013544816-A/8: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
CTTGTCGTTCT
>LX057292.1 JP 2015532097-A/118: HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
GTGTTCGTCGT
>LX057291.1 JP 2015532097-A/117: HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
NTCTTCNTCNT
>LX057203.1 JP 2015532097-A/29: HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
TGCTGCTTGTG
>LX057177.1 JP 2015532097-A/3: HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
TGCTGCTTGTG
>LX057176.1 JP 2015532097-A/2: HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
TNCTNCTTCTN
>LX057138.1 JP 2015528282-A/16: METHOD AND KIT FOR NUCLEIC ACID SEQUENCING
ACCTTGATGAA
>LX057128.1 JP 2015528282-A/6: METHOD AND KIT FOR NUCLEIC ACID SEQUENCING
TAGCCTTTGGC
>LX078043.1 WO 2017047741-A/357: Antisense Nucleic Acid for Treatment of Amyotrophia
CAGTGTTTGTG
>LX077774.1 WO 2017047741-A/88: Antisense Nucleic Acid for Treatment of Amyotrophia
CCTGGGTTCAT
>LX077772.1 WO 2017047741-A/86: Antisense Nucleic Acid for Treatment of Amyotrophia
GTAGGAGTCTC
>LX077771.1 WO 2017047741-A/85: Antisense Nucleic Acid for Treatment of Amyotrophia
CACAAACACTG
>LX077679.1 WO 2017047707-A/146: Antisense Nucleic Acid
ACAGTTTGCCG
>LX077677.1 WO 2017047707-A/144: Antisense Nucleic Acid
CCTGGAGTTCC
>LX077324.1 WO 2017043639-A/3: Chimera Decoy
TTCCCAGGAAA
>LX056123.1 JP 2015523864-A/105: TARGET DETECTION AND SIGNAL AMPLIFICATION
GCNNNNNNNGC
>LX056122.1 JP 2015523864-A/104: TARGET DETECTION AND SIGNAL AMPLIFICATION
CCNNNNNNNGG
>LX056120.1 JP 2015523864-A/102: TARGET DETECTION AND SIGNAL AMPLIFICATION
ACNNNNNCTCC
>LX056117.1 JP 2015523864-A/99: TARGET DETECTION AND SIGNAL AMPLIFICATION
ACNNNNNCTCC
>LX056116.1 JP 2015523864-A/98: TARGET DETECTION AND SIGNAL AMPLIFICATION
GCCNNNNNGGC
>LX056108.1 JP 2015523864-A/90: TARGET DETECTION AND SIGNAL AMPLIFICATION
GCCNNNNNGGC
>LX072348.1 JP 2017060474-A/7: Epigenetic Markers of Colorectal and Diagnostic Methods Using The Same
AGTGATCAGCA
>LX072346.1 JP 2017060474-A/5: Epigenetic Markers of Colorectal and Diagnostic Methods Using The Same
ACAGAGTCGTA
>LX063521.1 JP 2016501523-A/2: DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
CTAACCCTAAC
>LX063519.1 JP 2016501522-A/1: ANTIOXIDANT DIETARY SUPPLEMENT AND RELATED METHOD
GTGACTCAGCA
>LX062488.1 JP 2015533510-A/33: RETROVIRAL VECTOR WITH MINI-PROMOTER CASSETTE
GGAAAGTCCCC
>LV580203.1 JP 2015232018-A/57: Unnatural Reactive Amino Acid Genetic Code Additions
GGTTCGANTCC
>LV579156.1 JP 2015192672-A/172: ENDOTHELIAL CELL EXPRESSION PATTERNS
AACACAGTGCC
>LV579155.1 JP 2015192672-A/171: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAAACCCGGTA
>LV579154.1 JP 2015192672-A/170: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTAAAAAAA
>LV579153.1 JP 2015192672-A/169: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGCAGTGCTG
>LV579152.1 JP 2015192672-A/168: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCGTGCTTTGT
>LV579151.1 JP 2015192672-A/167: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTCTCACCTA
>LV579150.1 JP 2015192672-A/166: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTCCGGTGTG
>LV579149.1 JP 2015192672-A/165: ENDOTHELIAL CELL EXPRESSION PATTERNS
GACCGCGGCTT
>LV579148.1 JP 2015192672-A/164: ENDOTHELIAL CELL EXPRESSION PATTERNS
TAAAGGCACAG
>LV579147.1 JP 2015192672-A/163: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCATCTGTGC
>LV579146.1 JP 2015192672-A/162: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATAACCTGCAG
>LV579145.1 JP 2015192672-A/161: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCACTAATTT
>LV579144.1 JP 2015192672-A/160: ENDOTHELIAL CELL EXPRESSION PATTERNS
TAAATACTTGT
>LV579143.1 JP 2015192672-A/159: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCAAAGTGCCC
>LV579142.1 JP 2015192672-A/158: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCAGTGACCAG
>LV579141.1 JP 2015192672-A/157: ENDOTHELIAL CELL EXPRESSION PATTERNS
AATATCTGACT
>LV579140.1 JP 2015192672-A/156: ENDOTHELIAL CELL EXPRESSION PATTERNS
AAGGAGAACTG
>LV579139.1 JP 2015192672-A/155: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAATTCACCAG
>LV579138.1 JP 2015192672-A/154: ENDOTHELIAL CELL EXPRESSION PATTERNS
TATTAAAATAG
>LV579137.1 JP 2015192672-A/153: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTTCAAAAA
>LV579136.1 JP 2015192672-A/152: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGTTCAAGGG
>LV579135.1 JP 2015192672-A/151: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTAGAGGAAAA
>LV579134.1 JP 2015192672-A/150: ENDOTHELIAL CELL EXPRESSION PATTERNS
AAGATGCACAC
>LV579133.1 JP 2015192672-A/149: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAAAAGGCC
>LV579132.1 JP 2015192672-A/148: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTTGAAAAAA
>LV579131.1 JP 2015192672-A/147: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATTGCCAATCT
>LV579130.1 JP 2015192672-A/146: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTTGTTTTGC
>LV579129.1 JP 2015192672-A/145: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTTTAAGGATG
>LV579128.1 JP 2015192672-A/144: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGGAAGAGGG
>LV579127.1 JP 2015192672-A/143: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTTAAAAAA
>LV579126.1 JP 2015192672-A/142: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGGCTGACGC
>LV579125.1 JP 2015192672-A/141: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTAGCGTTTTA
>LV579124.1 JP 2015192672-A/140: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCTCACGTCTC
>LV579123.1 JP 2015192672-A/139: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATCCCTTCCCG
>LV579122.1 JP 2015192672-A/138: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCTTGCCTTT
>LV579121.1 JP 2015192672-A/137: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCCACACGGG
>LV579120.1 JP 2015192672-A/136: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTCGGTTGGTC
>LV579119.1 JP 2015192672-A/135: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGTCACATAGT
>LV579118.1 JP 2015192672-A/134: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATCAAAGGTTT
>LV579117.1 JP 2015192672-A/133: ENDOTHELIAL CELL EXPRESSION PATTERNS
GATGAGGAGAC
>LV579116.1 JP 2015192672-A/132: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCCACACAGT
>LV579115.1 JP 2015192672-A/131: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGAAATGACC
>LV579114.1 JP 2015192672-A/130: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTATGTTTAAT
>LV579113.1 JP 2015192672-A/129: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGTGTTGTA
>LV579112.1 JP 2015192672-A/128: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGGAGACGGA
>LV579109.1 JP 2015192672-A/125: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCAAAACCAC
>LV579108.1 JP 2015192672-A/124: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGAAACCACGG
>LV579107.1 JP 2015192672-A/123: ENDOTHELIAL CELL EXPRESSION PATTERNS
CATTATCCAAA
>LV579106.1 JP 2015192672-A/122: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGGGTGAAAA
>LV579105.1 JP 2015192672-A/121: ENDOTHELIAL CELL EXPRESSION PATTERNS
TACAAATCGTT
>LV579104.1 JP 2015192672-A/120: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTACCATAAC
>LV579103.1 JP 2015192672-A/119: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCCCAAAGTG
>LV579102.1 JP 2015192672-A/118: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCCCCCAGGAG
>LV579101.1 JP 2015192672-A/117: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGACATACTGA
>LV579100.1 JP 2015192672-A/116: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAAATAGCAC
>LV579099.1 JP 2015192672-A/115: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCCCTTTCTCT
>LV579098.1 JP 2015192672-A/114: ENDOTHELIAL CELL EXPRESSION PATTERNS
TACCACCTCCC
>LV579097.1 JP 2015192672-A/113: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTTCCACAGAA
>LV579096.1 JP 2015192672-A/112: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTATAGGAGAC
>LV579095.1 JP 2015192672-A/111: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCACTGCAACC
>LV579094.1 JP 2015192672-A/110: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAGACTGTTA
>LV579093.1 JP 2015192672-A/109: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAAAAGTCAC
>LV579092.1 JP 2015192672-A/108: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCACAGGGGAT
>LV579091.1 JP 2015192672-A/107: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTACACACACC
>LV579090.1 JP 2015192672-A/106: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGTGAGACCC
>LV579089.1 JP 2015192672-A/105: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTTTAGATGG
>LV579088.1 JP 2015192672-A/104: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATTTTGTATGA
>LV579087.1 JP 2015192672-A/103: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGGTTTTCC
>LV579086.1 JP 2015192672-A/102: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTTTAAGAAC
>LV579085.1 JP 2015192672-A/101: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCTGGTTCAGT
>LV579084.1 JP 2015192672-A/100: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGAAATGTCAA
>LV579083.1 JP 2015192672-A/99: ENDOTHELIAL CELL EXPRESSION PATTERNS
CAGGAGACCCC
>LV579082.1 JP 2015192672-A/98: ENDOTHELIAL CELL EXPRESSION PATTERNS
TATTAACTCTC
>LV579081.1 JP 2015192672-A/97: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTTCTTTGAG
>LV579080.1 JP 2015192672-A/96: ENDOTHELIAL CELL EXPRESSION PATTERNS
CATTTTTATCT
>LV579079.1 JP 2015192672-A/95: ENDOTHELIAL CELL EXPRESSION PATTERNS
GATCTCCGTGT
>LV579078.1 JP 2015192672-A/94: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGGCTGCCCA
>LV579077.1 JP 2015192672-A/93: ENDOTHELIAL CELL EXPRESSION PATTERNS
CGTGGGGTGTA
>LV579076.1 JP 2015192672-A/92: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCGATGGAGA
>LV579075.1 JP 2015192672-A/91: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCAGAGACAA
>LV579074.1 JP 2015192672-A/90: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCAGTCACTT
>LV579073.1 JP 2015192672-A/89: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCAGGGTCCC
>LV579072.1 JP 2015192672-A/88: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGTGGCTACC
>LV579071.1 JP 2015192672-A/87: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGAACAGTGA
>LV579070.1 JP 2015192672-A/86: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGTAGGGTGA
>LV579069.1 JP 2015192672-A/85: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAAGACACTTG
>LV579068.1 JP 2015192672-A/84: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCAAGCAATCA
>LV579067.1 JP 2015192672-A/83: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAATGTGTAA
>LV579066.1 JP 2015192672-A/82: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTCTCCAAACC
>LV579065.1 JP 2015192672-A/81: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCATTTTCTA
>LV579064.1 JP 2015192672-A/80: ENDOTHELIAL CELL EXPRESSION PATTERNS
AAATATGTGTT
>LV579063.1 JP 2015192672-A/79: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGCAGTGGCT
>LV579062.1 JP 2015192672-A/78: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCCCCTCTCTC
>LV579061.1 JP 2015192672-A/77: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTAGTTCTGGA
>LV579060.1 JP 2015192672-A/76: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAATGCTCTTG
>LV579059.1 JP 2015192672-A/75: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGACTGTATTA
>LV579058.1 JP 2015192672-A/74: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCAGCAGCAGC
>LV579057.1 JP 2015192672-A/73: ENDOTHELIAL CELL EXPRESSION PATTERNS
CATCACGGATC
>LV579056.1 JP 2015192672-A/72: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTGCTTTTTT
>LV579055.1 JP 2015192672-A/71: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCTAATAATGT
>LV579054.1 JP 2015192672-A/70: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTCTCTTGAG
>LV579053.1 JP 2015192672-A/69: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAGTACCCA
>LV579052.1 JP 2015192672-A/68: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGTTGTTGCGG
>LV579051.1 JP 2015192672-A/67: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCTTAGGATG
>LV579050.1 JP 2015192672-A/66: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCTGCTTCTAG
>LV579049.1 JP 2015192672-A/65: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGGCTCCTGGC
>LV579048.1 JP 2015192672-A/64: ENDOTHELIAL CELL EXPRESSION PATTERNS
CAGATGGAGGC
>LV579047.1 JP 2015192672-A/63: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCTGTTCAGC
>LV579046.1 JP 2015192672-A/62: ENDOTHELIAL CELL EXPRESSION PATTERNS
CGAGAGTGTGA
>LV579045.1 JP 2015192672-A/61: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGAATTTGTT
>LV579044.1 JP 2015192672-A/60: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCGGCCCCTCC
>LV579043.1 JP 2015192672-A/59: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGCTACTTCT
>LV579042.1 JP 2015192672-A/58: ENDOTHELIAL CELL EXPRESSION PATTERNS
AATAGGGGAAA
>LV579041.1 JP 2015192672-A/57: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTAATGACAGA
>LV579040.1 JP 2015192672-A/56: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGTATAGAA
>LV579039.1 JP 2015192672-A/55: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATACTATAATT
>LV579038.1 JP 2015192672-A/54: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCGTTCTGTA
>LV579037.1 JP 2015192672-A/53: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACTGAAAGAAG
>LV579036.1 JP 2015192672-A/52: ENDOTHELIAL CELL EXPRESSION PATTERNS
AACAGGGGCCA
>LV579035.1 JP 2015192672-A/51: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTCATCCACT
>LV579034.1 JP 2015192672-A/50: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGGGAAACCTG
>LV579033.1 JP 2015192672-A/49: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCCAGGTGCA
>LV579032.1 JP 2015192672-A/48: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCACAGCCCCC
>LV579031.1 JP 2015192672-A/47: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCACTCCTGT
>LV579030.1 JP 2015192672-A/46: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGCCTGGATA
>LV579029.1 JP 2015192672-A/45: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACATTCCAAGT
>LV579028.1 JP 2015192672-A/44: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCACCGTGGAC
>LV579027.1 JP 2015192672-A/43: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAGTACTGT
>LV579026.1 JP 2015192672-A/42: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATCACACAGCT
>LV579025.1 JP 2015192672-A/41: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCTAACCCCTG
>LV579024.1 JP 2015192672-A/40: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGCCCTACAGT
>LV579023.1 JP 2015192672-A/39: ENDOTHELIAL CELL EXPRESSION PATTERNS
GAGCCATCATA
>LV579022.1 JP 2015192672-A/38: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTCCCTGCCTT
>LV579021.1 JP 2015192672-A/37: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTTTAATACA
>LV579020.1 JP 2015192672-A/36: ENDOTHELIAL CELL EXPRESSION PATTERNS
TACTTTATAAG
>LV579019.1 JP 2015192672-A/35: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCCTGTCCCTC
>LV579018.1 JP 2015192672-A/34: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACAAAGCATTT
>LV579017.1 JP 2015192672-A/33: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCAGTAAGAT
>LV579016.1 JP 2015192672-A/32: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTACAAAGAG
>LV579015.1 JP 2015192672-A/31: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCACGGGATTC
>LV579014.1 JP 2015192672-A/30: ENDOTHELIAL CELL EXPRESSION PATTERNS
TATGAGGGTAA
>LV579013.1 JP 2015192672-A/29: ENDOTHELIAL CELL EXPRESSION PATTERNS
GATAACTACAT
>LV579012.1 JP 2015192672-A/28: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCAATTTAACC
>LV579011.1 JP 2015192672-A/27: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGAAGCTAAGT
>LV579010.1 JP 2015192672-A/26: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCGGCGCCCG
>LV579009.1 JP 2015192672-A/25: ENDOTHELIAL CELL EXPRESSION PATTERNS
CAACAATAATA
>LV579008.1 JP 2015192672-A/24: ENDOTHELIAL CELL EXPRESSION PATTERNS
CTTCTGGATAA
>LV579007.1 JP 2015192672-A/23: ENDOTHELIAL CELL EXPRESSION PATTERNS
AGCTTGTGGCC
>LV579006.1 JP 2015192672-A/22: ENDOTHELIAL CELL EXPRESSION PATTERNS
GCACAAGTTCT
>LV579005.1 JP 2015192672-A/21: ENDOTHELIAL CELL EXPRESSION PATTERNS
CAGGTTTCATA
>LV579004.1 JP 2015192672-A/20: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCTCTGAGCAT
>LV579003.1 JP 2015192672-A/19: ENDOTHELIAL CELL EXPRESSION PATTERNS
AAGATCAAGAT
>LV579002.1 JP 2015192672-A/18: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGTTCTGGAGA
>LV579001.1 JP 2015192672-A/17: ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCTTTCACAC
>LV579000.1 JP 2015192672-A/16: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTTTATGGATA
>LV578999.1 JP 2015192672-A/15: ENDOTHELIAL CELL EXPRESSION PATTERNS
GTGCTAAGCGG
>LV578998.1 JP 2015192672-A/14: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTCTCCCAAAT
>LV578997.1 JP 2015192672-A/13: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTAGTGTCGTA
>LV578996.1 JP 2015192672-A/12: ENDOTHELIAL CELL EXPRESSION PATTERNS
GGGATTAAAGC
>LV578995.1 JP 2015192672-A/11: ENDOTHELIAL CELL EXPRESSION PATTERNS
ATGTCTTTTCT
>LV578994.1 JP 2015192672-A/10: ENDOTHELIAL CELL EXPRESSION PATTERNS
TAATCCTCAAG
>LV578993.1 JP 2015192672-A/9: ENDOTHELIAL CELL EXPRESSION PATTERNS
TCCCTGGCAGA
>LV578992.1 JP 2015192672-A/8: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTCTGCTCTTG
>LV578991.1 JP 2015192672-A/7: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACACTTCTTTC
>LV578990.1 JP 2015192672-A/6: ENDOTHELIAL CELL EXPRESSION PATTERNS
ACCATTGGATT
>LV578989.1 JP 2015192672-A/5: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTGCTGACTTT
>LV578987.1 JP 2015192672-A/3: ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGCACCTTT
>LV578986.1 JP 2015192672-A/2: ENDOTHELIAL CELL EXPRESSION PATTERNS
TGCACTTCAAG
>LV578985.1 JP 2015192672-A/1: ENDOTHELIAL CELL EXPRESSION PATTERNS
CATATCATTAA
>LV709053.1 JP 2016027825-A/109: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
TGACTACGGTG
>LV709051.1 JP 2016027825-A/107: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
TGACTACAGTA
>LV619809.1 JP 2016002084-A/401: ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
CTAACTGGGGA
>LV619498.1 JP 2016002084-A/90: ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
CTAACTGGGGA
>LV578591.1 JP 2017501730-A/3: METHODS OF ASSESSING EPIGENETIC REGULATION OF GENOME FUNCTION VIA DNA METHYLATION STATUS AND SYSTEMS AND KITS THEREFOR
TCGCAGCGCGA
>LV578221.1 JP 2017500870-A/10: Production system
AGCCACCATGG
>LV577426.1 JP 2017500034-A/4: MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
AAAAAGCAAAA
>LV577424.1 JP 2017500034-A/2: MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
TTTTGCTTTTT
>LV577054.1 JP 2017500032-A/2: METHODS FOR FULL-LENGTH AMPLIFICATION OF DOUBLE-STRANDED LINEAR NUCLEIC ACID OF UNKNOWN SEQUENCE
AGACTCCGACT
>LV573114.1 JP 2017500020-A/2: NUCLEIC ACID AMPLIFICATION
GAGCAACCGTT
>LV573113.1 JP 2017500020-A/1: NUCLEIC ACID AMPLIFICATION
AACGGTTGCTC
>LV572697.1 JP 2017501683-A/38: Method for the Detection of multiple target nucleic acids using Clamping Probes and Detection Probes
TGGAGCTGTTG
>LV572696.1 JP 2017501683-A/37: Method for the Detection of multiple target nucleic acids using Clamping Probes and Detection Probes
TGGAGCTGATG
>LV572601.1 JP 2017500004-A/17: METHODS AND SYSTEMS FOR GENOTYPING GENETIC SAMPLES
GAACGTTGCTA
>LV572600.1 JP 2017500004-A/16: METHODS AND SYSTEMS FOR GENOTYPING GENETIC SAMPLES
AGACGAGTTTC
>LV572594.1 JP 2017500004-A/10: METHODS AND SYSTEMS FOR GENOTYPING GENETIC SAMPLES
TTGGATATGGG
>LV571463.1 JP 2017035102-A/25: PALINDROMIC PRIMER
CCATTATACGC
>LV571462.1 JP 2017035102-A/24: PALINDROMIC PRIMER
GCGTATAATGG
>LV542184.1 JP 2017023084-A/11: A method for detecting Acidovorax avenae subsp. citrulli and Acidovorax avenae subsp. avenae
ATAAAGGGAGG
>LV542181.1 JP 2017023084-A/8: A method for detecting Acidovorax avenae subsp. citrulli and Acidovorax avenae subsp. avenae
ATAAAGGGGGG
>LV542180.1 JP 2017023084-A/7: A method for detecting Acidovorax avenae subsp. citrulli and Acidovorax avenae subsp. avenae
ATAAAGGGGGG
>LV507499.1 JP 2017012189-A/1: RNA aptamer and sensor using the same
TATTAGGACCA
>LV506954.1 JP 2017000158-A/94: TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, ALPHA SUBUNIT (SCN1A) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCN1A
GCCAGTCACAA
>LV502102.1 JP 2017018098-A/13: BIOSYNTHETIC SYSTEM THAT PRODUCES IMMUNOGENIC POLYSACCHARIDES IN PROKARYOTIC CELLS
AAAAAGCTAGC
>LV501738.1 JP 2017012171-A/2: METHOD OF DNA SEQUENCING BY HYBRIDISATION
ACAGCCAGCCG
>LV539719.1 JP 2016538865-A/103: Novel genome alteration system for microorganisms
GTTATTTAATG
>LV539715.1 JP 2016538865-A/99: Novel genome alteration system for microorganisms
AATAATTTTCT
>LV539706.1 JP 2016538865-A/90: Novel genome alteration system for microorganisms
TATTTATTACC
>LV539698.1 JP 2016538865-A/82: Novel genome alteration system for microorganisms
CCGACATAGAT
>LV539678.1 JP 2016538865-A/62: Novel genome alteration system for microorganisms
GGTAGCCAAAT
>LV539657.1 JP 2016538865-A/41: Novel genome alteration system for microorganisms
CACATCCATAA
>LV539650.1 JP 2016538865-A/34: Novel genome alteration system for microorganisms
GTTCCGGCGCG
>LV539621.1 JP 2016538865-A/5: Novel genome alteration system for microorganisms
TCTGTAAATAA
>LV539725.1 JP 2016538865-A/109: Novel genome alteration system for microorganisms
ATGAGCCCGAC
>LV539724.1 JP 2016538865-A/108: Novel genome alteration system for microorganisms
CATAACCCGAA
>LV533936.1 JP 2016539639-A/83: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
GACCGGCCCCT
>LV533932.1 JP 2016539639-A/79: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TATGGCACGAA
>LV533928.1 JP 2016539639-A/75: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TATACGCGCAT
>LV533960.1 JP 2016539639-A/107: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
AGATCAGCGCG
>LV533916.1 JP 2016539639-A/63: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
GATAGTTTAGA
>LV533888.1 JP 2016539639-A/35: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TATGGACGGCT
>LV533876.1 JP 2016539639-A/23: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
ACTCCCACGCT
>LV533868.1 JP 2016539639-A/15: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
GATAGGGGGGA
>LV533860.1 JP 2016539639-A/7: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
ATGTGCGCCAA
>LV533949.1 JP 2016539639-A/96: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
ATAGAGCCCTT
>LV533889.1 JP 2016539639-A/36: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TTGTGGTCGAG
>LV533861.1 JP 2016539639-A/8: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
GTGGGTAGGGT
>LV533854.1 JP 2016539639-A/1: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
ACAGCTCAGAA
>LV533942.1 JP 2016539639-A/89: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
GACGTCTATGG
>LV533922.1 JP 2016539639-A/69: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
CTTTCCTCTCT
>LV533918.1 JP 2016539639-A/65: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TAATGGTGGGT
>LV533886.1 JP 2016539639-A/33: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TCTGCGGGACA
>LV533882.1 JP 2016539639-A/29: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TCTTCGCTATC
>LV533931.1 JP 2016539639-A/78: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TCGATGGNNNT
>LV533927.1 JP 2016539639-A/74: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
GGGTAGGTTGC
>LV533855.1 JP 2016539639-A/2: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
CTTCCGCAGGT
>LV533963.1 JP 2016539639-A/110: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TTTGCGGCGGA
>LV533907.1 JP 2016539639-A/54: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
ATTGTCCACTG
>LV533899.1 JP 2016539639-A/46: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TTGCGCCCTGT
>LV533879.1 JP 2016539639-A/26: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TTTCCCCTCCG
>LV533875.1 JP 2016539639-A/22: KITS-OF-PARTS COMPRISING NUCLEIC ACIDS ABLE TO FORM A KISSING COMPLEX AND THEIR USES THEREOF
TTTTGAGTGAT
>LV534422.1 JP 2016539443-A/1: SYSTEMS AND METHODS FOR USING PAIRED-END DATA IN DIRECTED ACYCLIC STRUCTURE
TTGGATATGGG
>LV526726.1 JP 2016540275-A/11: METHODS AND SYSTEMS FOR DETECTING SEQUENCE VARIANTS
TTGGATATGGG
>LV526661.1 JP 2016537012-A/1223: Mutant calreticulin for the diagnosis of myeloid malignancies
CCATCCTTGTC
>LV526659.1 JP 2016537012-A/1221: Mutant calreticulin for the diagnosis of myeloid malignancies
GAGGAGGCAGT
>LV514480.1 WO 2017010568-A/53: RNA-Protein Complex and use thereof
GTCCCGACTCC
>KH351102.1 Sequence 128 from patent US 9487784
GCGTTCTTCCG
>KH351101.1 Sequence 127 from patent US 9487784
ATAGTGCTCAT
>KH351100.1 Sequence 126 from patent US 9487784
TGCTCATACTC
>KH351099.1 Sequence 125 from patent US 9487784
CTCTCGCAAGG
>KH351093.1 Sequence 118 from patent US 9487784
TCTCAGATGGT
>KH351088.1 Sequence 109 from patent US 9487784
CTTCGATAGTG
>KH351080.1 Sequence 101 from patent US 9487784
TTTGCAACCCC
>KH351079.1 Sequence 100 from patent US 9487784
AATAGGGTTGG
>KH351061.1 Sequence 79 from patent US 9487784
GGCATCGTCGC
>KH351045.1 Sequence 63 from patent US 9487784
ACGTTGAGGGG
>KH316049.1 Sequence 29 from patent US 9476101
CACATTATTAT
>KH316047.1 Sequence 27 from patent US 9476101
GTGTTTATTAT
>KH316043.1 Sequence 23 from patent US 9476101
GTGTTTATAAT
>KH315849.1 Sequence 722 from patent US 9476097
CACACTCCATA
>KH311404.1 Sequence 70 from patent US 9476042
GTAAGTCTGCC
>KH311402.1 Sequence 68 from patent US 9476042
ATACTTACCTG
>KH309198.1 Sequence 8 from patent US 9476033
GTTTTTTCTAA
>KH309191.1 Sequence 1 from patent US 9476033
TTTTTTTCTAA
>KH306693.1 Sequence 15 from patent US 9474798
TATTAGTAGAA
>KH306140.1 Sequence 143 from patent US 9469881
GACTTGATACC
>KH305919.1 Sequence 88 from patent US 9469857
NNNGTTTCCAN
>KH305918.1 Sequence 87 from patent US 9469857
NNNGTTTATCN
>KH305913.1 Sequence 81 from patent US 9469857
GCANNNNNTGC
>KH305911.1 Sequence 79 from patent US 9469857
CCNNNNNNNGG
>KH305910.1 Sequence 78 from patent US 9469857
GCTCTTCNNNN
>KH305908.1 Sequence 76 from patent US 9469857
GCTCTTCNNNN
>KH305890.1 Sequence 16 from patent US 9469857
NNNNGAAGAGC
>KH305888.1 Sequence 14 from patent US 9469857
CCANNNNNTGG
>KH305886.1 Sequence 12 from patent US 9469857
GCNNNNNNNGC
>KH305885.1 Sequence 11 from patent US 9469857
CCNNNNNNNGG
>KH305883.1 Sequence 9 from patent US 9469857
NNNNNGAGACC
>KH305881.1 Sequence 7 from patent US 9469857
GCCNNNNNGGC
>KH305880.1 Sequence 6 from patent US 9469857
NNNNNGAGACG
>KH293297.1 Sequence 10057 from patent US 9469685
GCAGCGCGTCC
>KH293282.1 Sequence 10042 from patent US 9469685
TCTTCACGCTC
>KH293279.1 Sequence 10039 from patent US 9469685
GGGGTTATCAG
>KH293239.1 Sequence 9999 from patent US 9469685
ACCTCCTCGGC
>KH293230.1 Sequence 9990 from patent US 9469685
TGTGCGAAAGA
>KH293228.1 Sequence 9988 from patent US 9469685
TGTACCACAGA
>KH293223.1 Sequence 9983 from patent US 9469685
TGTGCGAGAGA
>KH293221.1 Sequence 9981 from patent US 9469685
TGTACCACAGA
>KH293217.1 Sequence 9977 from patent US 9469685
TGTGCGAGAGA
>KH293215.1 Sequence 9975 from patent US 9469685
TGTGCGAAAGA
>KH293203.1 Sequence 9963 from patent US 9469685
TGTGCGAAGGA
>KH293197.1 Sequence 9957 from patent US 9469685
TGTGCGAAAGA
>KH293195.1 Sequence 9955 from patent US 9469685
TGTGCGCGAGA
>KH293189.1 Sequence 9949 from patent US 9469685
TGTGCGCCAGA
>KH293184.1 Sequence 9944 from patent US 9469685
TGTGCGACAGA
>KH293178.1 Sequence 9938 from patent US 9469685
TGTGCGAAAGA
>KH293174.1 Sequence 9934 from patent US 9469685
TGTACGAGAGA
>KH293170.1 Sequence 9930 from patent US 9469685
TGTACTAGAGA
>KH293168.1 Sequence 9928 from patent US 9469685
TGTGCGAGAGA
>KH291784.1 Sequence 7624 from patent US 9469685
TTGACTACTGG
>KH291751.1 Sequence 7591 from patent US 9469685
TTGACTCCTGG
>KH291726.1 Sequence 7566 from patent US 9469685
TTGACTCCTGG
>KH291688.1 Sequence 7528 from patent US 9469685
TTGACTCCTGG
>KH291683.1 Sequence 7523 from patent US 9469685
TTGCCTACTGG
>KH291673.1 Sequence 7513 from patent US 9469685
TTGACTACTGG
>KH291671.1 Sequence 7511 from patent US 9469685
TTGATTACTGG
>KH291660.1 Sequence 7500 from patent US 9469685
TTGACTCCTGG
>KH291657.1 Sequence 7497 from patent US 9469685
TTGACTATTGG
>KH291636.1 Sequence 7476 from patent US 9469685
TTGCCTACTGG
>KH291618.1 Sequence 7458 from patent US 9469685
TTGACTTTTGG
>KH291609.1 Sequence 7449 from patent US 9469685
GGATCGAAGAT
>KH291607.1 Sequence 7447 from patent US 9469685
AACGAAAACAA
>KH291604.1 Sequence 7444 from patent US 9469685
GGATCGAAGAT
>KH291603.1 Sequence 7443 from patent US 9469685
GGATCGAAGAT
>KH291598.1 Sequence 7438 from patent US 9469685
ATTCGCCTGGG
>KH291590.1 Sequence 7430 from patent US 9469685
TTCCAGTCCTC
>KH291580.1 Sequence 7420 from patent US 9469685
CTCCCCCCCCG
>KH291575.1 Sequence 7415 from patent US 9469685
CTGAGGTGCGA
>KH291571.1 Sequence 7411 from patent US 9469685
TGCGGAGGGGC
>KH291568.1 Sequence 7408 from patent US 9469685
CGGGAGGCAGT
>KH291566.1 Sequence 7406 from patent US 9469685
CCAACCCCCCG
>KH291550.1 Sequence 7390 from patent US 9469685
GTCCTTTTTCT
>KH291540.1 Sequence 7380 from patent US 9469685
GGTGATTTCGT
>KH291531.1 Sequence 7371 from patent US 9469685
TACGACACGAA
>KH291529.1 Sequence 7369 from patent US 9469685
GCAGTGGCTGG
>KH291527.1 Sequence 7367 from patent US 9469685
TTTGGAGTGGT
>KH291511.1 Sequence 7351 from patent US 9469685
GGTACGGTGGG
>KH291510.1 Sequence 7350 from patent US 9469685
ATCGTGGTCGT
>KH291499.1 Sequence 7339 from patent US 9469685
GCAGTGGCTGG
>KH291474.1 Sequence 7314 from patent US 9469685
GCGGTCAGTGG
>KH291461.1 Sequence 7301 from patent US 9469685
ACGGTGACTAC
>KH291455.1 Sequence 7295 from patent US 9469685
ATTACTATTAT
>KH291448.1 Sequence 7288 from patent US 9469685
TGGATACAGCT
>KH291441.1 Sequence 7281 from patent US 9469685
GCAGCTCGCCC
>KH291438.1 Sequence 7278 from patent US 9469685
TGACTGGCTAT
>KH291400.1 Sequence 7240 from patent US 9469685
TGGATGGGGGA
>KH291396.1 Sequence 7236 from patent US 9469685
CTAACTGGGGA
>KH291376.1 Sequence 7216 from patent US 9469685
CATTTTTGGAG
>KH291368.1 Sequence 7208 from patent US 9469685
GGGGGGAAGGC
>KH291362.1 Sequence 7202 from patent US 9469685
TAGGGACTGAG
>KH291361.1 Sequence 7201 from patent US 9469685
GATCCGACCCC
>KH291351.1 Sequence 7191 from patent US 9469685
AAGAGGGGTGG
>KH291327.1 Sequence 7167 from patent US 9469685
CACGGGGACCC
>KH291325.1 Sequence 7165 from patent US 9469685
CAGGCGATTGG
>KH291322.1 Sequence 7162 from patent US 9469685
CCTGAAGCACA
>KH291319.1 Sequence 7159 from patent US 9469685
GCCCCGAGAGG
>KH291318.1 Sequence 7158 from patent US 9469685
ATCAAGTGGAC
>KH291239.1 Sequence 7079 from patent US 9469685
CCCAACAGTCT
>KH291113.1 Sequence 6953 from patent US 9469685
TGTGCGAAAGA
>KH291108.1 Sequence 6948 from patent US 9469685
TGTGCGAGACA
>KH291105.1 Sequence 6945 from patent US 9469685
TGTGCGAGACA
>KH291102.1 Sequence 6942 from patent US 9469685
TGTGCGAGAGA
>KH291101.1 Sequence 6941 from patent US 9469685
TGTGCGAGACA
>KH291100.1 Sequence 6940 from patent US 9469685
TGTGCGAGAGA
>KH291096.1 Sequence 6936 from patent US 9469685
TGTGCGAGAGA
>KH291095.1 Sequence 6935 from patent US 9469685
TGTGCGAGAGA
>KH291094.1 Sequence 6934 from patent US 9469685
TGTGCGAGACA
>KH291093.1 Sequence 6933 from patent US 9469685
TGTGCGAGACA
>KH291092.1 Sequence 6932 from patent US 9469685
TGTGCGAGACA
>KH291091.1 Sequence 6931 from patent US 9469685
TGTGCGAGAGA
>KH291090.1 Sequence 6930 from patent US 9469685
TGTGCGAGACA
>KH291088.1 Sequence 6928 from patent US 9469685
TGTGCAAGAGA
>KH291085.1 Sequence 6925 from patent US 9469685
TGTGCGAGAGA
>KH291084.1 Sequence 6924 from patent US 9469685
TGTGCGAGAGA
>KH291083.1 Sequence 6923 from patent US 9469685
TGTGCGAGAGA
>KH291082.1 Sequence 6922 from patent US 9469685
TGTGCGAGAGA
>KH291080.1 Sequence 6920 from patent US 9469685
TGTGCGAGAGA
>KH291079.1 Sequence 6919 from patent US 9469685
TGTGCGAGACA
>KH291078.1 Sequence 6918 from patent US 9469685
TGTGGGAGACA
>KH291077.1 Sequence 6917 from patent US 9469685
TGTGCGAGAGA
>KH291070.1 Sequence 6910 from patent US 9469685
TGTGCGAGACA
>KH291069.1 Sequence 6909 from patent US 9469685
TGTGCGAGACA
>KH291068.1 Sequence 6908 from patent US 9469685
TGTGCGAGAGA
>KH291067.1 Sequence 6907 from patent US 9469685
TGTGTGAAAGA
>KH291065.1 Sequence 6905 from patent US 9469685
TGTGCAAGAGA
>KH291064.1 Sequence 6904 from patent US 9469685
TGTGCGAGAGA
>KH291063.1 Sequence 6903 from patent US 9469685
TGTGCGAGACA
>KH291062.1 Sequence 6902 from patent US 9469685
TGTGTAAGAGA
>KH291061.1 Sequence 6901 from patent US 9469685
TGTGCGGGACA
>KH291059.1 Sequence 6899 from patent US 9469685
TGTGCGAGAGA
>KH291058.1 Sequence 6898 from patent US 9469685
TGTGCGAAAGA
>KH291054.1 Sequence 6894 from patent US 9469685
TGTGCGAGAGA
>KH291053.1 Sequence 6893 from patent US 9469685
TGTGCGAGAGA
>KH291050.1 Sequence 6890 from patent US 9469685
TGTGCGAGAGA
>KH291049.1 Sequence 6889 from patent US 9469685
TGTGCGAGGGA
>KH291048.1 Sequence 6888 from patent US 9469685
TGTGCGAGAGA
>KH291047.1 Sequence 6887 from patent US 9469685
TGTGCGAGAGA
>KH291041.1 Sequence 6881 from patent US 9469685
TGTGCGAGAGA
>KH291040.1 Sequence 6880 from patent US 9469685
TGTACTAGAGA
>KH291039.1 Sequence 6879 from patent US 9469685
TGTGCGAGAGA
>KH291038.1 Sequence 6878 from patent US 9469685
TGTGCGAGAGA
>KH291037.1 Sequence 6877 from patent US 9469685
TGTACGAGAGA
>KH291036.1 Sequence 6876 from patent US 9469685
TGTGCAAAAGA
>KH291035.1 Sequence 6875 from patent US 9469685
TGTGCGAGAGA
>KH291034.1 Sequence 6874 from patent US 9469685
TGTGCGAAAGA
>KH291030.1 Sequence 6870 from patent US 9469685
TGTGCGAGAGA
>KH291026.1 Sequence 6866 from patent US 9469685
TGTGCAAAGGA
>KH291025.1 Sequence 6865 from patent US 9469685
TGTGCGAAAGA
>KH291023.1 Sequence 6863 from patent US 9469685
TGTGCGAAAGA
>KH291021.1 Sequence 6861 from patent US 9469685
TGTTCGAGAGA
>KH291019.1 Sequence 6859 from patent US 9469685
TGTGCGAGAGG
>KH291015.1 Sequence 6855 from patent US 9469685
TGTGCGAGAGA
>KH291014.1 Sequence 6854 from patent US 9469685
TGTGCGAGAGG
>KH291013.1 Sequence 6853 from patent US 9469685
TGTTTGAGAGA
>KH291012.1 Sequence 6852 from patent US 9469685
TGTGCGAGAGA
>KH291011.1 Sequence 6851 from patent US 9469685
TGTGGGAAAGA
>KH291010.1 Sequence 6850 from patent US 9469685
TGTGTGAGAGG
>KH289840.1 Sequence 5680 from patent US 9469685
GCAGCTTTGCT
>KH289735.1 Sequence 5575 from patent US 9469685
GCACTGTCTCT
>KH288771.1 Sequence 2197 from patent US 9469685
TTGACTACTGG
>KH288766.1 Sequence 2192 from patent US 9469685
TGTACACTTTT
>KH288763.1 Sequence 2189 from patent US 9469685
TTGACTATTGG
>KH288761.1 Sequence 2187 from patent US 9469685
TTGACTACTGG
>KH288756.1 Sequence 2182 from patent US 9469685
TTGACTCCTGG
>KH288750.1 Sequence 2176 from patent US 9469685
TTGGCTACTGG
>KH288744.1 Sequence 2170 from patent US 9469685
TTGACTACTGG
>KH288736.1 Sequence 2162 from patent US 9469685
TGTACACTTTT
>KH288732.1 Sequence 2158 from patent US 9469685
TTGACTCCTGG
>KH288731.1 Sequence 2157 from patent US 9469685
TTGCCTACTGG
>KH288709.1 Sequence 2135 from patent US 9469685
GACGGGTTGGG
>KH288704.1 Sequence 2130 from patent US 9469685
GCAGTGGCTGG
>KH288702.1 Sequence 2128 from patent US 9469685
GCAGTGGCTGG
>KH288690.1 Sequence 2116 from patent US 9469685
TAGGACGGGGG
>KH288689.1 Sequence 2115 from patent US 9469685
ACGAAGACTAC
>KH288682.1 Sequence 2108 from patent US 9469685
TGGAGGAGTAT
>KH288677.1 Sequence 2103 from patent US 9469685
GAGGTGGCTAC
>KH288665.1 Sequence 2091 from patent US 9469685
CTACGCTGACT
>KH288664.1 Sequence 2090 from patent US 9469685
CTAGGCCTGAC
>KH288655.1 Sequence 2081 from patent US 9469685
CAAGGGGACCC
>KH288602.1 Sequence 2028 from patent US 9469685
TGTGCGAGAGA
>KH288600.1 Sequence 2026 from patent US 9469685
TGTGCGAGAGA
>KH288586.1 Sequence 2012 from patent US 9469685
TGTGCGAGAGA
>KH288580.1 Sequence 2006 from patent US 9469685
TGTGCGAGAGA
>KH288578.1 Sequence 2004 from patent US 9469685
TGTGCGAGAGA
>KH288576.1 Sequence 2002 from patent US 9469685
TGTGCCAGAGA
>KH288573.1 Sequence 1999 from patent US 9469685
TGTGCGAGAGA
>KH288562.1 Sequence 1988 from patent US 9469685
TGTGCGAGAGA
>KH288559.1 Sequence 1985 from patent US 9469685
TGTGCGAGAGG
>KH288557.1 Sequence 1983 from patent US 9469685
TGTGCGAGAGA
>KH288553.1 Sequence 1979 from patent US 9469685
TGTGCGAGAGA
>KH288551.1 Sequence 1977 from patent US 9469685
TGTGCGAGACA
>KH288548.1 Sequence 1974 from patent US 9469685
TGTGTAAAAGA
>KH288544.1 Sequence 1970 from patent US 9469685
TGTGCGAGAGA
>KH288542.1 Sequence 1968 from patent US 9469685
TGTGTGAGAGA
>KH288538.1 Sequence 1964 from patent US 9469685
TGTGTGAGAGA
>KH288536.1 Sequence 1962 from patent US 9469685
TGTGCGAGAGA
>KH278377.1 Sequence 5 from patent US 9458500
GTGCAGATCTG
>KH277508.1 Sequence 12 from patent US 9458458
ACACCAATGCC
>KH277507.1 Sequence 11 from patent US 9458458
TAGGGGATGCG
>KH272755.1 Sequence 21 from patent US 9458215
GCCCACCATGG
>KH272493.1 Sequence 87 from patent US 9458205
ACTGGGNNNNN
>KH272492.1 Sequence 85 from patent US 9458205
TTGACTATCCT
>KH272491.1 Sequence 84 from patent US 9458205
TTGACGATCCT
>KH272490.1 Sequence 83 from patent US 9458205
TTGACCATCCT
>KH272489.1 Sequence 82 from patent US 9458205
TTGACAATCCT
>KH272244.1 Sequence 148 from patent US 9457053
ACGCCGTCATT
>KH199706.1 Sequence 21 from patent US 9447465
CTTCTCCGTCG
>KH199692.1 Sequence 7 from patent US 9447465
CTTCTCCGTCG
>KH199686.1 Sequence 1 from patent US 9447465
TCCATGCAAGC
>KH179199.1 Sequence 5 from patent US 9441277
CCCCATCCCAC
>KH175679.1 Sequence 53 from patent US 9441275
TTTTTTTTTTT
>KH173190.1 Sequence 32 from patent US 9441221
CAGGTAAGTAT
>KH171971.1 Sequence 5686 from patent US 9441016
GAGCTAATAAA
>KH171945.1 Sequence 5660 from patent US 9441016
TTTACTTCCTC
>KH171776.1 Sequence 5484 from patent US 9441016
TTATAACACCT
>KH171651.1 Sequence 5352 from patent US 9441016
TAGGATAAGAA
>KH171485.1 Sequence 5174 from patent US 9441016
GAATAGCTATC
>KH171398.1 Sequence 5084 from patent US 9441016
TATATCTACTC
>KH171268.1 Sequence 4949 from patent US 9441016
ATTATTTGAGC
>KH171100.1 Sequence 4772 from patent US 9441016
ATTTTCACAAC
>KH171021.1 Sequence 4692 from patent US 9441016
GATTATCACCT
>KH170928.1 Sequence 4596 from patent US 9441016
AAAATTCCTCC
>KH170862.1 Sequence 4526 from patent US 9441016
AATATTCCTCC
>KH170738.1 Sequence 4398 from patent US 9441016
CCGTGATTAAT
>KH170565.1 Sequence 4221 from patent US 9441016
GGTGATTAACT
>KH170527.1 Sequence 4182 from patent US 9441016
GCGGTGGTATC
>KH170526.1 Sequence 4181 from patent US 9441016
GAGGAATTGAC
>KH170325.1 Sequence 3969 from patent US 9441016
GAGGATGAATT
>KH170307.1 Sequence 3950 from patent US 9441016
AATTGGAAGAT
>KH170210.1 Sequence 3848 from patent US 9441016
AATTAATTAAA
>KH170140.1 Sequence 3775 from patent US 9441016
AGGGTGAAAAT
>KH170105.1 Sequence 3738 from patent US 9441016
AAGCTTGTAGC
>KH170064.1 Sequence 3696 from patent US 9441016
CTTATTTTCAC
>KH169978.1 Sequence 3606 from patent US 9441016
ATTTATTATTT
>KH169973.1 Sequence 3601 from patent US 9441016
GAGTGTTTAGT
>KH169941.1 Sequence 3567 from patent US 9441016
TTTTGATTTGT
>KH169930.1 Sequence 3556 from patent US 9441016
TTTTGATTTGT
>KH169885.1 Sequence 3508 from patent US 9441016
AAAATTAGAAC
>KH169878.1 Sequence 3499 from patent US 9441016
GAGTTGAATAT
>KH169876.1 Sequence 3495 from patent US 9441016
GGAGAATTTTT
>KH169865.1 Sequence 3483 from patent US 9441016
AAGGTGAGAAT
>KH169789.1 Sequence 3395 from patent US 9441016
AATAAAATTTT
>KH169733.1 Sequence 3338 from patent US 9441016
TTGTGAATCAG
>KH169677.1 Sequence 3280 from patent US 9441016
TTCGACCAATT
>KH169481.1 Sequence 3078 from patent US 9441016
GATTTTTAATC
>KH169284.1 Sequence 2881 from patent US 9441016
TAGTGAAACTA
>KH169254.1 Sequence 2851 from patent US 9441016
CTCTTTTAGAG
>KH169142.1 Sequence 2739 from patent US 9441016
TTTTATAAAAA
>KH169008.1 Sequence 2605 from patent US 9441016
TTAAAATTTAA
>KH168860.1 Sequence 2457 from patent US 9441016
TTTATCATAAA
>KH168644.1 Sequence 2241 from patent US 9441016
TTTATTTTAAA
>KH168559.1 Sequence 2156 from patent US 9441016
CTTTTAAAAAG
>KH168405.1 Sequence 2002 from patent US 9441016
TATTTTTAATA
>KH168395.1 Sequence 1992 from patent US 9441016
CTATGGAATAG
>KH168391.1 Sequence 1988 from patent US 9441016
TCCTTAAAGGG
>KH168275.1 Sequence 1872 from patent US 9441016
TAGTTTTACTA
>KH168235.1 Sequence 1832 from patent US 9441016
GATTTACAATC
>KH152745.1 Sequence 323 from patent US 9434988
ACTGGACCTGA
>KH152386.1 Sequence 7 from patent US 9434981
CTTACCTCAGC
>KH151260.1 Sequence 242 from patent US 9434966
CAATNTCTNCK
>KH151250.1 Sequence 232 from patent US 9434966
CRSGCYWGKGC
>KH151245.1 Sequence 227 from patent US 9434966
GNCCSARTNGC
>KH151225.1 Sequence 207 from patent US 9434966
CAYAMRTGYNC
>KH151206.1 Sequence 188 from patent US 9434966
GCCAGACCTAC
>KH151192.1 Sequence 174 from patent US 9434966
CYNNGGSSANC
>KH151189.1 Sequence 171 from patent US 9434966
ARRARAAAGGN
>KH151161.1 Sequence 143 from patent US 9434966
TTTYCACATGC
>KH151158.1 Sequence 140 from patent US 9434966
AAANGGNARAM
>KH151155.1 Sequence 137 from patent US 9434966
YKNTTTWYYTC
>KH151150.1 Sequence 132 from patent US 9434966
GNGCCRSNNTM
>KH151135.1 Sequence 117 from patent US 9434966
TTKTTTTYTTC
>KH122410.1 Sequence 69 from patent US 9433687
CGTGGGAAAAT
>LV465494.1 JP 2016536698-A/11: METHODS AND SYSTEMS FOR ALIGNING SEQUENCES
TTGGATATGGG
>LF951370.1 JP 2016220687-A/98: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TATGCTAGTAA
>LF951357.1 JP 2016220687-A/85: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCACTCATACA
>LF951356.1 JP 2016220687-A/84: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TATAGACATCA
>LF951355.1 JP 2016220687-A/83: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TAGCTCTATCA
>LF951354.1 JP 2016220687-A/82: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CTCTACGCTCA
>LF951347.1 JP 2016220687-A/75: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCACGCGAGAA
>LF951346.1 JP 2016220687-A/74: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CTACGCTCTAA
>LF951345.1 JP 2016220687-A/73: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGCGTATACAA
>LF951344.1 JP 2016220687-A/72: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGATCGTATAA
>LF951325.1 JP 2016220687-A/53: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGCAGTACGAA
>LF951324.1 JP 2016220687-A/52: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACTAGCAGTAA
>LF951303.1 JP 2016220687-A/31: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACGACAGCTCA
>LF951302.1 JP 2016220687-A/30: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGTCGTCGCAA
>LF951301.1 JP 2016220687-A/29: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGTAGTGTGAA
>LF951300.1 JP 2016220687-A/28: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGAGTCAGTAA
>LF951299.1 JP 2016220687-A/27: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCGCTGCGTAA
>LF951298.1 JP 2016220687-A/26: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCGATAGTGAA
>LF951297.1 JP 2016220687-A/25: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
AGCTCACGTAA
>LF951296.1 JP 2016220687-A/24: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACAGTATATAA
>LF951295.1 JP 2016220687-A/23: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGTGAGTAGTA
>LF951294.1 JP 2016220687-A/22: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCTAGCGACTA
>LF951293.1 JP 2016220687-A/21: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TAGTGTAGATA
>LF951292.1 JP 2016220687-A/20: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CTACGACTGCA
>LF951291.1 JP 2016220687-A/19: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGTCGATCTCA
>LF951290.1 JP 2016220687-A/18: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGAGACGCGCA
>LF951289.1 JP 2016220687-A/17: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CATACTCTACA
>LF951288.1 JP 2016220687-A/16: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CACGTGTCGCA
>LF951287.1 JP 2016220687-A/15: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ATCTACTGACA
>LF951286.1 JP 2016220687-A/14: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ATAGATAGACA
>LF951285.1 JP 2016220687-A/13: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
AGTAGTGATCA
>LF951284.1 JP 2016220687-A/12: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
AGAGCGTCACA
>LF951283.1 JP 2016220687-A/11: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACTCATCTACA
>LF951282.1 JP 2016220687-A/10: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACGTCTCATCA
>LF948525.1 JP 2016220679-A/1: VESICULAR STOMATITIS VIRUSES
TATGAAAAAAA
>LF954412.1 JP 2016533749-A/27: COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA
ACGGGTAGGAC
>LF954390.1 JP 2016533749-A/5: COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA
TTAAGAAAAAA
>HL998132.1 Sequence 9 from patent US 9453239
AGCCCGGGACC
>HL997829.1 Sequence 89 from patent US 9453232
GCTCTTCNNNN
>HL997816.1 Sequence 47 from patent US 9453232
CGTCTCNNNNN
>HL997813.1 Sequence 42 from patent US 9453232
CGTCTCNNNNN
>HL997807.1 Sequence 29 from patent US 9453232
GACNNNNNGTC
>HL997775.1 Sequence 97 from patent US 9453228
TCTGACNTTCT
>HL997774.1 Sequence 95 from patent US 9453228
TCTGACNTTCT
>HL997773.1 Sequence 94 from patent US 9453228
TCTGTCNTTCT
>HL997772.1 Sequence 93 from patent US 9453228
TCTGTCGTTCT
>HL997769.1 Sequence 90 from patent US 9453228
TCTGACNTTCT
>HL997768.1 Sequence 89 from patent US 9453228
TCTCTGACGTT
>HL997767.1 Sequence 88 from patent US 9453228
TCTGACNTTCT
>HL997766.1 Sequence 87 from patent US 9453228
TCTGACNTTCT
>HL997765.1 Sequence 86 from patent US 9453228
TCTGACGTTCT
>HL997764.1 Sequence 85 from patent US 9453228
ACGTTCTCTGT
>HL997762.1 Sequence 83 from patent US 9453228
CTATCTGACGT
>HL997758.1 Sequence 79 from patent US 9453228
ACGTTCTCTGT
>HL997749.1 Sequence 70 from patent US 9453228
CTATCTAGCGT
>HL997740.1 Sequence 61 from patent US 9453228
CTATCTAGCGT
>HL997737.1 Sequence 58 from patent US 9453228
CTATCTGACGT
>HL997732.1 Sequence 52 from patent US 9453228
CCTACTAGCGT
>HL997707.1 Sequence 23 from patent US 9453228
ACGTTCTCTGT
>HL997705.1 Sequence 21 from patent US 9453228
TCTGACGTTCT
>HL997701.1 Sequence 11 from patent US 9453228
TCAACCACACA
>HL997693.1 Sequence 3 from patent US 9453228
TCTGACNTTCT
>HL996928.1 Sequence 347 from patent US 9453224
TCTCCAAAAGG
>HL996925.1 Sequence 344 from patent US 9453224
ACTCAAAATGG
>HL996924.1 Sequence 343 from patent US 9453224
AATCACTAACC
>HL996921.1 Sequence 340 from patent US 9453224
AGGGCTTAGCT
>HL996901.1 Sequence 320 from patent US 9453224
ATGCATTCTCT
>HL996900.1 Sequence 319 from patent US 9453224
ATGCATTCTGT
>HL996899.1 Sequence 318 from patent US 9453224
AAGTATCCTTT
>HL996833.1 Sequence 248 from patent US 9453224
CTGCAAACACT
>HL996832.1 Sequence 247 from patent US 9453224
CAGAACACATT
>HL996831.1 Sequence 246 from patent US 9453224
CAGCAAGCACT
>HL996810.1 Sequence 225 from patent US 9453224
AGCGGGAAGGT
>HL996769.1 Sequence 184 from patent US 9453224
TTCCCATTCTC
>HL996768.1 Sequence 183 from patent US 9453224
TTCCCTTGCTC
>HL996767.1 Sequence 182 from patent US 9453224
TCCCCTCTGTC
>HL996766.1 Sequence 181 from patent US 9453224
TTCCCTATCTC
>HL996758.1 Sequence 173 from patent US 9453224
TTTGTGCAAAT
>HL996757.1 Sequence 172 from patent US 9453224
TGTGTGGATAA
>HL996742.1 Sequence 156 from patent US 9453224
CTCCTTTCCTT
>HL996741.1 Sequence 155 from patent US 9453224
CTCTTTGCCCC
>HL996740.1 Sequence 154 from patent US 9453224
TTCCTTTCCCT
>HL996739.1 Sequence 153 from patent US 9453224
CTATTTTCCGT
>HL996738.1 Sequence 152 from patent US 9453224
CTTTTTCCCCT
>HL996737.1 Sequence 151 from patent US 9453224
CTCTTTTTCCC
>HL996736.1 Sequence 150 from patent US 9453224
CTCTCTTCACT
>HL996735.1 Sequence 149 from patent US 9453224
CTCTTTTCAGT
>HL996734.1 Sequence 148 from patent US 9453224
TTATTTTCCCT
>HL996719.1 Sequence 133 from patent US 9453224
AATCATGTGCC
>HL996718.1 Sequence 132 from patent US 9453224
ACTCCTGACCT
>HL996717.1 Sequence 131 from patent US 9453224
ACTGATAAGCT
>HL996716.1 Sequence 130 from patent US 9453224
ACTCCTGGGCT
>HL996687.1 Sequence 101 from patent US 9453224
GGTTCTTCAGC
>HL996686.1 Sequence 100 from patent US 9453224
AATTCTTCAGG
>HL996685.1 Sequence 99 from patent US 9453224
AGTTCTTCACA
>HL996658.1 Sequence 72 from patent US 9453224
CAGCAAGCACT
>HL996636.1 Sequence 49 from patent US 9453224
AGTTCTTCACA
>HL996634.1 Sequence 46 from patent US 9453224
TTCCCTATCTC
>HL996626.1 Sequence 38 from patent US 9453224
TTATTTTCCCT
>HL996624.1 Sequence 36 from patent US 9453224
AAGTATCCTTT
>HL996276.1 Sequence 26 from patent US 9453219
WTCCAAGGGGG
>HL996026.1 Sequence 38 from patent US 9453213
CCGTTAAATTT
>HL996025.1 Sequence 37 from patent US 9453213
GTACTAAAACC
>HL994477.1 Sequence 36 from patent US 9452219
GCGGTTTGCGG
>HL994463.1 Sequence 20 from patent US 9452219
GGTGGTGGTGG
>LF860780.1 JP 2015146813-A/6: CELLULAR ASSAY EMPLOYING DETECTABLE PROTEIN
GGGAAATTCCC
>LF858409.1 JP 2015180206-A/16: Methods and Devices Based upon a Novel Form of Nucleic Acid Duplex on a Surface
GCCCACTACAG
>LF858408.1 JP 2015180206-A/15: Methods and Devices Based upon a Novel Form of Nucleic Acid Duplex on a Surface
CGCCCACTACA
>LF854303.1 JP 2015126746-A/652: Albumin Fusion Proteins
CCGCCACCATG
>LF851589.1 JP 2015119735-A/7: Recombinant influenza viruses for vaccines and gene therapy
TATTAGTAGAA
>LF945128.1 JP 2016531845-A/1438: METHODS AND COMPOSITIONS FOR SYNTHESIZING IMPROVED SILK FIBERS
GGTACGTCTTC
>LF941345.1 JP 2016531569-A/216: NUCLEASE PROFILING SYSTEM
ACATCACAGGG
>LF940897.1 JP 2016532689-A/912: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATGAATCTA
>LF940896.1 JP 2016532689-A/911: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTCTTCATTA
>LF940895.1 JP 2016532689-A/910: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATCTACATA
>LF940894.1 JP 2016532689-A/909: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATACATCTA
>LF940893.1 JP 2016532689-A/908: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATAGTGATT
>LF940892.1 JP 2016532689-A/907: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTTGATGATA
>LF940891.1 JP 2016532689-A/906: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATAGAGAAG
>LF940890.1 JP 2016532689-A/905: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTAATAAGGT
>LF940889.1 JP 2016532689-A/904: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATAATGGAT
>LF940888.1 JP 2016532689-A/903: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTAATTAGGAT
>LF940887.1 JP 2016532689-A/902: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTAATTGAGTA
>LF940886.1 JP 2016532689-A/901: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTTAGGTAAA
>LF940885.1 JP 2016532689-A/900: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATGAATCTA
>LF940884.1 JP 2016532689-A/899: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTCTTCATTA
>LF940882.1 JP 2016532689-A/897: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATCTACATA
>LF940881.1 JP 2016532689-A/896: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATACATCTA
>LF935070.1 JP 2016192940-A/1: A probe for detecting CYP3A4*1b and a probe for detecting CYP3A5*3
GGGCARGAGAG
>LF935016.1 JP 2016189726-A/25: Primers and methods for detecting Streptococcus uberis
ATACGAGGCTG
>HL981821.1 Sequence 68 from patent US 9428749
TGTTCGTCTTA
>HL981820.1 Sequence 67 from patent US 9428749
TGTTCGTCTTA
>HL981819.1 Sequence 66 from patent US 9428749
TGCTCGTCTTA
>HL981818.1 Sequence 65 from patent US 9428749
TGCTCGTCTTA
>HL981770.1 Sequence 17 from patent US 9428749
TGCACGTCTTA
>HL981769.1 Sequence 16 from patent US 9428749
TGCACGTCTTA
>HL981768.1 Sequence 15 from patent US 9428749
TGCTCGTCTTA
>HL981767.1 Sequence 14 from patent US 9428749
TGCTCGTCTTA
>HL981755.1 Sequence 2 from patent US 9428749
TGTTCGTCTTA
>HL981754.1 Sequence 1 from patent US 9428749
TGCTCGTCTTA
>HL981625.1 Sequence 1 from patent US 9428736
TATGAAAAAAA
>HL981591.1 Sequence 8 from patent US 9428586
GTAAGAAATGA
>HL980172.1 Sequence 87 from patent US 9422599
ATCTTCCTCGC
>HL980171.1 Sequence 86 from patent US 9422599
AGCTTCCTGTA
>HL980170.1 Sequence 85 from patent US 9422599
TTCTTCCTATG
>HL980169.1 Sequence 84 from patent US 9422599
CCATTCCTAGG
>HL980168.1 Sequence 83 from patent US 9422599
AACTTCCTGTC
>HL980167.1 Sequence 82 from patent US 9422599
GCTCTCCTCGG
>HL980166.1 Sequence 81 from patent US 9422599
GCTCTCCTCCC
>HL980165.1 Sequence 80 from patent US 9422599
AACCTCCTCTC
>HL980164.1 Sequence 79 from patent US 9422599
GGTCTCCTAAA
>HL980163.1 Sequence 78 from patent US 9422599
AGTCTCCTTTC
>HL980162.1 Sequence 77 from patent US 9422599
ATGCTCCTACA
>HL980161.1 Sequence 76 from patent US 9422599
TGGCTCCTACC
>HL980160.1 Sequence 75 from patent US 9422599
ACGCTCCTGCT
>HL980137.1 Sequence 52 from patent US 9422599
CCTCGAGCGAC
>HL980136.1 Sequence 51 from patent US 9422599
AATCGAGCTGT
>HL979388.1 Sequence 136 from patent US 9422582
GTTTAAACAGT
>HL978756.1 Sequence 136 from patent US 9422581
GTTTAAACAGT
>HL978215.1 Sequence 104 from patent US 9422564
TCGAACGTTCG
>HL977009.1 Sequence 46 from patent US 9422559
WTCCAAGGGGG
>HL966314.1 Sequence 69 from patent US 9421255
GGGTTTTTGGG
>HL966304.1 Sequence 58 from patent US 9421255
GGTTTTTTTGG
>HL993649.1 Sequence 12 from patent US 9429561
AATCGCCGTTT
>HL993612.1 Sequence 5 from patent US 9429518
CTGATAGACGT
>HL964957.1 Sequence 31 from patent US 9416402
GGCAATGTGAT
>HL952728.1 Sequence 10 from patent US 9410201
AAATTCCGGCA
>HL952727.1 Sequence 9 from patent US 9410201
GGATCAAGCTA
>HL952726.1 Sequence 8 from patent US 9410201
ATCCTTTAAGC
>HL952120.1 Sequence 35 from patent US 9410193
TCTCCTTCCTC
>HL952118.1 Sequence 33 from patent US 9410193
TCTCCTTCCTC
>HL952117.1 Sequence 32 from patent US 9410193
TCTCCTTCCTC
>HL944603.1 Sequence 3 from patent US 9404156
CCCCCCCCCCC
>HL944600.1 Sequence 8 from patent US 9404154
GNGNGCNNNAG
>HL944596.1 Sequence 4 from patent US 9404154
CNGNCTNNNAC
>HL943358.1 Sequence 20 from patent US 9404112
CTAACCCTAAC
>HL943353.1 Sequence 13 from patent US 9404112
GTTAGGGTTAG
>HL943346.1 Sequence 6 from patent US 9404112
GTGGAAGGCGG
>HL942000.1 Sequence 718 from patent US 9403904
CTAACTGGGGA
>HL940327.1 Sequence 214 from patent US 9399800
GCCGCCTGAAA
>HL935951.1 Sequence 14 from patent US 9399649
ATAATTCCCCC
>HL935373.1 Sequence 43 from patent US 9395356
CCCTTAAGGGC
>HL934115.1 Sequence 46 from patent US 9394538
WTCCAAGGGGG
>HL932799.1 Sequence 77 from patent US 9394323
CATCTTTAAAT
>HL932798.1 Sequence 76 from patent US 9394323
GTTAGAAGACT
>HL930654.1 Sequence 10113 from patent US 9392790
GTTCCCACGTT
>HL930651.1 Sequence 10110 from patent US 9392790
GTTGGCCCATT
>HL930648.1 Sequence 10107 from patent US 9392790
GTTGGTACATT
>HL930645.1 Sequence 10104 from patent US 9392790
GTTGGCACGTT
>HL920588.1 Sequence 11 from patent US 9390226
TTGGATATGGG
>HL920328.1 Sequence 38 from patent US 9388473
CGGGCGCTGGT
>HL917683.1 Sequence 20 from patent US 9388416
CTAACCCTAAC
>HL917678.1 Sequence 13 from patent US 9388416
GTTAGGGTTAG
>HL917671.1 Sequence 6 from patent US 9388416
GTGGAAGGCGG
>HL917664.1 Sequence 20 from patent US 9388415
CTAACCCTAAC
>HL917659.1 Sequence 13 from patent US 9388415
GTTAGGGTTAG
>HL917652.1 Sequence 6 from patent US 9388415
GTGGAAGGCGG
>HL916188.1 Sequence 3 from patent US 9388407
NNNNNNAGTAC
>HL913931.1 Sequence 111 from patent US 9382586
GGCGGNCGGCG
>HL913913.1 Sequence 93 from patent US 9382586
CGCCGNCCGCC
>HL905013.1 Sequence 500 from patent US 9382535
CCTNNNNNAGG
>HL905012.1 Sequence 499 from patent US 9382535
CGTCTCNNNNN
>HL904998.1 Sequence 485 from patent US 9382535
ACCTGCNNNNN
>HL904997.1 Sequence 484 from patent US 9382535
NNNNNNGACTC
>HL904994.1 Sequence 481 from patent US 9382535
NNNNNNGAGAC
>HL904993.1 Sequence 480 from patent US 9382535
GAGTCNNNNNN
>HL904991.1 Sequence 478 from patent US 9382535
GCNNNNNNNGC
>HL904982.1 Sequence 469 from patent US 9382535
CCTCNNNNNNN
>HL904974.1 Sequence 461 from patent US 9382535
CCCGCNNNNNN
>HL904968.1 Sequence 455 from patent US 9382535
GCATCNNNNNN
>HL904966.1 Sequence 453 from patent US 9382535
ACTGGGNNNNN
>HL904954.1 Sequence 441 from patent US 9382535
GCCNNNNNGGC
>HL904953.1 Sequence 440 from patent US 9382535
GGTCTCNNNNN
>HL904952.1 Sequence 439 from patent US 9382535
GACNNNNNGTC
>HL904947.1 Sequence 434 from patent US 9382535
CCANNNNNTGG
>HL904946.1 Sequence 433 from patent US 9382535
GCANNNNNTGC
>HL904222.1 Sequence 24 from patent US 9382518
CTGGAAAATAT
>HL903671.1 Sequence 89 from patent US 9382299
TAATGACCGGT
>HL903263.1 Sequence 321 from patent US 9381208
CAAGTTTCGAG
>HL902087.1 Sequence 37 from patent US 9376702
CGACTTACGAA
>HL897564.1 Sequence 21 from patent US 9375485
CTAACCCTAAC
>HL897559.1 Sequence 16 from patent US 9375485
GTTAGGGTTAG
>HL897558.1 Sequence 15 from patent US 9375485
TAGGGTTAGAC
>HL897550.1 Sequence 7 from patent US 9375485
GTGGAAGGCGG
>HL897232.1 Sequence 1339 from patent US 9371570
CCATCCTTGTC
>HL897230.1 Sequence 1337 from patent US 9371570
GAGGAGGCAGT
>HL871256.1 Sequence 95 from patent US 9371531
GCCNNNNNGGC
>HL871255.1 Sequence 94 from patent US 9371531
GCTCTTCNNNN
>HL871250.1 Sequence 88 from patent US 9371531
NNNGTTTCCAN
>HL871249.1 Sequence 87 from patent US 9371531
NNNGTTTATCN
>HL871244.1 Sequence 81 from patent US 9371531
GCANNNNNTGC
>HL871242.1 Sequence 79 from patent US 9371531
CCNNNNNNNGG
>HL871241.1 Sequence 78 from patent US 9371531
GCTCTTCNNNN
>HL871239.1 Sequence 76 from patent US 9371531
GCTCTTCNNNN
>HL871221.1 Sequence 16 from patent US 9371531
NNNNGAAGAGC
>HL871219.1 Sequence 14 from patent US 9371531
CCANNNNNTGG
>HL871217.1 Sequence 12 from patent US 9371531
GCNNNNNNNGC
>HL871216.1 Sequence 11 from patent US 9371531
CCNNNNNNNGG
>HL871214.1 Sequence 9 from patent US 9371531
NNNNNGAGACC
>HL871212.1 Sequence 7 from patent US 9371531
GCCNNNNNGGC
>HL871211.1 Sequence 6 from patent US 9371531
NNNNNGAGACG
>HL868385.1 Sequence 43 from patent US 9366667
CCCTTAAGGGC
>HL862515.1 Sequence 91 from patent US 9365838
TTTTTTGAAAT
>HL862514.1 Sequence 90 from patent US 9365838
CCCCCCGAAAT
>HL856765.1 Sequence 17 from patent US 9364495
ATTGTCACACT
>HL856753.1 Sequence 5 from patent US 9364495
TGTCACACTCC
>HL855907.1 Sequence 6 from patent US 9359643
AGTAATCATAC
>HL855906.1 Sequence 5 from patent US 9359643
ACTAATGATAC
>HL855905.1 Sequence 4 from patent US 9359643
ACTAATCATAC
>HL855903.1 Sequence 2 from patent US 9359643
ASTAATSATAC
>HL855598.1 Sequence 276 from patent US 9359636
CCCTAAGGCTT
>HL855566.1 Sequence 244 from patent US 9359636
CGCTGTGTTCC
>HL855551.1 Sequence 229 from patent US 9359636
CCTCTGCAGTG
>HL855546.1 Sequence 224 from patent US 9359636
GGGCAAGAGGG
>HL855541.1 Sequence 219 from patent US 9359636
AAGCCTTAGGG
>HL855509.1 Sequence 187 from patent US 9359636
GGAACACAGCG
>HL855494.1 Sequence 172 from patent US 9359636
CACTGCAGAGG
>HL855489.1 Sequence 167 from patent US 9359636
CCCTCTTGCCC
>HL847375.1 Sequence 4765 from patent US 9354228
CTAACTGGGGA
>HL841344.1 Sequence 29 from patent US 9353370
AAAGAGATGGC
>HL833715.1 Sequence 26 from patent US 9351951
GTGATACAGCA
>HL833714.1 Sequence 24 from patent US 9351951
GCGATTCTCCA
>HL833713.1 Sequence 23 from patent US 9351951
GTGATTCTCCA
>HL833712.1 Sequence 22 from patent US 9351951
GTGATACTGCA
>HL833711.1 Sequence 21 from patent US 9351951
GTGATACTGCA
>HL833710.1 Sequence 20 from patent US 9351951
GTGATACTGCA
>HL833709.1 Sequence 19 from patent US 9351951
GTGATACTGCA
>HL833708.1 Sequence 18 from patent US 9351951
GTGACTCAGCA
>HL833693.1 Sequence 3 from patent US 9351951
ATGACTAAGCC
>HL833692.1 Sequence 2 from patent US 9351951
ATGAGTTTGCC
>HL833691.1 Sequence 1 from patent US 9351951
GTGATACTGCA
>HL832540.1 Sequence 80 from patent US 9347095
TAGCTACCGAG
>HL832539.1 Sequence 79 from patent US 9347095
TAGCTACTGAG
>HL832538.1 Sequence 78 from patent US 9347095
TAGCTACTGTG
>HL832531.1 Sequence 71 from patent US 9347095
TAGCTACATAG
>HL832530.1 Sequence 70 from patent US 9347095
TAGCTACACAG
>HL832529.1 Sequence 69 from patent US 9347095
TAGCTACACTG
>HL831915.1 Sequence 175 from patent US 9347064
TCTNNCNTTCT
>HL831914.1 Sequence 174 from patent US 9347064
TCTNNCNTTCT
>HL831913.1 Sequence 173 from patent US 9347064
TCTNNCGTTCT
>HL831912.1 Sequence 172 from patent US 9347064
TCTCTGACGTT
>HL831911.1 Sequence 171 from patent US 9347064
TCTNNCNTTCT
>HL831910.1 Sequence 170 from patent US 9347064
TCTNNCNTTCT
>HL831909.1 Sequence 169 from patent US 9347064
TCTNNCGTTCT
>HL831717.1 Sequence 4 from patent US 9347063
TCTTGTTCTCC
>HL831716.1 Sequence 2 from patent US 9347063
GGAGAACAAGA
>LG169086.1 KR 1020160007541-A/13: DNA BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF
AATTTGTCGAT
>LG228104.1 KR 1020160044457-A/375: DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
CCNNNNNNNGG
>LG227635.1 KR 1020160056869-A/465: DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING VIRAL COMPONENTS
CCNNNNNNNGG
>LG166829.1 KR 1020150140703-A/20: MODIFIED TGF-BETA2 OLIGONUCLEOTIDES
AGTATTTGGTC
>LG166808.1 KR 1020150140702-A/416: MODIFIED TGF-BETA OLIGONUCLEOTIDE FOR USE IN A METHOD OF PREVENTING AND/OR TREATING AN OPHTHALMIC DISEASE
AGTATTTGGTC
>LG253600.1 KR 1020160062127-A/11: METHODS AND SYSTEM FOR DETECTING SEQUENCE VARIANTS
TTGGATATGGG
>LG227059.1 KR 1020160030187-A/782: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CCNNNNNNNGG
>LG165914.1 KR 1020160002819-A/19: METHOD FOR PRODUCING PROTEIN
GAGNNNNNACV
>LG226119.1 KR 1020160034901-A/290: OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
CCNNNNNNNGG
>LG225531.1 KR 1020160019553-A/464: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCNNNNNNNGG
>LG162863.1 KR 1020160010398-A/6: CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES
GGGATCCTACC
>LG247873.1 KR 1020160047570-A/41: COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA
ACGGGTAGGAC
>LG247851.1 KR 1020160047570-A/13: COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA
TTAAGAAAAAA
>LG241766.1 KR 1020160036065-A/581: COMPOSITIONS AND METHODS FOR MODULATING RNA
CTCCGCCCTCC
>LG241762.1 KR 1020160036065-A/577: COMPOSITIONS AND METHODS FOR MODULATING RNA
CCGCCCTCCAG
>LG241746.1 KR 1020160036065-A/561: COMPOSITIONS AND METHODS FOR MODULATING RNA
CAAAAGCAGGA
>LG241744.1 KR 1020160036065-A/559: COMPOSITIONS AND METHODS FOR MODULATING RNA
CCTCAAAAGCA
>LG241729.1 KR 1020160036065-A/544: COMPOSITIONS AND METHODS FOR MODULATING RNA
GCTCTCCGACA
>LG241726.1 KR 1020160036065-A/541: COMPOSITIONS AND METHODS FOR MODULATING RNA
TCCGACAGTCT
>LG241721.1 KR 1020160036065-A/536: COMPOSITIONS AND METHODS FOR MODULATING RNA
CAGTCTGGGTG
>LG241671.1 KR 1020160036065-A/486: COMPOSITIONS AND METHODS FOR MODULATING RNA
GACCCCTGGTG
>LG241669.1 KR 1020160036065-A/484: COMPOSITIONS AND METHODS FOR MODULATING RNA
CACTGGCCGCA
>LG241666.1 KR 1020160036065-A/481: COMPOSITIONS AND METHODS FOR MODULATING RNA
CTCCGCCCTCC
>LG241662.1 KR 1020160036065-A/477: COMPOSITIONS AND METHODS FOR MODULATING RNA
CCGCCCTCCAG
>LG239866.1 KR 1020160036061-A/217: NUCLEASE PROFILING SYSTEM
ACATCACAGGG
>LG237789.1 KR 1020160039229-A/912: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATGAATCTA
>LG237788.1 KR 1020160039229-A/911: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTCTTCATTA
>LG237787.1 KR 1020160039229-A/910: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATCTACATA
>LG237786.1 KR 1020160039229-A/909: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATACATCTA
>LG237785.1 KR 1020160039229-A/908: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATAGTGATT
>LG237784.1 KR 1020160039229-A/907: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTTGATGATA
>LG237783.1 KR 1020160039229-A/906: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATAGAGAAG
>LG237782.1 KR 1020160039229-A/905: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTAATAAGGT
>LG237781.1 KR 1020160039229-A/904: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATAATGGAT
>LG237780.1 KR 1020160039229-A/903: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTAATTAGGAT
>LG237779.1 KR 1020160039229-A/902: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTAATTGAGTA
>LG237778.1 KR 1020160039229-A/901: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTTAGGTAAA
>LG237777.1 KR 1020160039229-A/900: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATGAATCTA
>LG237776.1 KR 1020160039229-A/899: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTTCTTCATTA
>LG237774.1 KR 1020160039229-A/897: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATCTACATA
>LG237773.1 KR 1020160039229-A/896: QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING
TTATACATCTA
>LG148580.1 KR 1020160051061-A/5: COMPOSITION FOR SIMULTANEOUS DETECTION OF HEPATITIS B VIRUS (HBV) AND LAMIVUDINE-RESISTANT HBV
CGTTTCTCCTG
>LG178261.1 KR 1020160014036-A/140: RNA-GUIDEDED TRANSCRIPTIONAL REGULATION
GCCCCTTCTTC
>LF849701.1 JP 2016528897-A/581: COMPOSITIONS AND METHODS FOR MODULATING RNA
CTCCGCCCTCC
>LF849697.1 JP 2016528897-A/577: COMPOSITIONS AND METHODS FOR MODULATING RNA
CCGCCCTCCAG
>LF849681.1 JP 2016528897-A/561: COMPOSITIONS AND METHODS FOR MODULATING RNA
CAAAAGCAGGA
>LF849679.1 JP 2016528897-A/559: COMPOSITIONS AND METHODS FOR MODULATING RNA
CCTCAAAAGCA
>LF849664.1 JP 2016528897-A/544: COMPOSITIONS AND METHODS FOR MODULATING RNA
GCTCTCCGACA
>LF849661.1 JP 2016528897-A/541: COMPOSITIONS AND METHODS FOR MODULATING RNA
TCCGACAGTCT
>LF849656.1 JP 2016528897-A/536: COMPOSITIONS AND METHODS FOR MODULATING RNA
CAGTCTGGGTG
>LF849606.1 JP 2016528897-A/486: COMPOSITIONS AND METHODS FOR MODULATING RNA
GACCCCTGGTG
>LF849604.1 JP 2016528897-A/484: COMPOSITIONS AND METHODS FOR MODULATING RNA
CACTGGCCGCA
>LF849601.1 JP 2016528897-A/481: COMPOSITIONS AND METHODS FOR MODULATING RNA
CTCCGCCCTCC
>LF849597.1 JP 2016528897-A/477: COMPOSITIONS AND METHODS FOR MODULATING RNA
CCGCCCTCCAG
>LF806904.1 WO 2016167320-A/31: Method for detecting genetic mutation
CCGGAGCCCAG
>LF806420.1 WO 2016159197-A/19: RNA aptamer and sensor using the same
AGGAATGGACC
>LF806419.1 WO 2016159197-A/18: RNA aptamer and sensor using the same
AGACGAGGTGC
>LF806417.1 WO 2016159197-A/16: RNA aptamer and sensor using the same
AGACTAGGACC
>LF806416.1 WO 2016159197-A/15: RNA aptamer and sensor using the same
AGTCGAGGACC
>LF806415.1 WO 2016159197-A/14: RNA aptamer and sensor using the same
AGATGAGGACC
>LF806414.1 WO 2016159197-A/13: RNA aptamer and sensor using the same
AGACAAGGACC
>LF806413.1 WO 2016159197-A/12: RNA aptamer and sensor using the same
AGATTAGGACC
>LF806412.1 WO 2016159197-A/11: RNA aptamer and sensor using the same
AGACGAGGACC
>LF806411.1 WO 2016159197-A/10: RNA aptamer and sensor using the same
AGWYDAGGACC
>LF806410.1 WO 2016159197-A/9: RNA aptamer and sensor using the same
AGNNNAGGACC
>LF806406.1 WO 2016159197-A/5: RNA aptamer and sensor using the same
AGNHNWGGWSC
>LF806402.1 WO 2016159197-A/1: RNA aptamer and sensor using the same
AGNNNWGGWSC
>LF806138.1 WO 2016162997-A/3: Gene analysis system
CCATCTCATCC
>LF790711.1 JP 2016182120-A/6: POLYNUCLEOTIDE MOLECULES FOR GENE REGULATION IN PLANTS
ACGCATAAAAT
>LF790699.1 JP 2016174608-A/16: SINGLE MOLECULE ARRAYS FOR GENETIC AND CHEMICAL ANALYSIS
TGAGCGATTCG
>LF790698.1 JP 2016174608-A/15: SINGLE MOLECULE ARRAYS FOR GENETIC AND CHEMICAL ANALYSIS
CATTAACGGAC
>LF716726.1 WO 2016152812-A/20: High sensitivity detection method of target nucleic acid
TGAGGGGACGC
>LF716718.1 WO 2016152812-A/12: High sensitivity detection method of target nucleic acid
CTATCAAGACA
>LF716714.1 WO 2016152812-A/8: High sensitivity detection method of target nucleic acid
CCGCCCAAAAT
>LF713525.1 JP 2016165291-A/38: GENE AND VARIATIONS ASSOCIATED WITH BM1 PHENOTYPE, MOLECULAR MARKERS, AND THEIR USE
TACTGATATCT
>LF777557.1 JP 2016523076-A/77: TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
AGTCCAGTGCA
>LF707091.1 JP 2016163556-A/56: VECTOR FOR INSERTION OF DNA BINDING DOMAIN AND SET THEREOF, FUSION PROTEIN CODING VECTOR AND SET THEREOF AND PRODUCTION METHOD THEREOF, DESTINATION VECTOR, EXPRESSION VECTOR FOR PLANT CELL AND PRODUCTION METHOD THEREOF, KIT FOR PRODUCTION OF EXPRESSION VECTOR FOR PLANT CELLS, TRANSFECTION METHOD AND GENOME EDITING METHOD
CGTCTCNACCC
>LF707090.1 JP 2016163556-A/55: VECTOR FOR INSERTION OF DNA BINDING DOMAIN AND SET THEREOF, FUSION PROTEIN CODING VECTOR AND SET THEREOF AND PRODUCTION METHOD THEREOF, DESTINATION VECTOR, EXPRESSION VECTOR FOR PLANT CELL AND PRODUCTION METHOD THEREOF, KIT FOR PRODUCTION OF EXPRESSION VECTOR FOR PLANT CELLS, TRANSFECTION METHOD AND GENOME EDITING METHOD
TCAANGAGACG
>HL829776.1 Sequence 7 from patent US 9342651
GAAAATCCCTT
>HL829775.1 Sequence 6 from patent US 9342651
CAAAATCAATA
>HL829774.1 Sequence 5 from patent US 9342651
NAANNTCNNTN
>HL829772.1 Sequence 3 from patent US 9342651
GAATATCCGTC
>HL820029.1 Sequence 51 from patent US 9340830
ACAGAAAGACA
>HL812932.1 Sequence 40 from patent US 9336349
ACTACTACGGT
>HL812929.1 Sequence 37 from patent US 9336349
AGGAACCATAG
>HL812928.1 Sequence 36 from patent US 9336349
CAGGAACCATA
>HL812907.1 Sequence 15 from patent US 9336349
CTACTGCCGTC
>HL812905.1 Sequence 13 from patent US 9336349
CCATCCACTTT
>HL812901.1 Sequence 9 from patent US 9336349
TCACAAACGAA
>HL812900.1 Sequence 8 from patent US 9336349
AAGGCCACAGA
>HL802939.1 Sequence 8 from patent US 9328384
NTATNTATGCN
>HL802938.1 Sequence 7 from patent US 9328384
NTATTTCTGCN
>HL789066.1 Sequence 41 from patent US 9322006
NGACGCTGCTN
>HL789065.1 Sequence 40 from patent US 9322006
NGAGTGAGGAN
>HL789053.1 Sequence 28 from patent US 9322006
NGACGCTGCTN
>HL789052.1 Sequence 27 from patent US 9322006
NGAGTGAGGAN
>HL789039.1 Sequence 4 from patent US 9322006
NGACGGTGCTN
>HL789038.1 Sequence 3 from patent US 9322006
NGAGTGAGGAN
>HL788767.1 Sequence 184 from patent US 9322005
TTGACGATCCT
>HL788766.1 Sequence 183 from patent US 9322005
TTGACTATCCT
>HL788765.1 Sequence 182 from patent US 9322005
TTGACCATCCT
>HL788764.1 Sequence 181 from patent US 9322005
TTGACTATCCT
>HL788763.1 Sequence 180 from patent US 9322005
TTGACGATCCT
>HL788762.1 Sequence 179 from patent US 9322005
TTGACCATCCT
>HL788761.1 Sequence 178 from patent US 9322005
TTGACAATCCT
>HL781430.1 Sequence 10 from patent US 9315536
AAATTTCCGGG
>HL767434.1 Sequence 205 from patent US 9301510
CTAACTGGGGA
>HL764055.1 Sequence 117 from patent US 9297013
CCCTCTTACTA
>HL764052.1 Sequence 114 from patent US 9297013
CTCTTGCATTA
>HL764049.1 Sequence 111 from patent US 9297013
CCCTCTTACTA
>HL764045.1 Sequence 107 from patent US 9297013
AGCTCACTGGT
>HL764042.1 Sequence 104 from patent US 9297013
GGTAAACCCCT
>HL764027.1 Sequence 87 from patent US 9297013
GTCCATGGCGG
>HL764025.1 Sequence 85 from patent US 9297013
GCCTAATGGAT
>HL764024.1 Sequence 84 from patent US 9297013
GCGCTAGGTCT
>HL764023.1 Sequence 83 from patent US 9297013
GGGCCGAAGCT
>HL764011.1 Sequence 71 from patent US 9297013
TCGGGAGGCTC
>HL764008.1 Sequence 68 from patent US 9297013
GGACGAAACAG
>HL763990.1 Sequence 50 from patent US 9297013
GGCTCTCACTC
>HL763989.1 Sequence 49 from patent US 9297013
GAGGACACCGA
>HL763953.1 Sequence 6 from patent US 9297013
CAATCCGACAT
>HL761973.1 Sequence 1107 from patent US 9296809
CCGCCACCATG
>HL758324.1 Sequence 17 from patent US 9296791
GGGTACCCTGC
>HL754968.1 Sequence 35 from patent US 9290816
CACATTATTAT
>HL754966.1 Sequence 33 from patent US 9290816
GTGTTTATTAT
>HL754962.1 Sequence 29 from patent US 9290816
GTGTTTATAAT
>HL754811.1 Sequence 55 from patent US 9290811
TATAGCGGGGG
>LF653418.1 JP 2016519573-A/416: Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease
AGTATTTGGTC
>LF652860.1 JP 2016521120-A/2: NUCLEIC ACID AMPLIFICATION
GAGCAACCGTT
>LF652859.1 JP 2016521120-A/1: NUCLEIC ACID AMPLIFICATION
AACGGTTGCTC
>LF647531.1 JP 2016145219-A/237: NOVEL COELENTERAZINE SUBSTRATES AND METHODS OF USE
GCTCGAGCGGA
>LF645413.1 JP 2016144454-A/237: Oplophorus-Derived Luciferases, Novel Coelenterazine Substrates, and Methods of Use
GCTCGAGCGGA
>LF704946.1 JP 2016521714-A/8: METHODS AND COMPOSITIONS FOR TEMPLATED ASSEMBLY OF NUCLEIC ACID SPECIFIC HETEROCOMPOUNDS
CCCACCACCAC
>LF704945.1 JP 2016521714-A/7: METHODS AND COMPOSITIONS FOR TEMPLATED ASSEMBLY OF NUCLEIC ACID SPECIFIC HETEROCOMPOUNDS
ACACCGACGGC
>LF658934.1 JP 2016521554-A/139: RNA-Guided Transcriptional Regulation
GCCCCTTCTTC
>LQ677245.1 Sequence 2 from Patent EP3080303
AGACTCCGACT
>LQ672280.1 Sequence 4 from Patent EP3080289
AAAAAGCAAAA
>LQ672278.1 Sequence 2 from Patent EP3080289
TTTTGCTTTTT
>LQ668732.1 Sequence 4 from Patent EP3087082
AATTACATTCA
>LQ668731.1 Sequence 3 from Patent EP3087082
AATTGCATTCA
>LQ668730.1 Sequence 2 from Patent EP3087082
TAGGATCAGGT
>LQ668729.1 Sequence 1 from Patent EP3087082
TAGGAGCAGGT
>LQ666249.1 Sequence 76 from Patent EP3077542
GGAGGCGCAGG
>LQ664038.1 Sequence 47 from Patent EP3090064
GGGGGGGGGGG
>LQ664031.1 Sequence 40 from Patent EP3090064
TTTTTTTTTTT
>LQ661080.1 Sequence 101 from Patent EP3090058
GTGCCTTATCC
>LQ638948.1 Sequence 366 from Patent WO2016170176
GGGTTTTTGGG
>LQ638937.1 Sequence 355 from Patent WO2016170176
GGTTTTTTTGG
>LQ636377.1 Sequence 6 from Patent WO2016172362
CTAATCGGATC
>LQ636376.1 Sequence 5 from Patent WO2016172362
GTCAGTCAATG
>LQ636375.1 Sequence 4 from Patent WO2016172362
ACGTAGGGTCA
>LQ636374.1 Sequence 3 from Patent WO2016172362
TAGCCTAGTAA
>LQ636373.1 Sequence 2 from Patent WO2016172362
ACTGTCAGTAG
>LQ635154.1 Sequence 23 from Patent WO2016172346
CTAACCCTAAC
>LQ635147.1 Sequence 16 from Patent WO2016172346
GTTAGGGTTAG
>LQ635140.1 Sequence 9 from Patent WO2016172346
GTGGAAGGCGG
>LQ635135.1 Sequence 4 from Patent WO2016172346
GTTAGGGTTAG
>LQ627229.1 Sequence 9 from Patent EP3093350
ACTACRGTCAA
>LQ627228.1 Sequence 8 from Patent EP3093350
CGTACKAAGAG
>LQ622555.1 Sequence 52 from Patent WO2016173719
TGACANCTTTT
>LQ622554.1 Sequence 51 from Patent WO2016173719
GACACNTGGGG
>LQ620946.1 Sequence 39 from Patent WO2016177682
GTTTTTGTACT
>LQ620932.1 Sequence 25 from Patent WO2016177682
AATCATTTGAG
>LQ620931.1 Sequence 24 from Patent WO2016177682
TTTCATTTGAG
>LQ620675.1 Sequence 3 from Patent WO2016174151
TCAAGTTTTCC
>DM033041.1 Polypeptide mutagenesis method
CATCTTACGGA
>DM033040.1 Polypeptide mutagenesis method
CCGGAGCTGAA
>DM033039.1 Polypeptide mutagenesis method
ACGACGGGCAG
>DM033038.1 Polypeptide mutagenesis method
CATCTTACGGA
>DM033037.1 Polypeptide mutagenesis method
AAACTATTAAC
>DM033036.1 Polypeptide mutagenesis method
GAAAAGCATCT
>LF636475.1 JP 2016517437-A/5: CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES
GGGATCCTACC
>LF401097.1 JP 2014526899-A/9: Compositions and Methods for High Fidelity Assembly of Nucleic Acids
CCAGAGNNNNN
>LF633783.1 JP 2016517276-A/328: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>LF633782.1 JP 2016517276-A/327: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>LF633763.1 JP 2016517276-A/308: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
TCAACCGGTGG
>LF633452.1 JP 2016519055-A/5: SYNTHETIC POLYMERS CONTAINING AMINO ACID SIDE CHAINS
AGTTGCACGTM
>LF633449.1 JP 2016519055-A/2: SYNTHETIC POLYMERS CONTAINING AMINO ACID SIDE CHAINS
AGTTGCACGTM
>LF633262.1 JP 2016516395-A/1: EGFR Mutation Blood Testing
CCAGCGTGGAT
>LF633255.1 JP 2016516005-A/15: NOVEL ANDROGEN RECEPTOR MUTATION
AAGCGAACTGA
>LF632447.1 WO 2016114405-A/9: A Gene expression system by the use of stealth-type RNA and a gene introduction vector including the same
CTTCTACCCGT
>LF632446.1 WO 2016114405-A/8: A Gene expression system by the use of stealth-type RNA and a gene introduction vector including the same
TTTTTCTTATT
>LF629091.1 JP 2016127850-A/2156: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
TCCCCAGTTAG
>LF628341.1 JP 2016127850-A/1406: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
GCCNNNNNGGC
>LF396451.1 JP 2014518618-A/98: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TATGCTAGTAA
>LF396438.1 JP 2014518618-A/85: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCACTCATACA
>LF396437.1 JP 2014518618-A/84: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TATAGACATCA
>LF396436.1 JP 2014518618-A/83: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TAGCTCTATCA
>LF396435.1 JP 2014518618-A/82: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CTCTACGCTCA
>LF396428.1 JP 2014518618-A/75: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCACGCGAGAA
>LF396427.1 JP 2014518618-A/74: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CTACGCTCTAA
>LF396426.1 JP 2014518618-A/73: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGCGTATACAA
>LF396425.1 JP 2014518618-A/72: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGATCGTATAA
>LF396406.1 JP 2014518618-A/53: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGCAGTACGAA
>LF396405.1 JP 2014518618-A/52: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACTAGCAGTAA
>LF397999.1 JP 2014528713-A/28: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
CGAGTCACGTC
>LF397997.1 JP 2014528713-A/26: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
CGAGTCACGTC
>LF396384.1 JP 2014518618-A/31: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACGACAGCTCA
>LF396383.1 JP 2014518618-A/30: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGTCGTCGCAA
>LF396382.1 JP 2014518618-A/29: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGTAGTGTGAA
>LF396381.1 JP 2014518618-A/28: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGAGTCAGTAA
>LF396380.1 JP 2014518618-A/27: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCGCTGCGTAA
>LF396379.1 JP 2014518618-A/26: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCGATAGTGAA
>LF396378.1 JP 2014518618-A/25: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
AGCTCACGTAA
>LF396377.1 JP 2014518618-A/24: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACAGTATATAA
>LF396376.1 JP 2014518618-A/23: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TGTGAGTAGTA
>LF396375.1 JP 2014518618-A/22: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TCTAGCGACTA
>LF396374.1 JP 2014518618-A/21: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
TAGTGTAGATA
>LF396373.1 JP 2014518618-A/20: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CTACGACTGCA
>LF396372.1 JP 2014518618-A/19: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGTCGATCTCA
>LF396371.1 JP 2014518618-A/18: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CGAGACGCGCA
>LF396370.1 JP 2014518618-A/17: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CATACTCTACA
>LF396369.1 JP 2014518618-A/16: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
CACGTGTCGCA
>LF396368.1 JP 2014518618-A/15: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ATCTACTGACA
>LF396367.1 JP 2014518618-A/14: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ATAGATAGACA
>LF396366.1 JP 2014518618-A/13: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
AGTAGTGATCA
>LF396365.1 JP 2014518618-A/12: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
AGAGCGTCACA
>LF396364.1 JP 2014518618-A/11: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACTCATCTACA
>LF396363.1 JP 2014518618-A/10: IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH A SAMPLE
ACGTCTCATCA
>LF643698.1 JP 2016516432-A/22: A method for DNA amplification with a blocking oligonucleotide
TAGGTCGTCAT
>LF642839.1 JP 2016516416-A/20: Modified TGF-beta2 oligonucleotides
AGTATTTGGTC
>LF402218.1 JP 2014532400-A/19: Double-stranded RNA for immunostimulation
CCCCCNGGGGG
>LF402217.1 JP 2014532400-A/18: Double-stranded RNA for immunostimulation
GGGGGNCCCCC
>LF402216.1 JP 2014532400-A/17: Double-stranded RNA for immunostimulation
CCCCCNCCCCC
>LF402215.1 JP 2014532400-A/16: Double-stranded RNA for immunostimulation
GGGGGNGGGGG
>LF401850.1 JP 2015502754-A/12: METHOD OF DNA DETECTION AND QUANTIFICATION BY SINGLE-MOLECULE HYBRIDIZATION AND MANIPULATION
CAGCCGATGAC
>LF401840.1 JP 2015502754-A/2: METHOD OF DNA DETECTION AND QUANTIFICATION BY SINGLE-MOLECULE HYBRIDIZATION AND MANIPULATION
ATGACAATCAG
>LF389169.1 JP 2014509852-A/76: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GGGCAGCCCTG
>LF389163.1 JP 2014509852-A/70: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GCAGAGCTTTG
>LF389162.1 JP 2014509852-A/69: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
ACAATSCAGAC
>LF389159.1 JP 2014509852-A/66: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
CCTGGCGTCGT
>LF389154.1 JP 2014509852-A/61: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GGCGTCGTGAT
>LF389148.1 JP 2014509852-A/55: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
CGCGCGCCGGC
>LF389140.1 JP 2014509852-A/47: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GACTGRACGTC
>LF389132.1 JP 2014509852-A/39: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GGGGRGCTATA
>LF389130.1 JP 2014509852-A/37: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
CTGAGGGATTT
>LF389128.1 JP 2014509852-A/35: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
TGATGAACCAG
>LF389127.1 JP 2014509852-A/34: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GCGACCCGCAG
>LF389125.1 JP 2014509852-A/32: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
TCAGCCCGCGC
>LF389124.1 JP 2014509852-A/31: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
TCTTAAACCAC
>LF389123.1 JP 2014509852-A/30: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GCGGATTGTTG
>LF389122.1 JP 2014509852-A/29: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
CCAGTCRACAG
>LF389119.1 JP 2014509852-A/26: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
TTGTGYCATTA
>LF389114.1 JP 2014509852-A/21: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
TACTTTRGAAA
>LF389113.1 JP 2014509852-A/20: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GAGGCCCATCA
>LF389112.1 JP 2014509852-A/19: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
CAGCCCTGGCG
>LF389109.1 JP 2014509852-A/16: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
GCTGGAYTACA
>LF389108.1 JP 2014509852-A/15: MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (MIR-155) LINKS INFLAMMATION AND CANCER
CCTTGAYTTAT
>LF389072.1 JP 2014507950-A/24: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
GGCAGAGCCCG
>LF389071.1 JP 2014507950-A/23: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
GGCAGGGCCCG
>LF389068.1 JP 2014507950-A/20: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
GAGCTSGTGGC
>LF389067.1 JP 2014507950-A/19: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
GCCACSAGCTC
>LF389056.1 JP 2014507950-A/8: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
AGCTGGTGGCG
>LF389055.1 JP 2014507950-A/7: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
AGCTGTTGGCG
>LF389052.1 JP 2014507950-A/4: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
CGCCACCAGCT
>LF389051.1 JP 2014507950-A/3: KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
CGCCAACAGCT
>LF389040.1 JP 2014502155-A/2: Detection of Genetic or Molecular Aberrations Associated With Cancer
TACGTCATGCT
>LF389039.1 JP 2014502155-A/1: Detection of Genetic or Molecular Aberrations Associated With Cancer
ATGCCTGAATC
>LF387932.1 JP 2014508541-A/56: Host Cells and Methods for Production of Isobutanol
GTTTAAACAGT
>LF386855.1 JP 2014508512-A/2: DNA Expression Construct
AAAAACTGGAC
>LF386309.1 JP 2014500723-A/193812: Polycomb-Associated Non-Coding RNAs
GGATGAAGAAG
>LF386231.1 JP 2014500723-A/193734: Polycomb-Associated Non-Coding RNAs
CTTCTTCATCC
>LF385820.1 JP 2014500723-A/193323: Polycomb-Associated Non-Coding RNAs
GGATGAAGAAG
>LF385742.1 JP 2014500723-A/193245: Polycomb-Associated Non-Coding RNAs
CTTCTTCATCC
>LF627202.1 JP 2016127850-A/267: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
CTAACTGGGGA
>LQ284419.1 Sequence 1 from Patent WO2016035044
TTCACTTATTC
>LQ278120.1 Sequence 19 from Patent WO2016066995
GACAAGTGCGG
>LQ263680.1 Sequence 36 from Patent EP3011974
GCGGTTTGCGG
>LQ263664.1 Sequence 20 from Patent EP3011974
GGTGGTGGTGG
>LQ261443.1 Sequence 6 from Patent EP2997166
AATTGTTGCCC
>LQ261442.1 Sequence 5 from Patent EP2997166
GCCCTTGACTG
>LQ261441.1 Sequence 4 from Patent EP2997166
ACTGAATTGAA
>LQ260274.1 Sequence 114 from Patent EP2999788
CATCCCCGATT
>LQ338803.1 Sequence 8 from Patent EP3004351
CCCACCACCAC
>LQ338802.1 Sequence 7 from Patent EP3004351
ACACCGACGGC
>LQ250370.1 Sequence 81 from Patent EP3000886
TTACTATGATA
>LQ316791.1 Sequence 140 from Patent EP3003392
GCCCCTTCTTC
>LQ249367.1 Sequence 188 from Patent EP3009522
CTTGCCCAGGC
>LQ488925.1 Sequence 17 from Patent EP3058332
GAACGTTGCTA
>LQ488924.1 Sequence 16 from Patent EP3058332
AGACGAGTTTC
>LQ488918.1 Sequence 10 from Patent EP3058332
TTGGATATGGG
>LQ432150.1 Sequence 8 from Patent EP3063317
GGTGGGGGTGG
>LQ432019.1 Sequence 23 from Patent WO2016132129
GCGTATAATGG
>LQ429995.1 Sequence 179 from Patent EP3037549
GAAGGAGCTGA
>LQ429985.1 Sequence 169 from Patent EP3037549
GCATTCCTCAC
>LQ429984.1 Sequence 168 from Patent EP3037549
GCATTCCTCAG
>LQ429970.1 Sequence 154 from Patent EP3037549
AAAGGGAGCCA
>LQ429959.1 Sequence 143 from Patent EP3037549
ACGTCGGAGAT
>LQ429945.1 Sequence 129 from Patent EP3037549
GCACAGAGCAT
>LQ429944.1 Sequence 128 from Patent EP3037549
GCACAGAGCAC
>LQ429905.1 Sequence 89 from Patent EP3037549
GGACGAGTAGC
>LQ429904.1 Sequence 88 from Patent EP3037549
GGACGAGTAGA
>LQ429899.1 Sequence 83 from Patent EP3037549
TTCAGGTGGCT
>LQ429865.1 Sequence 49 from Patent EP3037549
GGTGTCGGAAA
>LQ429864.1 Sequence 48 from Patent EP3037549
GGTGTCGGAAC
>LQ429853.1 Sequence 37 from Patent EP3037549
GAGCTGGTGAA
>LQ429852.1 Sequence 36 from Patent EP3037549
GAGCTGGTGAG
>LQ429702.1 Sequence 912 from Patent EP3027773
TTATGAATCTA
>LQ429701.1 Sequence 911 from Patent EP3027773
TTTCTTCATTA
>LQ429700.1 Sequence 910 from Patent EP3027773
TTATCTACATA
>LQ429699.1 Sequence 909 from Patent EP3027773
TTATACATCTA
>LQ429698.1 Sequence 908 from Patent EP3027773
TTATAGTGATT
>LQ429697.1 Sequence 907 from Patent EP3027773
TTTTGATGATA
>LQ429696.1 Sequence 906 from Patent EP3027773
TTATAGAGAAG
>LQ429695.1 Sequence 905 from Patent EP3027773
TTTAATAAGGT
>LQ429694.1 Sequence 904 from Patent EP3027773
TTATAATGGAT
>LQ429693.1 Sequence 903 from Patent EP3027773
TTAATTAGGAT
>LQ429692.1 Sequence 902 from Patent EP3027773
TTAATTGAGTA
>LQ429691.1 Sequence 901 from Patent EP3027773
TTTTAGGTAAA
>LQ429690.1 Sequence 900 from Patent EP3027773
TTATGAATCTA
>LQ429689.1 Sequence 899 from Patent EP3027773
TTTCTTCATTA
>LQ429687.1 Sequence 897 from Patent EP3027773
TTATCTACATA
>LQ429686.1 Sequence 896 from Patent EP3027773
TTATACATCTA
>LQ486304.1 Sequence 86 from Patent WO2016087514
CCATCCTTGTC
>LQ486302.1 Sequence 84 from Patent WO2016087514
GAGGAGGCAGT
>LQ579398.1 Sequence 24 from Patent EP3068907
ATCTACATTAT
>LQ426323.1 Sequence 11 from Patent EP3037536
CTGTCTCTTAT
>LQ425384.1 Sequence 40 from Patent EP3067420
TTTCGTCTGCA
>LQ425380.1 Sequence 36 from Patent EP3067420
CACCAGGGCTT
>LQ425358.1 Sequence 14 from Patent EP3067420
CAGCTCGTCGG
>LQ425354.1 Sequence 10 from Patent EP3067420
CGCCATATCCT
>LQ425350.1 Sequence 6 from Patent EP3067420
ACGCCGAGTCC
>LQ425346.1 Sequence 2 from Patent EP3067420
CTTCCATGCTG
>LQ425385.1 Sequence 41 from Patent EP3067420
GTCTGCACCAT
>LQ425381.1 Sequence 37 from Patent EP3067420
ATTCCCGCAGC
>LQ425359.1 Sequence 15 from Patent EP3067420
CGGGCATTGGG
>LQ425355.1 Sequence 11 from Patent EP3067420
GAGCTGCACGG
>LQ425351.1 Sequence 7 from Patent EP3067420
CGGTTCGGCAC
>LQ425347.1 Sequence 3 from Patent EP3067420
CTGATCCCCTA
>LQ425382.1 Sequence 38 from Patent EP3067420
AGCACATCGAA
>LQ425378.1 Sequence 34 from Patent EP3067420
GTGAAAGGCTT
>LQ425360.1 Sequence 16 from Patent EP3067420
GGGATAGCGTA
>LQ425356.1 Sequence 12 from Patent EP3067420
ACGGACATACC
>LQ425352.1 Sequence 8 from Patent EP3067420
GCAATTCGTGC
>LQ425348.1 Sequence 4 from Patent EP3067420
GTCAGCGTTTG
>LQ425379.1 Sequence 35 from Patent EP3067420
AGGGCTTTCAT
>LQ425357.1 Sequence 13 from Patent EP3067420
CCGATTGAGCC
>LQ425353.1 Sequence 9 from Patent EP3067420
TGCGCATTCGC
>LQ425349.1 Sequence 5 from Patent EP3067420
TTTGCATGACG
>LQ425345.1 Sequence 1 from Patent EP3067420
GTGAAAGGCTT
>LQ422854.1 Sequence 48 from Patent EP3040425
GGTCAGGAGTT
>LQ576590.1 Sequence 131 from Patent EP3017043
TACACTTGTCA
>LQ576584.1 Sequence 125 from Patent EP3017043
AAAATTAGTAA
>LQ576582.1 Sequence 123 from Patent EP3017043
CACATTATTAA
>LQ419567.1 Sequence 6 from Patent WO2016124793
TAATTGAATCA
>LQ419566.1 Sequence 5 from Patent WO2016124793
TAATCCAATCA
>LQ419565.1 Sequence 4 from Patent WO2016124793
TAATTTAATCA
>LQ419564.1 Sequence 3 from Patent WO2016124793
TAACCCAATCA
>LQ419563.1 Sequence 2 from Patent WO2016124793
TAAYBYAATCA
>LQ419562.1 Sequence 1 from Patent WO2016124793
TAAYYBAATCA
>LQ410439.1 Sequence 93 from Patent WO2016128376
TTCAGGACCCA
>LQ499921.1 Sequence 312 from Patent WO2016075339
TTATTAATGCC
>LQ499920.1 Sequence 311 from Patent WO2016075339
TTTATTAATGC
>LQ499918.1 Sequence 309 from Patent WO2016075339
GTCTATGACGA
>LQ499917.1 Sequence 308 from Patent WO2016075339
GGTCTATGACG
>LQ499915.1 Sequence 306 from Patent WO2016075339
GGACGCGTATC
>LQ499914.1 Sequence 305 from Patent WO2016075339
TGGACGCGTAT
>LQ499912.1 Sequence 303 from Patent WO2016075339
ACTACCAAATA
>LQ499911.1 Sequence 302 from Patent WO2016075339
CACTACCAAAT
>LQ499909.1 Sequence 300 from Patent WO2016075339
CCCTAAACACT
>LQ499908.1 Sequence 299 from Patent WO2016075339
TCCCTAAACAC
>LQ499906.1 Sequence 297 from Patent WO2016075339
TGGTCCATTCA
>LQ499905.1 Sequence 296 from Patent WO2016075339
CTGGTCCATTC
>LQ448504.1 Sequence 1339 from Patent EP3020727
CCATCCTTGTC
>LQ448502.1 Sequence 1337 from Patent EP3020727
GAGGAGGCAGT
>LQ591535.1 Sequence 2826 from Patent EP3046585
GGTACGTCTTC
>LQ585457.1 Sequence 9 from Patent WO2016106319
TCACACAGGAC
>LQ442472.1 Sequence 1 from Patent EP3029154
CTAACCCTAAC
>LQ407995.1 Sequence 93 from Patent WO2016128060
TTCAGGACCCA
>LQ570087.1 Sequence 4 from Patent EP3041948
AAAAAGCAAAA
>LQ570085.1 Sequence 2 from Patent EP3041948
TTTTGCTTTTT
>LQ403265.1 Sequence 60 from Patent EP3036260
CTTGCGTGAGC
>LQ401939.1 Sequence 11 from Patent EP3036344
TTGGATATGGG
>LQ567037.1 Sequence 7 from Patent EP3034629
AGTGATCAGCA
>LQ567035.1 Sequence 5 from Patent EP3034629
ACAGAGTCGTA
>LQ400045.1 Sequence 14 from Patent EP3053585
AAAAAGCAAAA
>LQ400043.1 Sequence 12 from Patent EP3053585
TTTTGCTTTTT
>LQ566955.1 Sequence 7 from Patent EP3034628
AGTGATCAGCA
>LQ566953.1 Sequence 5 from Patent EP3034628
ACAGAGTCGTA
>LQ566886.1 Sequence 1 from Patent EP3034627
ACGTACGACGT
>LQ565128.1 Sequence 51 from Patent WO2016139321
TGAATGAATGA
>LQ564376.1 Sequence 27 from Patent WO2016135675
GATCTCTAGAT
>LQ396169.1 Sequence 32 from Patent EP3071953
GCGTCGATGAG
>LQ395891.1 Sequence 2 from Patent EP3071713
GAGCAACCGTT
>LQ395890.1 Sequence 1 from Patent EP3071713
AACGGTTGCTC
>LQ465477.1 Sequence 3 from Patent WO2016112963
GGGGGGGGGGG
>LQ523206.1 Sequence 171 from Patent WO2016123230
AATTTCTACTG
>LQ523205.1 Sequence 170 from Patent WO2016123230
AATTTCTACTG
>LQ523204.1 Sequence 169 from Patent WO2016123230
AATTTCTACTG
>LQ523203.1 Sequence 168 from Patent WO2016123230
AATTTCTACTG
>LQ460634.1 Sequence 27 from Patent EP3061826
GATCTCTAGAT
>LQ512864.1 Sequence 104 from Patent WO2016081740
CATGTCAGAGT
>LQ512861.1 Sequence 101 from Patent WO2016081740
TGAGACTGTAC
>LQ501869.1 Sequence 24 from Patent EP3047855
CTGGAAAATAT
>LQ247022.1 Sequence 54 from Patent WO2016040395
TTCANGAGACC
>LQ247021.1 Sequence 53 from Patent WO2016040395
GGTCTCNATAA
>LQ247018.1 Sequence 50 from Patent WO2016040395
GCTCTTCNATA
>LQ247015.1 Sequence 47 from Patent WO2016040395
ATAANGAGACC
>LQ247014.1 Sequence 46 from Patent WO2016040395
GGTCTCNCACC
>LQ247013.1 Sequence 45 from Patent WO2016040395
ATAAGAAGAGC
>LQ247009.1 Sequence 41 from Patent WO2016040395
CACCNGAGACC
>LQ247008.1 Sequence 40 from Patent WO2016040395
GGTCTCNGACT
>LQ247007.1 Sequence 39 from Patent WO2016040395
CACNGAAGAGC
>LQ247006.1 Sequence 38 from Patent WO2016040395
GCTCTTCNACT
>LQ242862.1 Sequence 5 from Patent EP3015552
DDDDCGCGCGG
>LQ293206.1 Sequence 34 from Patent WO2016059436
TTTNTTNNTTT
>LF170232.1 JP 2016515216-A/4: QUANTITATIVE ASSESSMENT FOR CAP EFFICIENCY OF MESSENGER RNA
GGGATCCTACC
>LF170224.1 JP 2016514970-A/4: QUANTITATIVE ASSESSMENT FOR CAP EFFICIENCY OF MESSENGER RNA
GGGATCCTACC
>LF170183.1 JP 2016513470-A/5: Ribonucleic Acids with 4'-Thio-Modified Nucleotides and Related Methods
GGGATCCTACC
>LF170132.1 JP 2016513669-A/17: FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF
GGCCTCCCTAA
>LF170131.1 JP 2016513669-A/16: FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF
CCGGTTAGGGA
>LF163514.1 JP 2016513959-A/115: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
ATTTCACTGTA
>LF163508.1 JP 2016513959-A/109: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
TAAAGTTCCAG
>LF163496.1 JP 2016513959-A/97: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
TCCAACATGTC
>LF163490.1 JP 2016513959-A/91: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
GTACCCTTGGA
>LF163481.1 JP 2016513959-A/82: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
CTGAGATGGAG
>LF163472.1 JP 2016513959-A/73: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
ACTCCAGCCAC
>LF163466.1 JP 2016513959-A/67: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
TACAGTGATGC
>LF163463.1 JP 2016513959-A/64: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
ACTGGATGTGC
>LF163460.1 JP 2016513959-A/61: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
GAATACTATAG
>LF163414.1 JP 2016513959-A/15: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
TTATTTCTGCT
>LF163413.1 JP 2016513959-A/14: METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS
TTATTTATGCT
>LF159182.1 WO 2016093333-A/3: A method for detecting a base mutation and a kit therefore and a method for suppressing PCR amplification of a nucleic acid sample
CCTACGCCACC
>LF159162.1 WO 2016093229-A/53: Nucleic acid complex, method for making hybridization of nucleic acid, pharmaceutical composition, probe for detecting nucleic acid and complementary strand nucleic acid complex
GGAGCNGCAGC
>LF158190.1 JP 2016104027-A/2: Compositions and methods related to mRNA translational enhancer elements
RNSGAGMGRMR
>LF158189.1 JP 2016104027-A/1: Compositions and methods related to mRNA translational enhancer elements
MSCSGCNGMWA
>LF176149.1 JP 2016513973-A/2: METHODS FOR PURIFICATION OF MESSENGER RNA
GGGATCCTACC
>DJ352338.1 JP 2007525948-A/22: SYSTEM FOR DETECTING POLYNUCLEOTIDES
TGCCTCCCGTA
>LQ228439.1 Sequence 24 from Patent EP2986710
CCAGGTGGGCG
>LQ228438.1 Sequence 23 from Patent EP2986710
CCAGGTGGGYG
>LQ226111.1 Sequence 1107 from Patent EP2990417
CCGCCACCATG
>LQ218481.1 Sequence 170 from Patent EP2988760
CTTCGNTCAAG
>LQ218480.1 Sequence 169 from Patent EP2988760
CATGANTGTCC
>LQ218479.1 Sequence 168 from Patent EP2988760
GGAAANCTACT
>LQ218478.1 Sequence 167 from Patent EP2988760
CCCTGNAGGAG
>LQ218477.1 Sequence 166 from Patent EP2988760
ACTGCNACAAC
>LQ218476.1 Sequence 165 from Patent EP2988760
CCCCGNCTCCT
>LQ218475.1 Sequence 164 from Patent EP2988760
GGCAGNTGCGG
>LQ218474.1 Sequence 163 from Patent EP2988760
ACAGGNCGTAG
>LQ218473.1 Sequence 162 from Patent EP2988760
GGAAANAAGAC
>LQ218472.1 Sequence 161 from Patent EP2988760
AAAGTNGGGGG
>LQ218471.1 Sequence 160 from Patent EP2988760
ACTCGNTGATG
>LQ218470.1 Sequence 159 from Patent EP2988760
GCTCCNATGAG
>LQ218469.1 Sequence 158 from Patent EP2988760
CTGTANCTTCG
>LQ218468.1 Sequence 157 from Patent EP2988760
CCGAGNTGCCG
>LQ218467.1 Sequence 156 from Patent EP2988760
CCACANCTCCC
>LQ218466.1 Sequence 155 from Patent EP2988760
TCAGGNGGCAC
>LQ218465.1 Sequence 154 from Patent EP2988760
TGGGCNTGGCC
>LQ218464.1 Sequence 153 from Patent EP2988760
CAGCANAGGCC
>LQ218463.1 Sequence 152 from Patent EP2988760
CTGATNCTGCC
>LQ218462.1 Sequence 151 from Patent EP2988760
TGGCCNCCTGC
>LQ218461.1 Sequence 150 from Patent EP2988760
CAGGGNGAATG
>LQ218460.1 Sequence 149 from Patent EP2988760
CAGGANGCCCC
>LQ218459.1 Sequence 148 from Patent EP2988760
CCTTCNCCTTT
>LQ218458.1 Sequence 147 from Patent EP2988760
AGGGCNCCCCG
>LQ218457.1 Sequence 146 from Patent EP2988760
GTGCANGTGGG
>LQ218456.1 Sequence 145 from Patent EP2988760
GAGAGNCGGGG
>LQ218455.1 Sequence 144 from Patent EP2988760
TCCAGNCCAGT
>LQ218454.1 Sequence 143 from Patent EP2988760
TTTCANTTTTG
>LQ218453.1 Sequence 142 from Patent EP2988760
AACTGNTATAA
>LQ218452.1 Sequence 141 from Patent EP2988760
TCTTTNTGCTG
>LQ218451.1 Sequence 140 from Patent EP2988760
CATTCNCTCTT
>LQ218450.1 Sequence 139 from Patent EP2988760
CTCGGNGGCTC
>LQ218449.1 Sequence 138 from Patent EP2988760
CCTCANAGCTG
>LQ218447.1 Sequence 136 from Patent EP2988760
AAAGGNCTGGA
>LQ218446.1 Sequence 135 from Patent EP2988760
GGGTGNTTTTT
>LQ218445.1 Sequence 134 from Patent EP2988760
TCTTCNTCTCC
>LQ218444.1 Sequence 133 from Patent EP2988760
TGGACNCGGGC
>LQ218443.1 Sequence 132 from Patent EP2988760
CGGCCNGAGGC
>LQ218442.1 Sequence 131 from Patent EP2988760
TGTGGNCTTGT
>LQ218441.1 Sequence 130 from Patent EP2988760
GGGAGNAAAAA
>LQ218440.1 Sequence 129 from Patent EP2988760
GTTCTNGTGAC
>LQ218439.1 Sequence 128 from Patent EP2988760
GTTTTNTGCAT
>LQ218438.1 Sequence 127 from Patent EP2988760
GACCGNTTCGC
>LQ218437.1 Sequence 126 from Patent EP2988760
ACTTTNTTTAA
>LQ218436.1 Sequence 125 from Patent EP2988760
TGGGANAGGCG
>LQ218435.1 Sequence 124 from Patent EP2988760
CGTTTNTTACA
>LQ218434.1 Sequence 123 from Patent EP2988760
GCATCNCCTCA
>LQ218433.1 Sequence 122 from Patent EP2988760
AGGGCNAAGTT
>LQ218432.1 Sequence 121 from Patent EP2988760
GGATGNTCTTA
>LQ218431.1 Sequence 120 from Patent EP2988760
TGACTNTCTTG
>LQ218430.1 Sequence 119 from Patent EP2988760
CTTTTNATAAT
>LQ218429.1 Sequence 118 from Patent EP2988760
TTGATNAACAT
>LQ218428.1 Sequence 117 from Patent EP2988760
AGTTTNCATAG
>LQ218427.1 Sequence 116 from Patent EP2988760
GTCTTNGGGTG
>LQ218426.1 Sequence 115 from Patent EP2988760
TCTTCNAAGCA
>LQ218425.1 Sequence 114 from Patent EP2988760
GCCATNATCTG
>LQ218424.1 Sequence 113 from Patent EP2988760
AATCANAAAGA
>LQ218423.1 Sequence 112 from Patent EP2988760
GGTCCNCCGGC
>LQ218422.1 Sequence 111 from Patent EP2988760
GAAATNTTATA
>LQ218421.1 Sequence 110 from Patent EP2988760
CCAGCNACAGC
>LQ218420.1 Sequence 109 from Patent EP2988760
AACTCNTCAAC
>LQ218419.1 Sequence 108 from Patent EP2988760
TAAACNTGCAC
>LQ218418.1 Sequence 107 from Patent EP2988760
TTTTTNCGTCT
>LQ218417.1 Sequence 106 from Patent EP2988760
GGACGNCAGCG
>LQ218416.1 Sequence 105 from Patent EP2988760
TCACTNAGTTG
>LQ218415.1 Sequence 104 from Patent EP2988760
ACTTANTTTAT
>LQ218414.1 Sequence 103 from Patent EP2988760
TGGGANATGTC
>LQ218413.1 Sequence 102 from Patent EP2988760
GATTTNCAAGT
>LQ218412.1 Sequence 101 from Patent EP2988760
GACATNAAATT
>LQ218411.1 Sequence 100 from Patent EP2988760
GTTCANCTCAA
>LQ218410.1 Sequence 99 from Patent EP2988760
CTACTNGTGAG
>LQ218409.1 Sequence 98 from Patent EP2988760
GATTTNCTCTG
>LQ218408.1 Sequence 97 from Patent EP2988760
CTTCTNGAGGG
>LQ218407.1 Sequence 96 from Patent EP2988760
CACTTNGGAGC
>LQ218406.1 Sequence 95 from Patent EP2988760
TTTTGNAAATT
>LQ218405.1 Sequence 94 from Patent EP2988760
CAATTNGCCAG
>LQ218404.1 Sequence 93 from Patent EP2988760
GGCATNATGGC
>LQ218403.1 Sequence 92 from Patent EP2988760
TAAACNATCAG
>LQ218402.1 Sequence 91 from Patent EP2988760
AAAATNATGCA
>LQ218401.1 Sequence 90 from Patent EP2988760
GGGAGNAGAAA
>LQ218400.1 Sequence 89 from Patent EP2988760
GTTCTNAACTA
>LQ218399.1 Sequence 88 from Patent EP2988760
CCACGNAGTCA
>LQ218398.1 Sequence 87 from Patent EP2988760
CTGTCNAATGT
>LQ218397.1 Sequence 86 from Patent EP2988760
CCGAGNTCATG
>LQ218396.1 Sequence 85 from Patent EP2988760
TGGTCNAGCTA
>LQ218395.1 Sequence 84 from Patent EP2988760
CGACTNCCCCA
>LQ218394.1 Sequence 83 from Patent EP2988760
GATCCNGTCTC
>LQ218393.1 Sequence 82 from Patent EP2988760
GTGCCNGTCCA
>LQ218392.1 Sequence 81 from Patent EP2988760
TGTCGNAGCGC
>LQ218391.1 Sequence 80 from Patent EP2988760
TGTTGNATGTT
>LQ218390.1 Sequence 79 from Patent EP2988760
AATACNAACAA
>LQ218389.1 Sequence 78 from Patent EP2988760
CTTCCNGCTTG
>LQ218388.1 Sequence 77 from Patent EP2988760
GGGAANAGAAG
>LQ218387.1 Sequence 76 from Patent EP2988760
AGACTNATCTC
>LQ218386.1 Sequence 75 from Patent EP2988760
GCTGTNTGGAG
>LQ218385.1 Sequence 74 from Patent EP2988760
CCTCCNCTGTG
>LQ218384.1 Sequence 73 from Patent EP2988760
ATTTTNATTTT
>LQ218383.1 Sequence 72 from Patent EP2988760
AAGGANGGAGG
>LQ218382.1 Sequence 71 from Patent EP2988760
AATTTNCATAG
>LQ218381.1 Sequence 70 from Patent EP2988760
TCTCANCATAG
>LQ218380.1 Sequence 69 from Patent EP2988760
TTTGGNAATCA
>LQ218379.1 Sequence 68 from Patent EP2988760
TGCACNAAGCT
>LQ218378.1 Sequence 67 from Patent EP2988760
AAATTNCCTAC
>LQ218377.1 Sequence 66 from Patent EP2988760
CCAAGNAAATT
>LQ218376.1 Sequence 65 from Patent EP2988760
CGGGGNCCCGG
>LQ218375.1 Sequence 64 from Patent EP2988760
GGCTGNCCAGA
>LQ218374.1 Sequence 63 from Patent EP2988760
GGTGANAGTCC
>LQ218373.1 Sequence 62 from Patent EP2988760
GGCTGNTGAAG
>LQ218372.1 Sequence 61 from Patent EP2988760
ATTGTNCAAGA
>LQ218371.1 Sequence 60 from Patent EP2988760
GTTTTNCTTCT
>LQ218370.1 Sequence 59 from Patent EP2988760
GACTTNGCCCA
>LQ218369.1 Sequence 58 from Patent EP2988760
TCTGGNAATGG
>LQ218368.1 Sequence 57 from Patent EP2988760
TCATTNTTCGG
>LQ218367.1 Sequence 56 from Patent EP2988760
AGTGGNGCCGG
>LQ218366.1 Sequence 55 from Patent EP2988760
TGCATNGACAT
>LQ218365.1 Sequence 54 from Patent EP2988760
AGAAANCCCTC
>LQ218364.1 Sequence 53 from Patent EP2988760
TCAGANGCAGA
>LQ218363.1 Sequence 52 from Patent EP2988760
AACCANCCTTC
>LQ218362.1 Sequence 51 from Patent EP2988760
ATTTTNTTGAA
>LQ218361.1 Sequence 50 from Patent EP2988760
AACTCNCTGCG
>LQ218360.1 Sequence 49 from Patent EP2988760
AGATGNCCCAT
>LQ218359.1 Sequence 48 from Patent EP2988760
ATTTTNGGGAC
>LQ218358.1 Sequence 47 from Patent EP2988760
GGCCCNCCATG
>LQ218357.1 Sequence 46 from Patent EP2988760
AATGTNCGTGC
>LQ218356.1 Sequence 45 from Patent EP2988760
CATTTNTTTGC
>LQ218355.1 Sequence 44 from Patent EP2988760
TTCAANCATGT
>LQ218354.1 Sequence 43 from Patent EP2988760
CTCCTNGTCTC
>LQ218353.1 Sequence 42 from Patent EP2988760
TGATANTACTA
>LQ218352.1 Sequence 41 from Patent EP2988760
GGGCTNCTTCC
>LQ218351.1 Sequence 40 from Patent EP2988760
CACTTNAGGAA
>LQ218350.1 Sequence 39 from Patent EP2988760
GGGGGNCAGGC
>LQ218349.1 Sequence 38 from Patent EP2988760
CAGCTNGCCCA
>LQ218348.1 Sequence 37 from Patent EP2988760
AATGCNACCAG
>LQ218347.1 Sequence 36 from Patent EP2988760
GACATNCTCTA
>LQ218346.1 Sequence 35 from Patent EP2988760
ATCACNCCGGA
>LQ218345.1 Sequence 34 from Patent EP2988760
ATTACNGCAGC
>LQ218344.1 Sequence 33 from Patent EP2988760
CCACCNGCTCA
>LQ218343.1 Sequence 32 from Patent EP2988760
TTTTTNCTCGG
>LQ218342.1 Sequence 31 from Patent EP2988760
CCCCCNCAGTG
>LQ218341.1 Sequence 30 from Patent EP2988760
TTCGGNGGCGG
>LQ218340.1 Sequence 29 from Patent EP2988760
TTTGGNTTTAT
>LQ218339.1 Sequence 28 from Patent EP2988760
GAAGANTTTGG
>LQ218338.1 Sequence 27 from Patent EP2988760
AGGCGNGCACA
>LQ218337.1 Sequence 26 from Patent EP2988760
GAAGGNCTTCT
>LQ218336.1 Sequence 25 from Patent EP2988760
CGGTCNCCCAG
>LQ218335.1 Sequence 24 from Patent EP2988760
AGACANGCCCC
>LQ218333.1 Sequence 22 from Patent EP2988760
ATCGANGTCAA
>LQ218332.1 Sequence 21 from Patent EP2988760
AGGTANAGCAG
>LQ218331.1 Sequence 20 from Patent EP2988760
CTGGGNCTTAC
>LQ218330.1 Sequence 19 from Patent EP2988760
ACCCANAGATG
>LQ218329.1 Sequence 18 from Patent EP2988760
TCTTGNAGAAG
>LQ218328.1 Sequence 17 from Patent EP2988760
CCTGANGAATT
>LQ218327.1 Sequence 16 from Patent EP2988760
AGTTGNTGGAC
>LQ218326.1 Sequence 15 from Patent EP2988760
AAGCANAGCAC
>LQ218325.1 Sequence 14 from Patent EP2988760
TGTCACACTCA
>LQ218324.1 Sequence 13 from Patent EP2988760
ACCTACTTTGA
>LQ218323.1 Sequence 12 from Patent EP2988760
GATTCGGAAGT
>LQ218322.1 Sequence 11 from Patent EP2988760
ATCTGCGGTTC
>LQ218321.1 Sequence 10 from Patent EP2988760
ACAAGNCGGCC
>LQ218320.1 Sequence 9 from Patent EP2988760
CCGTGNTGAGT
>LQ218319.1 Sequence 8 from Patent EP2988760
AACAANGTCAT
>LQ218318.1 Sequence 7 from Patent EP2988760
TTACCNCAATC
>LQ218317.1 Sequence 6 from Patent EP2988760
CGCACNCACCT
>LQ218316.1 Sequence 5 from Patent EP2988760
GCCCGNGATGG
>LQ218315.1 Sequence 4 from Patent EP2988760
AGGAGNGACGC
>LQ218314.1 Sequence 3 from Patent EP2988760
GGTCANTATTA
>LQ218313.1 Sequence 2 from Patent EP2988760
AAAACNTCCAG
>LQ218312.1 Sequence 1 from Patent EP2988760
CCCTANCTGGG
>LQ216522.1 Sequence 68 from Patent EP2985348
CTCCTTCCTCC
>LQ217046.1 Sequence 19 from Patent EP2990476
GAGNNNNNACV
>HL722448.1 Sequence 10 from patent US 9284602
CGTCTCCAACC
>HL721594.1 Sequence 979 from patent US 9284562
TAAAGGAGGAA
>HL721593.1 Sequence 976 from patent US 9284562
AGAGGTGGTGT
>HL721592.1 Sequence 975 from patent US 9284562
AAAGGAGGTGT
>HL721544.1 Sequence 925 from patent US 9284562
AGGAGGTCATC
>HL716725.1 Sequence 3 from patent US 9279154
GGGGGTAAAAC
>HL716286.1 Sequence 41 from patent US 9279129
TGCATTGTCTC
>HL714588.1 Sequence 1 from patent US 9274077
CGATCGATCGA
>HL714065.1 Sequence 27 from patent US 9273357
TCAGGRTTAAC
>HL714018.1 Sequence 77 from patent US 9273356
TGCACACAGTA
>HL714009.1 Sequence 67 from patent US 9273356
TGCACACAGTG
>HL713998.1 Sequence 55 from patent US 9273356
TAGCGTTGAAG
>HL713987.1 Sequence 43 from patent US 9273356
TAGCGTTGAAT
>HL713978.1 Sequence 33 from patent US 9273356
AGGCTGAGCGA
>HL713969.1 Sequence 23 from patent US 9273356
AGGCTGAGCGG
>HL713960.1 Sequence 13 from patent US 9273356
GTAAGCCTAAC
>HL713951.1 Sequence 3 from patent US 9273356
GTAAGCCTAAG
>HL711897.1 Sequence 42 from patent US 9273288
AGCAAATAGAC
>HL711896.1 Sequence 41 from patent US 9273288
GTCTATTTGCT
>HL711895.1 Sequence 40 from patent US 9273288
TGCATATTGAC
>HL711894.1 Sequence 39 from patent US 9273288
ACCATATTGAC
>HL711893.1 Sequence 38 from patent US 9273288
AGGATATTGAC
>HL711892.1 Sequence 37 from patent US 9273288
AGCAAATTGAC
>HL711891.1 Sequence 36 from patent US 9273288
AGCATTTTGAC
>HL711890.1 Sequence 35 from patent US 9273288
AGCATAATGAC
>HL711889.1 Sequence 34 from patent US 9273288
AGCATATAGAC
>HL711888.1 Sequence 33 from patent US 9273288
AGCATATTCAC
>HL711887.1 Sequence 32 from patent US 9273288
AGCATATTGTC
>HL711886.1 Sequence 31 from patent US 9273288
AGCATATTGAG
>HL711885.1 Sequence 30 from patent US 9273288
AGCATATTGAC
>HL711884.1 Sequence 29 from patent US 9273288
GTCAATATGCA
>HL711883.1 Sequence 28 from patent US 9273288
GTCAATATGGT
>HL711882.1 Sequence 27 from patent US 9273288
GTCAATATCCT
>HL711881.1 Sequence 26 from patent US 9273288
GTCAATTTGCT
>HL711880.1 Sequence 25 from patent US 9273288
GTCAAAATGCT
>HL711879.1 Sequence 24 from patent US 9273288
GTCATTATGCT
>HL711878.1 Sequence 23 from patent US 9273288
GTCTATATGCT
>HL711877.1 Sequence 22 from patent US 9273288
GTGAATATGCT
>HL711876.1 Sequence 21 from patent US 9273288
GACAATATGCT
>HL711875.1 Sequence 20 from patent US 9273288
CTCAATATGCT
>HL711864.1 Sequence 3 from patent US 9273288
GTGAACATGTT
>HL711863.1 Sequence 2 from patent US 9273288
GTCAATATGCT
>HL701858.1 Sequence 3 from patent US 9267917
TACTTGATCGA
>HL701857.1 Sequence 2 from patent US 9267917
TACTTGNTCGA
>HL701856.1 Sequence 1 from patent US 9267917
TCTTGATGTAC
>HL700677.1 Sequence 153 from patent US 9267147
CATTTTTATCA
>HL700668.1 Sequence 144 from patent US 9267147
ATTTTTTATTA
>HL700649.1 Sequence 124 from patent US 9267147
CATTTTTATCA
>HL700640.1 Sequence 115 from patent US 9267147
ATTTTTTATTA
>HL698342.1 Sequence 53 from patent US 9267137
TCTAATAAGCT
>HL698341.1 Sequence 52 from patent US 9267137
ATCTAATAAGC
>HL698334.1 Sequence 45 from patent US 9267137
CTAATAAGCTA
>HL698328.1 Sequence 39 from patent US 9267137
TCTGATAAGCT
>HL698327.1 Sequence 38 from patent US 9267137
GTCTGATAAGC
>HL698312.1 Sequence 23 from patent US 9267137
CTGATAAGCTA
>HL698197.1 Sequence 140 from patent US 9267135
GCCCCTTCTTC
>HL697555.1 Sequence 2464 from patent US 9266964
CCTNNNNNAGG
>HL697552.1 Sequence 2461 from patent US 9266964
CGTCTCNNNNN
>HL697549.1 Sequence 2458 from patent US 9266964
CCANNNNNTGG
>HL697547.1 Sequence 2456 from patent US 9266964
GACNNNNNGTC
>HL697546.1 Sequence 2455 from patent US 9266964
GACNNNNNGTC
>HL697545.1 Sequence 2454 from patent US 9266964
NNNNNGAGACC
>HL697544.1 Sequence 2453 from patent US 9266964
GGTCTCNNNNN
>HL697543.1 Sequence 2452 from patent US 9266964
GCCNNNNNGGC
>HL697536.1 Sequence 2445 from patent US 9266964
GCANNNNNTGC
>HL693718.1 Sequence 13 from patent US 9260762
ACGTGGGTTGC
>HL578589.1 Sequence 52 from patent US 9243053
TGTCTGCAGCT
>HL578586.1 Sequence 47 from patent US 9243053
TGTCTGCAGCC
>HL578584.1 Sequence 44 from patent US 9243053
TGAGCTCAGCC
>HL578582.1 Sequence 41 from patent US 9243053
CCACCGGCGTG
>HL578548.1 Sequence 125 from patent US 9243050
CAGAAGCAGCA
>HL578547.1 Sequence 124 from patent US 9243050
TGCTGCTTCTG
>HL578545.1 Sequence 122 from patent US 9243050
CCNNCCNNCCC
>HL578541.1 Sequence 118 from patent US 9243050
CCCNNNCCCNN
>HL578540.1 Sequence 117 from patent US 9243050
TGCTGCTTGTG
>HL578539.1 Sequence 116 from patent US 9243050
TGCTGCTTGTG
>HL578537.1 Sequence 114 from patent US 9243050
TGCTGCTTGTG
>HL578536.1 Sequence 113 from patent US 9243050
GTCCTTTGCTG
>HL578535.1 Sequence 112 from patent US 9243050
GTCCTTTGCTG
>HL578534.1 Sequence 111 from patent US 9243050
TGCTGCCTTTG
>HL578533.1 Sequence 110 from patent US 9243050
TGCTGCCTTTG
>HL578532.1 Sequence 109 from patent US 9243050
GTCCTTGCTTG
>HL578531.1 Sequence 108 from patent US 9243050
TTCTGCTTCTG
>HL578530.1 Sequence 107 from patent US 9243050
TTCTGCTTCTG
>HL578529.1 Sequence 106 from patent US 9243050
TTCTGCTTCTG
>HL578528.1 Sequence 105 from patent US 9243050
GTCCTTGCTTG
>HL578527.1 Sequence 104 from patent US 9243050
GTCCTTGCTTG
>HL578526.1 Sequence 103 from patent US 9243050
CAACGAACCCT
>HL578525.1 Sequence 102 from patent US 9243050
AGTGTTTTCTG
>HL578524.1 Sequence 101 from patent US 9243050
TGCTGCTTCTG
>HL578523.1 Sequence 100 from patent US 9243050
TGCTGCTTCTG
>HL578522.1 Sequence 99 from patent US 9243050
AGTGTTTTCTG
>HL578521.1 Sequence 98 from patent US 9243050
TGCTGAGTGTT
>HL578520.1 Sequence 97 from patent US 9243050
AGCACAACTGT
>HL578519.1 Sequence 96 from patent US 9243050
CAACGACCTGT
>HL578518.1 Sequence 95 from patent US 9243050
AACTGTTGACC
>HL578517.1 Sequence 94 from patent US 9243050
CACTGTTGACA
>HL578516.1 Sequence 93 from patent US 9243050
CACTGTTGAGA
>HL578515.1 Sequence 92 from patent US 9243050
GCACACTTGTT
>HL578514.1 Sequence 91 from patent US 9243050
GTTTGCACAAC
>HL578513.1 Sequence 90 from patent US 9243050
TCTGAATTCAG
>HL578512.1 Sequence 89 from patent US 9243050
GTCCTTGCTTG
>HL578511.1 Sequence 88 from patent US 9243050
TTGGTTGTTTG
>HL578510.1 Sequence 87 from patent US 9243050
TGAAGCTTCTG
>HL578509.1 Sequence 86 from patent US 9243050
AGAAGCTTCTG
>HL578508.1 Sequence 84 from patent US 9243050
GTCCTTCAACT
>HL578507.1 Sequence 83 from patent US 9243050
AGTTGAAGGAC
>HL578499.1 Sequence 75 from patent US 9243050
TGCTGCTTGTG
>HL578498.1 Sequence 74 from patent US 9243050
GTCCTTGCTTG
>HL578497.1 Sequence 73 from patent US 9243050
TTGGTTGTTTG
>HL578496.1 Sequence 72 from patent US 9243050
GTCCTTGCTTG
>HL578495.1 Sequence 71 from patent US 9243050
TTGGTTGTTTG
>HL578494.1 Sequence 70 from patent US 9243050
TGTTRTGTGAC
>HL578493.1 Sequence 69 from patent US 9243050
GTCCTTCTCTG
>HL578492.1 Sequence 68 from patent US 9243050
TTCTGCTTCTG
>HL578491.1 Sequence 67 from patent US 9243050
TTCTGCTTCTG
>HL578490.1 Sequence 66 from patent US 9243050
TGCCTTGAACT
>HL578489.1 Sequence 65 from patent US 9243050
TTGCTGTTGCT
>HL578488.1 Sequence 63 from patent US 9243050
TGCTGCTTCTG
>HL578487.1 Sequence 62 from patent US 9243050
GTCCTTTGCTG
>HL578486.1 Sequence 61 from patent US 9243050
GTCCTTGCTTG
>HL578485.1 Sequence 60 from patent US 9243050
TGCTGCCTTTG
>HL578484.1 Sequence 59 from patent US 9243050
TTGGTTGTTTG
>HL578483.1 Sequence 58 from patent US 9243050
TGNTGCTTCTG
>HL578482.1 Sequence 57 from patent US 9243050
TGCTGCTTCTG
>HL578481.1 Sequence 56 from patent US 9243050
TGCTGCTTGTG
>HL578480.1 Sequence 55 from patent US 9243050
TGCTGCTTCTG
>HL578479.1 Sequence 54 from patent US 9243050
TGCTGCTTGTG
>HL578478.1 Sequence 53 from patent US 9243050
TGCTGCTTGTG
>HL578477.1 Sequence 52 from patent US 9243050
TGCTGCTTGTG
>HL578476.1 Sequence 51 from patent US 9243050
TGCTGCTTGTG
>HL578475.1 Sequence 50 from patent US 9243050
GTCCTTGCTTG
>HL578474.1 Sequence 49 from patent US 9243050
TTGGTTGTTTG
>HL578473.1 Sequence 48 from patent US 9243050
CTTTGGTGTGT
>HL578472.1 Sequence 47 from patent US 9243050
TTGGTTGTTTG
>HL578471.1 Sequence 46 from patent US 9243050
CTTTGGTGTGT
>HL578470.1 Sequence 45 from patent US 9243050
TTGCTGTTGCT
>HL578469.1 Sequence 44 from patent US 9243050
TTGCCCTTGCC
>HL578468.1 Sequence 43 from patent US 9243050
TGCTGCTGCTG
>HL578467.1 Sequence 42 from patent US 9243050
TGCTGCTTGTG
>HL578466.1 Sequence 41 from patent US 9243050
TGCTGCTGCTG
>HL578465.1 Sequence 40 from patent US 9243050
GTCCTTTGCTG
>HL578464.1 Sequence 39 from patent US 9243050
GTCCTTGCTTG
>HL578463.1 Sequence 38 from patent US 9243050
TGCTGCCTTTG
>HL578462.1 Sequence 37 from patent US 9243050
GGCTGCTTGTG
>HL578461.1 Sequence 36 from patent US 9243050
TGCTGCTTGTG
>HL578460.1 Sequence 35 from patent US 9243050
TGCTGCTTGTG
>HL578459.1 Sequence 34 from patent US 9243050
CTGGCGGCCTT
>HL578458.1 Sequence 33 from patent US 9243050
TGTTGTGTGAC
>HL578457.1 Sequence 32 from patent US 9243050
TGCTGCTTGTG
>HL578456.1 Sequence 31 from patent US 9243050
TGCTGCTTCTG
>HL578455.1 Sequence 30 from patent US 9243050
TGCTGCTTGTG
>HL578454.1 Sequence 29 from patent US 9243050
TGCTGCTTGTG
>HL578453.1 Sequence 28 from patent US 9243050
TGCTGCTTATG
>HL578452.1 Sequence 27 from patent US 9243050
TGCTGCTGCTG
>HL578451.1 Sequence 26 from patent US 9243050
TGCTGCTTGTG
>HL578450.1 Sequence 25 from patent US 9243050
TGCTGCTACTG
>HL578449.1 Sequence 24 from patent US 9243050
TGCTGCTTCTG
>HL578448.1 Sequence 23 from patent US 9243050
TGCTGCTTCTG
>HL578447.1 Sequence 22 from patent US 9243050
TGCTGCTTCTG
>HL578446.1 Sequence 21 from patent US 9243050
TGCTGCTTCTG
>HL578445.1 Sequence 20 from patent US 9243050
TGCTGCTTCTG
>HL578444.1 Sequence 19 from patent US 9243050
NTCCTTCAACT
>HL578443.1 Sequence 18 from patent US 9243050
TNCTNCTTCTN
>HL578442.1 Sequence 17 from patent US 9243050
TNCTNCTTCTN
>HL578441.1 Sequence 16 from patent US 9243050
NTCCTTCAACT
>HL578440.1 Sequence 15 from patent US 9243050
GTCCTTCAACT
>HL578439.1 Sequence 14 from patent US 9243050
TGCTGCTTCTG
>HL578438.1 Sequence 13 from patent US 9243050
GTCCTTCAACT
>HL578437.1 Sequence 12 from patent US 9243050
GTCCTTCAACT
>HL578436.1 Sequence 11 from patent US 9243050
TGCTGCTTCTG
>HL578435.1 Sequence 10 from patent US 9243050
TGCTGCTTCTG
>HL578434.1 Sequence 9 from patent US 9243050
TGCTGCTTCTG
>HL578431.1 Sequence 5 from patent US 9243050
GTGTGTGTGTG
>HL578430.1 Sequence 4 from patent US 9243050
TNCAANCTTNC
>HL578429.1 Sequence 3 from patent US 9243050
TCTGTGCTTCT
>HL578428.1 Sequence 2 from patent US 9243050
CTGTGCTTCTC
>HL578427.1 Sequence 1 from patent US 9243050
TGCTGCTTCTG
>HL578221.1 Sequence 150 from patent US 9243026
AGTCGGTAAGT
>HL578214.1 Sequence 143 from patent US 9243026
CAAGCAGAGAA
>HL578210.1 Sequence 139 from patent US 9243026
CACCCTCTGTG
>HL578209.1 Sequence 138 from patent US 9243026
AGGTTGTGTCA
>HL578207.1 Sequence 136 from patent US 9243026
CTGAGTAGGAG
>HL578203.1 Sequence 132 from patent US 9243026
TGTCACCAGAG
>HL578199.1 Sequence 128 from patent US 9243026
TTTTACTCCCT
>HL578195.1 Sequence 124 from patent US 9243026
ATTGTTTCATC
>HL578192.1 Sequence 121 from patent US 9243026
ATTTCTCAACA
>HL578189.1 Sequence 118 from patent US 9243026
ATAATGAAAAC
>HL578186.1 Sequence 115 from patent US 9243026
TTCCCAATTCT
>HL578183.1 Sequence 112 from patent US 9243026
CATTTGTATTT
>HL578180.1 Sequence 109 from patent US 9243026
AGGTTCAAGTG
>HL578173.1 Sequence 102 from patent US 9243026
AGTTGCTGCTC
>HL578170.1 Sequence 99 from patent US 9243026
CCGCTGCCCAA
>HL578168.1 Sequence 97 from patent US 9243026
TGTTCTGACAA
>HL578164.1 Sequence 93 from patent US 9243026
GCAAATTTGCT
>HL578161.1 Sequence 90 from patent US 9243026
TTGAGTCTTCG
>HL690840.1 Sequence 60 from patent US 9260714
TGGCTGGACAA
>HL605817.1 Sequence 13 from patent US 9255297
CATCTTGACCA
>HL604652.1 Sequence 111 from patent US 9255259
TTTAACCCACT
>HL602970.1 Sequence 190 from patent US 9250244
CGGAACAAGGG
>HL602969.1 Sequence 189 from patent US 9250244
CGGAACAAGGG
>HL597238.1 Sequence 96 from patent US 9249243
GCGTTCTTCCG
>HL597237.1 Sequence 95 from patent US 9249243
ATAGTGCTCAT
>HL597236.1 Sequence 94 from patent US 9249243
TGCTCATACTC
>HL597233.1 Sequence 75 from patent US 9249243
TCTCAGATGGT
>HL597228.1 Sequence 66 from patent US 9249243
CTTCGATAGTG
>HL595910.1 Sequence 26 from patent US 9249201
CCACCGGCGTG
>HL589971.1 Sequence 47 from patent US 9243297
GGTGCGAGCGT
>HL589945.1 Sequence 21 from patent US 9243297
ACGCTCGCACC
>HL554702.1 Sequence 3 from patent US 9238813
GTAGTAGAACT
>HL554701.1 Sequence 2 from patent US 9238813
AGTTCCACTAC
>HL554534.1 Sequence 122 from patent US 9238805
CNNCGAGGTCR
>HL554525.1 Sequence 112 from patent US 9238805
YGACCTCGNNG
>HL553853.1 Sequence 11 from patent US 9238671
CTGTCTCTTAT
>HL553569.1 Sequence 42 from patent US 9238041
AATTGTTTGGG
>HL553567.1 Sequence 40 from patent US 9238041
ATGTCACCCGA
>HL553541.1 Sequence 14 from patent US 9238041
CCCAAACAATT
>HL553540.1 Sequence 13 from patent US 9238041
ATACAACAATT
>HL553538.1 Sequence 11 from patent US 9238041
TAAAGTGACAT
>HL553503.1 Sequence 33 from patent US 9237740
AGCTGACTCAC
>HL553502.1 Sequence 32 from patent US 9237740
GGTGAGTCAGC
>HL530675.1 Sequence 55 from patent US 9234240
TATAGCGGGGG
>HL530617.1 Sequence 11 from patent US 9234239
TCGTGTGCTTC
>HL530616.1 Sequence 10 from patent US 9234239
ACTGGGTAACA
>HL530466.1 Sequence 19 from patent US 9234233
TAGCATACGAT
>HL530465.1 Sequence 18 from patent US 9234233
TAGCAGACGAT
>HL530464.1 Sequence 17 from patent US 9234233
TAGCACACGAT
>HL530463.1 Sequence 16 from patent US 9234233
TAGCAAACGAT
>HL529767.1 Sequence 89 from patent US 9234204
GCTCTTCNNNN
>HL529754.1 Sequence 47 from patent US 9234204
CGTCTCNNNNN
>HL529751.1 Sequence 42 from patent US 9234204
CGTCTCNNNNN
>HL529745.1 Sequence 29 from patent US 9234204
GACNNNNNGTC
>HL527585.1 Sequence 20 from patent US 9234194
GAATAGGAACT
>HL527584.1 Sequence 19 from patent US 9234194
AGTTCCTATAC
>HL524456.1 Sequence 44 from patent US 9228242
TATCGGGCAGG
>HL524453.1 Sequence 41 from patent US 9228242
AACCAATCAGA
>HL524452.1 Sequence 40 from patent US 9228242
AGTCCTCATTT
>HL520308.1 Sequence 118 from patent US 9228184
GTGTTCGTCGT
>HL520307.1 Sequence 117 from patent US 9228184
NTCTTCNTCNT
>HL520221.1 Sequence 29 from patent US 9228184
TGCTGCTTGTG
>HL520195.1 Sequence 3 from patent US 9228184
TGCTGCTTGTG
>HL520194.1 Sequence 2 from patent US 9228184
TNCTNCTTCTN
>HL518667.1 Sequence 73 from patent US 9228004
GAATTCATGGG
>HL518661.1 Sequence 67 from patent US 9228004
AAACCATGGCC
>HL518352.1 Sequence 98 from patent US 9226959
CGGCCCGCGGC
>HL518351.1 Sequence 97 from patent US 9226959
GCCGCGGGCCG
>HL518323.1 Sequence 69 from patent US 9226959
GGGTTTTTGGG
>HL518313.1 Sequence 58 from patent US 9226959
GGTTTTTTTGG
>HL496751.1 Sequence 20 from patent US 9222132
CCTTCCCCGGN
>HL496749.1 Sequence 18 from patent US 9222132
GGGGGAGGCCN
>HL485313.1 Sequence 3488 from patent US 9221902
TCCCCAGTTAG
>HL484568.1 Sequence 1899 from patent US 9221902
GCCNNNNNGGC
>HL483443.1 Sequence 272 from patent US 9221902
CTAACTGGGGA
>HL482417.1 Sequence 1107 from patent US 9221896
CCGCCACCATG
>HL449211.1 Sequence 60 from patent US 9217147
GACGGTCGTAA
>HL449206.1 Sequence 55 from patent US 9217147
ACGGTCGTAAT
>HL449201.1 Sequence 50 from patent US 9217147
CGGTCGTAATA
>HL449171.1 Sequence 20 from patent US 9217147
CATAATGCTGG
>HL447909.1 Sequence 5 from patent US 9212393
GTGCAGATCTG
>LF147624.1 JP 2016510218-A/2: BIOMOLECULAR PROCESSING PLATFORM AND USES THEREOF
GNTNCNANCGT
>LF143415.1 JP 2016073293-A/582: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
CGTTCGTTCTT
>LF143405.1 JP 2016073293-A/572: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TCTGATAAGCT
>LF143395.1 JP 2016073293-A/562: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
GATTAGCATTA
>LF143385.1 JP 2016073293-A/552: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TGGATTTGCAC
>LF143375.1 JP 2016073293-A/542: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TGTCACACTCC
>LF139232.1 JP 2016067306-A/7: Methods for infection defense of Human immunodeficiency virus
AGGAACAAAGC
>HL379033.1 Sequence 49 from patent US 9206481
AAAAAAAAAAA
>HL379032.1 Sequence 48 from patent US 9206481
AAAAATAAACA
>HL378703.1 Sequence 11 from patent US 9206471
GTAGAAGTAGG
>HL375704.1 Sequence 33 from patent US 9206439
NNGATAGCNNG
>HL374354.1 Sequence 97 from patent US 9206430
TCTGACNTTCT
>HL374353.1 Sequence 95 from patent US 9206430
TCTGACNTTCT
>HL374352.1 Sequence 94 from patent US 9206430
TCTGTCNTTCT
>HL374351.1 Sequence 93 from patent US 9206430
TCTGTCGTTCT
>HL374348.1 Sequence 90 from patent US 9206430
TCTGACNTTCT
>HL374347.1 Sequence 89 from patent US 9206430
TCTCTGACGTT
>HL374346.1 Sequence 88 from patent US 9206430
TCTGACNTTCT
>HL374345.1 Sequence 87 from patent US 9206430
TCTGACNTTCT
>HL374344.1 Sequence 86 from patent US 9206430
TCTGACGTTCT
>HL374343.1 Sequence 85 from patent US 9206430
ACGTTCTCTGT
>HL374341.1 Sequence 83 from patent US 9206430
CTATCTGACGT
>HL374337.1 Sequence 79 from patent US 9206430
ACGTTCTCTGT
>HL374328.1 Sequence 70 from patent US 9206430
CTATCTAGCGT
>HL374319.1 Sequence 61 from patent US 9206430
CTATCTAGCGT
>HL374316.1 Sequence 58 from patent US 9206430
CTATCTGACGT
>HL374311.1 Sequence 52 from patent US 9206430
CCTACTAGCGT
>HL374286.1 Sequence 23 from patent US 9206430
ACGTTCTCTGT
>HL374284.1 Sequence 21 from patent US 9206430
TCTGACGTTCT
>HL374280.1 Sequence 11 from patent US 9206430
TCAACCACACA
>HL374272.1 Sequence 3 from patent US 9206430
TCTGACNTTCT
>HL325678.1 Sequence 2 from patent US 9200327
CTAACCCTAAC
>HL312535.1 Sequence 67 from patent US 9198890
AGAAGNGCCTG
>HL312534.1 Sequence 66 from patent US 9198890
GCCAGNGCTGG
>HL312533.1 Sequence 65 from patent US 9198890
GCAGCNCCAGT
>HL312532.1 Sequence 64 from patent US 9198890
GCTGCNTAAGC
>HL312531.1 Sequence 63 from patent US 9198890
GGCCTNGGGCG
>HL312530.1 Sequence 62 from patent US 9198890
GCGACNGCCTC
>HL312529.1 Sequence 61 from patent US 9198890
TGCGTNAGCGG
>HL312528.1 Sequence 60 from patent US 9198890
GGGTGNGCCTC
>HL312527.1 Sequence 59 from patent US 9198890
AGGTGNAGCAA
>HL312526.1 Sequence 58 from patent US 9198890
CAAGCNGTGGA
>HL312525.1 Sequence 57 from patent US 9198890
TGCCCNGCGAC
>HL312524.1 Sequence 56 from patent US 9198890
GCTGCNGGTGC
>HL312523.1 Sequence 55 from patent US 9198890
TGCAGNCACTG
>HL312522.1 Sequence 54 from patent US 9198890
CAGACNCTGTC
>HL312521.1 Sequence 53 from patent US 9198890
GGTCGNTTTTG
>HL312520.1 Sequence 52 from patent US 9198890
TGGGTNGCTTT
>HL312519.1 Sequence 51 from patent US 9198890
AGCTGNGTAAG
>HL312518.1 Sequence 50 from patent US 9198890
GGAACNGGCAC
>HL312517.1 Sequence 49 from patent US 9198890
ACGTGNGCGGC
>HL312516.1 Sequence 48 from patent US 9198890
AGAAGNGCCTG
>HL312515.1 Sequence 47 from patent US 9198890
AAAACNGCAGA
>HL312513.1 Sequence 45 from patent US 9198890
ATTTGNGTGAA
>HL312512.1 Sequence 44 from patent US 9198890
ATCACNTGTTT
>HL312511.1 Sequence 43 from patent US 9198890
CAATCNTTGGC
>HL312510.1 Sequence 42 from patent US 9198890
TTTGANGTTGT
>HL312509.1 Sequence 41 from patent US 9198890
TCCTTNCTAAT
>HL312508.1 Sequence 40 from patent US 9198890
CTGCTNTGATG
>HL312507.1 Sequence 39 from patent US 9198890
TTTCCNCTCAA
>HL312506.1 Sequence 38 from patent US 9198890
AGCCTNTAGTG
>HL312505.1 Sequence 37 from patent US 9198890
TCACCNTGTCT
>HL312504.1 Sequence 36 from patent US 9198890
AGTCTNGAATT
>HL312503.1 Sequence 35 from patent US 9198890
CTCAGNCTGCA
>HL312502.1 Sequence 34 from patent US 9198890
TAATCNCCTGT
>HL312501.1 Sequence 33 from patent US 9198890
GGGGCNTTCTT
>HL312500.1 Sequence 32 from patent US 9198890
ACCTGNGATAG
>HL312499.1 Sequence 31 from patent US 9198890
TGCCGNAAAAT
>HL312498.1 Sequence 30 from patent US 9198890
AATACNAGTCT
>HL312497.1 Sequence 29 from patent US 9198890
AATGCNCAAGA
>HL312496.1 Sequence 28 from patent US 9198890
GTGAGNTACTT
>HL312495.1 Sequence 27 from patent US 9198890
TTATANGAGCA
>HL312494.1 Sequence 26 from patent US 9198890
AGGGANGGGAA
>HL312493.1 Sequence 25 from patent US 9198890
CTGGGNTAAAT
>HL312492.1 Sequence 24 from patent US 9198890
CTATTNTATTT
>HL312491.1 Sequence 23 from patent US 9198890
AGCAGNTTGCA
>HL312490.1 Sequence 22 from patent US 9198890
AAATTNAAACT
>HL312489.1 Sequence 21 from patent US 9198890
AAATANGTAGA
>HL312488.1 Sequence 20 from patent US 9198890
GTGAANACAAA
>HL312487.1 Sequence 19 from patent US 9198890
GAAAGNTATCA
>HL312486.1 Sequence 18 from patent US 9198890
GAAGCNTTGAA
>HL312485.1 Sequence 17 from patent US 9198890
GATTGNATTTG
>HL312484.1 Sequence 16 from patent US 9198890
CTATANTGGTG
>HL312483.1 Sequence 15 from patent US 9198890
GGATGNAGCAA
>HL312482.1 Sequence 14 from patent US 9198890
ATATTNATTTA
>HL312481.1 Sequence 13 from patent US 9198890
ATAAANCAGCA
>HL312480.1 Sequence 12 from patent US 9198890
GCTGTNATGTC
>HL312479.1 Sequence 11 from patent US 9198890
TCACTNTCTTT
>HL312478.1 Sequence 10 from patent US 9198890
TTCTCNATGGG
>HL312477.1 Sequence 9 from patent US 9198890
GCACTNTCAGG
>HL312476.1 Sequence 8 from patent US 9198890
CATCANCTGAG
>HL312475.1 Sequence 7 from patent US 9198890
ACATCNACCTT
>HL312474.1 Sequence 6 from patent US 9198890
AGAAGNACATT
>HL312473.1 Sequence 5 from patent US 9198890
TACCANTGGGG
>HL312472.1 Sequence 4 from patent US 9198890
ATATGNGTTCA
>HL312470.1 Sequence 2 from patent US 9198890
CTCTANTGAGT
>HL312469.1 Sequence 1 from patent US 9198890
GATTTNGCTAA
>HL310845.1 Sequence 2 from patent US 9194001
NNAGAAGCGGG
>HL310518.1 Sequence 573 from patent US 9193997
CGCCCGGGTGA
>HL310510.1 Sequence 565 from patent US 9193997
CGTTCGCCCAC
>HL302361.1 Sequence 9 from patent US 9187756
GTAAACCATGG
>HL302360.1 Sequence 8 from patent US 9187756
ATAAACCATGG
>HL296200.1 Sequence 56 from patent US 9187732
CAGGTAAGTAT
>HL296199.1 Sequence 55 from patent US 9187732
CAGGTAGATTG
>HL291323.1 Sequence 48 from patent US 9181593
GGTCAGGAGTT
>HL286880.1 Sequence 71 from patent US 9181556
ATGTAAACCAT
>HL285789.1 Sequence 14 from patent US 9181548
GTGCCTGCTGT
>HL285567.1 Sequence 21 from patent US 9181544
AGCGGCCGCCA
>HL284361.1 Sequence 6 from patent US 9181321
GGGATCCTACC
>HL277162.1 Sequence 5 from patent US 9163290
GAGCCACCATG
>HL276779.1 Sequence 217 from patent US 9163284
ACATCACAGGG
>HL267623.1 Sequence 40 from patent US 9157919
GCGGTTTGCGG
>HL267587.1 Sequence 2 from patent US 9157919
GCGGTTTGCGG
>HL267460.1 Sequence 7 from patent US 9157125
TGTCTYYCTCT
>HL267459.1 Sequence 6 from patent US 9157125
TGTCTYCCTCT
>HL267458.1 Sequence 5 from patent US 9157125
TGTCTCCCTCT
>HL267417.1 Sequence 7 from patent US 9157123
TCGAGAAAAAA
>HL265889.1 Sequence 7 from patent US 9157096
TATTAGTAGAA
>HL264122.1 Sequence 17 from patent US 9156892
GGGTACCCTGC
>HL263906.1 Sequence 475 from patent US 9156875
TTTTTTGGGGG
>HL263720.1 Sequence 289 from patent US 9156875
GTTTGTGTGGG
>HL263715.1 Sequence 284 from patent US 9156875
GTTGTGTGGGG
>HL262869.1 Sequence 207 from patent US 9155754
GGATGAAGAAG
>HL262791.1 Sequence 129 from patent US 9155754
CTTCTTCATCC
>HL262661.1 Sequence 25 from patent US 9155753
GTTGAGTGTAG
>HL262654.1 Sequence 16 from patent US 9155753
GTTAGGGTTAG
>HL262653.1 Sequence 15 from patent US 9155753
TAGGGTTAGAC
>HL262645.1 Sequence 7 from patent US 9155753
GTGGAAGGCGG
>HL230672.1 Sequence 639 from patent US 9150859
AAANNNNNNNN
>HL229764.1 Sequence 34 from patent US 9150855
AGGCAAGATGC
>HL227067.1 Sequence 589 from patent US 9149473
TTTATTAGATG
>HL227066.1 Sequence 588 from patent US 9149473
TTGTCGGTAAG
>HL227055.1 Sequence 573 from patent US 9149473
TTAACGAAAGA
>HL227054.1 Sequence 572 from patent US 9149473
TGTTCTTTCGT
>HL227051.1 Sequence 569 from patent US 9149473
TGCTTCTTCTA
>HL227050.1 Sequence 568 from patent US 9149473
TGCGAAAGAAA
>HL227047.1 Sequence 564 from patent US 9149473
TGAAACAATTG
>HL227045.1 Sequence 562 from patent US 9149473
TCTTTTTTCGC
>HL227043.1 Sequence 560 from patent US 9149473
TCTTTATATTC
>HL227032.1 Sequence 544 from patent US 9149473
TCAATTGCTTC
>HL227025.1 Sequence 533 from patent US 9149473
TAGAAGAAGCG
>HL227022.1 Sequence 529 from patent US 9149473
TACGAAAGAAG
>HL227018.1 Sequence 522 from patent US 9149473
TAACTCTTCTT
>HL227015.1 Sequence 518 from patent US 9149473
TAAATCTTCTA
>HL227013.1 Sequence 515 from patent US 9149473
TAAAGATAATG
>HL227011.1 Sequence 511 from patent US 9149473
GTATTAAAAGA
>HL227007.1 Sequence 506 from patent US 9149473
GCGAAAGAAGC
>HL227000.1 Sequence 498 from patent US 9149473
GAAGAAGTAGC
>HL226993.1 Sequence 491 from patent US 9149473
CTTTTGTAATA
>HL226989.1 Sequence 487 from patent US 9149473
CTTCTTTCGGA
>HL226981.1 Sequence 469 from patent US 9149473
CGCTTTTTATT
>HL226980.1 Sequence 467 from patent US 9149473
CGATTTTTCAA
>HL226979.1 Sequence 464 from patent US 9149473
CGATATAATTT
>HL226976.1 Sequence 459 from patent US 9149473
CATCAATTGTT
>HL226975.1 Sequence 456 from patent US 9149473
CACCTTTTACA
>HL226960.1 Sequence 437 from patent US 9149473
ATTAAAGATGG
>HL226956.1 Sequence 426 from patent US 9149473
AGCGAAAGAAG
>HL226955.1 Sequence 425 from patent US 9149473
AGAAGCGATGA
>HL226949.1 Sequence 415 from patent US 9149473
AAGAAGCGAAG
>HL226945.1 Sequence 410 from patent US 9149473
AAATGGTGAAG
>HL226887.1 Sequence 310 from patent US 9149473
CAGCTTTTTTA
>HL226878.1 Sequence 298 from patent US 9149473
ATTGATGAAGC
>HL226832.1 Sequence 197 from patent US 9149473
AAATTTTTTTT
>HL226831.1 Sequence 196 from patent US 9149473
AAAATTTTTTT
>HL226830.1 Sequence 195 from patent US 9149473
AAAAATTTTTT
>HL226829.1 Sequence 194 from patent US 9149473
AAAAAATTTTT
>HL226828.1 Sequence 193 from patent US 9149473
AAAAAAATTTT
>HL226827.1 Sequence 192 from patent US 9149473
AAAAAAAATTT
>HL226805.1 Sequence 137 from patent US 9149473
TTTTTTTTCCC
>HL226804.1 Sequence 136 from patent US 9149473
TTTTTTTCCCC
>HL226803.1 Sequence 135 from patent US 9149473
TTTTTTCCCCC
>HL226802.1 Sequence 134 from patent US 9149473
TTTTTCCCCCC
>HL226801.1 Sequence 133 from patent US 9149473
TTTTCCCCCCC
>HL226800.1 Sequence 132 from patent US 9149473
TTTCCCCCCCC
>HL226799.1 Sequence 131 from patent US 9149473
CCCGGGGGGGG
>HL226798.1 Sequence 130 from patent US 9149473
CCCCGGGGGGG
>HL226797.1 Sequence 129 from patent US 9149473
CCCCCGGGGGG
>HL226796.1 Sequence 128 from patent US 9149473
CCCCCCGGGGG
>HL226795.1 Sequence 127 from patent US 9149473
CCCCCCCGGGG
>HL226794.1 Sequence 126 from patent US 9149473
CCCCCCCCGGG
>HL226793.1 Sequence 125 from patent US 9149473
ATTTTTTTTTT
>HL226792.1 Sequence 124 from patent US 9149473
AATTTTTTTTT
>HL226791.1 Sequence 123 from patent US 9149473
AAAAAAAAATT
>HL226790.1 Sequence 122 from patent US 9149473
AAAAAAAAAAT
>HL226761.1 Sequence 34 from patent US 9149473
TTTTTTTTTTC
>HL226760.1 Sequence 33 from patent US 9149473
TTTTTTTTTCC
>HL226759.1 Sequence 32 from patent US 9149473
TTCCCCCCCCC
>HL226758.1 Sequence 31 from patent US 9149473
TCCCCCCCCCC
>HL226757.1 Sequence 30 from patent US 9149473
CGGGGGGGGGG
>HL226756.1 Sequence 29 from patent US 9149473
CCGGGGGGGGG
>HL226755.1 Sequence 28 from patent US 9149473
CCCCCCCCCGG
>HL226754.1 Sequence 27 from patent US 9149473
CCCCCCCCCCG
>HL148358.1 Sequence 214 from patent US 9121070
GCCGCCTGAAA
>HL147961.1 Sequence 12 from patent US 9121046
CAGATTAAGGA
>HL146800.1 Sequence 6 from patent US 9121022
ACGCATAAAAT
>HL224187.1 Sequence 15 from patent US 9145444
TATATATTGTT
>HL224180.1 Sequence 7 from patent US 9145444
TACATACCGCT
>HL224045.1 Sequence 28 from patent US 9144596
GCTGATGCGTG
>HL223192.1 Sequence 18 from patent US 9139849
TCCTGAGCTCA
>HL222875.1 Sequence 457 from patent US 9139836
GCTCGAGCGGA
>HL215294.1 Sequence 4 from patent US 9139828
CTGTTGAGAAA
>HL211406.1 Sequence 15 from patent US 9139620
TTAAAAGGGGG
>HL210589.1 Sequence 5 from patent US 9133523
CCCCATCCCAC
>HL209621.1 Sequence 1 from patent US 9133511
ACGTACGACGT
>HL209566.1 Sequence 271 from patent US 9133503
CGCTGGACCGT
>HL209255.1 Sequence 95 from patent US 9133495
GGTTCGANTCC
>HL192598.1 Sequence 53 from patent US 9133455
CGTTCGTTCTT
>HL192589.1 Sequence 44 from patent US 9133455
TCTGATAAGCT
>HL192580.1 Sequence 35 from patent US 9133455
GATTAGCATTA
>HL192571.1 Sequence 26 from patent US 9133455
TGGATTTGCAC
>HL192562.1 Sequence 17 from patent US 9133455
TGTCACACTCC
>HL192494.1 Sequence 8 from patent US 9133449
GGTTCGANTCC
>HL191803.1 Sequence 37 from patent US 9133265
TTAGGCTTATA
>HL191682.1 Sequence 7 from patent US 9133039
AAAATTCCATA
>HL191681.1 Sequence 6 from patent US 9133039
GTGGAGAGGAG
>HL191680.1 Sequence 5 from patent US 9133039
GAGTCAGCYYY
>HL191677.1 Sequence 15 from patent US 9132426
TGTTATTCAGT
>HL191676.1 Sequence 14 from patent US 9132426
TGTTATTCAGT
>HL191663.1 Sequence 1 from patent US 9132426
TGTTATTCAGT
>HL190675.1 Sequence 42 from patent US 9131725
TACTGATATCT
>HL189821.1 Sequence 12 from patent US 9127312
GCNNNNNNNGC
>HL189817.1 Sequence 8 from patent US 9127312
GCANNNNNTGC
>HL189816.1 Sequence 7 from patent US 9127312
CCNNNNNNNGG
>HL189814.1 Sequence 5 from patent US 9127312
GCCNNNNNGGC
>HL189812.1 Sequence 3 from patent US 9127312
ACNNNNGTAYC
>HL189810.1 Sequence 1 from patent US 9127312
GACNNNNNGTC
>HL189777.1 Sequence 19 from patent US 9127311
ATCACGCCTCG
>HL123324.1 Sequence 11 from patent US 9116866
TTGGATATGGG
>HL123283.1 Sequence 108 from patent US 9115410
CAATGCGGCGC
>HL122784.1 Sequence 15 from patent US 9115404
GGCCTTTAACC
>HL122783.1 Sequence 14 from patent US 9115404
GGGAGTTCCCC
>HL122554.1 Sequence 21057 from patent US 9115389
CGAACGATAAC
>HL122523.1 Sequence 21021 from patent US 9115389
TATCCTACTAT
>HL122473.1 Sequence 20966 from patent US 9115389
GCAATGCTAGC
>HL100799.1 Sequence 12 from patent US 9115361
CACNNNNNGTC
>HL100798.1 Sequence 11 from patent US 9115361
GACNNNNNGTC
>HL099552.1 Sequence 4 from patent US 9114398
TCTCCACAGGA
>HL099551.1 Sequence 3 from patent US 9114398
TCCTGTGGAGA
>HL099550.1 Sequence 2 from patent US 9114398
TCTCCTCAGGA
>HL099549.1 Sequence 1 from patent US 9114398
TCCTGAGGAGA
>HL076756.1 Sequence 179 from patent US 9111028
GAAGGAGCTGA
>HL076746.1 Sequence 169 from patent US 9111028
GCATTCCTCAC
>HL076745.1 Sequence 168 from patent US 9111028
GCATTCCTCAG
>HL076732.1 Sequence 154 from patent US 9111028
AAAGGGAGCCA
>HL076723.1 Sequence 143 from patent US 9111028
ACGTCGGAGAT
>HL076711.1 Sequence 129 from patent US 9111028
GCACAGAGCAT
>HL076710.1 Sequence 128 from patent US 9111028
GCACAGAGCAC
>HL076676.1 Sequence 89 from patent US 9111028
GGACGAGTAGC
>HL076675.1 Sequence 88 from patent US 9111028
GGACGAGTAGA
>HL076670.1 Sequence 83 from patent US 9111028
TTCAGGTGGCT
>HL076640.1 Sequence 49 from patent US 9111028
GGTGTCGGAAA
>HL076639.1 Sequence 48 from patent US 9111028
GGTGTCGGAAC
>HL076628.1 Sequence 37 from patent US 9111028
GAGCTGGTGAA
>HL076627.1 Sequence 36 from patent US 9111028
GAGCTGGTGAG
>HL076538.1 Sequence 8 from patent US 9110054
GGGAAATTCCC
>HL076530.1 Sequence 1 from patent US 9109861
GTGGCCCATAT
>HL074802.1 Sequence 32 from patent US 9109225
TGAAGCGGCGC
>HL074800.1 Sequence 30 from patent US 9109225
TGATCAGGCGC
>HL070537.1 Sequence 13 from patent US 9103827
GCCCTTTCGTC
>HL069392.1 Sequence 32 from patent US 9102944
GTGTCGCCCTT
>HL069391.1 Sequence 31 from patent US 9102944
AAGGGCGACAC
>HL069389.1 Sequence 29 from patent US 9102944
GTGTCGCCCTT
>HL041623.1 Sequence 9 from patent US 9097708
AAGATGGCGGC
>HL041616.1 Sequence 2 from patent US 9097708
GATCTCGGAAG
>HL040242.1 Sequence 113 from patent US 9096901
YTTACTCAGAG
>HL040238.1 Sequence 109 from patent US 9096901
MTGAGAGCTGT
>HL039955.1 Sequence 5 from patent US 9096898
GTGCAGATCTG
>HL039670.1 Sequence 79 from patent US 9096893
TTTCAGATGGT
>HL039668.1 Sequence 77 from patent US 9096893
ATTTGACAAAC
>HL039664.1 Sequence 73 from patent US 9096893
CGGGACAAGTG
>HL039660.1 Sequence 69 from patent US 9096893
ATCAGTCTGAT
>HL039646.1 Sequence 55 from patent US 9096893
CACAACCTACT
>HL039644.1 Sequence 53 from patent US 9096893
TACAACCTACT
>HL035682.1 Sequence 62 from patent US 9096858
CTGACGTTCTT
>HL035680.1 Sequence 60 from patent US 9096858
CTTGACGTTCT
>HL035679.1 Sequence 57 from patent US 9096858
CTTTGACGTTC
>HL035678.1 Sequence 56 from patent US 9096858
CTTGACGTTCT
>HL035675.1 Sequence 49 from patent US 9096858
CTGTCGTTCTT
>HL035673.1 Sequence 47 from patent US 9096858
CTTGTCGTTCT
>HL035672.1 Sequence 44 from patent US 9096858
CTTTGTCGTTC
>HL035670.1 Sequence 41 from patent US 9096858
CTTGTCGTTCT
>HL035660.1 Sequence 27 from patent US 9096858
TCTGTCGTTCT
>HL035659.1 Sequence 26 from patent US 9096858
TCTGTCGTTCT
>HL035658.1 Sequence 15 from patent US 9096858
CTCTGTCGTTA
>HL035657.1 Sequence 13 from patent US 9096858
TCTGACGTTCT
>HL035656.1 Sequence 12 from patent US 9096858
TCTGACGTTCT
>HL035655.1 Sequence 10 from patent US 9096858
CTTTGTCGTTC
>HL035654.1 Sequence 8 from patent US 9096858
CTTGTCGTTCT
>HL035197.1 Sequence 1178 from patent US 9096850
GTGCCTTAAAT
>HL035158.1 Sequence 1139 from patent US 9096850
GGTGAATGCCA
>HL035157.1 Sequence 1138 from patent US 9096850
TTAAGGCACGC
>HL035151.1 Sequence 1132 from patent US 9096850
TAGCTCGTGGT
>HL035150.1 Sequence 1131 from patent US 9096850
TGGCAGTGTCT
>HL035143.1 Sequence 1124 from patent US 9096850
TATAGGCACGC
>HL035137.1 Sequence 1118 from patent US 9096850
GGTGAATGCCA
>HL035136.1 Sequence 1117 from patent US 9096850
TTAAGGCACGC
>HL035130.1 Sequence 1111 from patent US 9096850
TTAAGGCACGC
>HL035129.1 Sequence 1110 from patent US 9096850
GGTGAATGCCA
>HL035114.1 Sequence 1095 from patent US 9096850
GGTGAATGCCA
>HL029583.1 Sequence 60 from patent US 9095592
CTTGCGTGAGC
>LF129017.1 JP 2016507218-A/148: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124
ACGCCGTCATT
>HZ797556.1 JP 2016052318-A/111: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
TCTAGCTACAG
>HZ797551.1 JP 2016052318-A/106: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
TCTCGATGGAG
>HZ797475.1 JP 2016052318-A/30: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
TAGTTGGAGCT
>HZ797470.1 JP 2016052318-A/25: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
GGAGCTGGGTG
>HZ797464.1 JP 2016052318-A/19: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
AGTTGGAGCTG
>HZ797456.1 JP 2016052318-A/11: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
TGGCGTAGGCA
>HZ797450.1 JP 2016052318-A/5: METHOD FOR LOCALIZED IN SITU DETECTION OF MRNA
GTGGCGTAGGC
>HZ796961.1 JP 2016053031-A/33: Collections of repeat proteins comprising repeat modules
GGTCTCNNNNN
>LF131310.1 JP 2016508032-A/161: Tobacco Specific Nitrosamine Reduction in Plants
AGTGGGAAGTG
>LF131308.1 JP 2016508032-A/159: Tobacco Specific Nitrosamine Reduction in Plants
CTGATGTAAAG
>LF131306.1 JP 2016508032-A/157: Tobacco Specific Nitrosamine Reduction in Plants
AATGAGAATGA
>LF131304.1 JP 2016508032-A/155: Tobacco Specific Nitrosamine Reduction in Plants
GGCTCCGCCAC
>LF131302.1 JP 2016508032-A/153: Tobacco Specific Nitrosamine Reduction in Plants
TTTTGGTTCTC
>LF131301.1 JP 2016508032-A/152: Tobacco Specific Nitrosamine Reduction in Plants
GAACTCACCTT
>LF131300.1 JP 2016508032-A/151: Tobacco Specific Nitrosamine Reduction in Plants
ATGAAGGAGTG
>LF131299.1 JP 2016508032-A/150: Tobacco Specific Nitrosamine Reduction in Plants
TCCCTGTCGTC
>LF131297.1 JP 2016508032-A/148: Tobacco Specific Nitrosamine Reduction in Plants
GTGGGAAGTGA
>LF131295.1 JP 2016508032-A/146: Tobacco Specific Nitrosamine Reduction in Plants
CCTTAATGAAA
>LF131294.1 JP 2016508032-A/145: Tobacco Specific Nitrosamine Reduction in Plants
CATGGATGAGA
>LF131290.1 JP 2016508032-A/141: Tobacco Specific Nitrosamine Reduction in Plants
TAACACAACCC
>LF131289.1 JP 2016508032-A/140: Tobacco Specific Nitrosamine Reduction in Plants
GCATCCCCTGA
>LF131286.1 JP 2016508032-A/137: Tobacco Specific Nitrosamine Reduction in Plants
TGTGCCATCTG
>LF131281.1 JP 2016508032-A/132: Tobacco Specific Nitrosamine Reduction in Plants
TTCTCCTTCTG
>LF131280.1 JP 2016508032-A/131: Tobacco Specific Nitrosamine Reduction in Plants
GATCTTATACA
>LF131278.1 JP 2016508032-A/129: Tobacco Specific Nitrosamine Reduction in Plants
TTGTCCTGGCA
>LF131276.1 JP 2016508032-A/127: Tobacco Specific Nitrosamine Reduction in Plants
TTCAATGAGAA
>LF131274.1 JP 2016508032-A/125: Tobacco Specific Nitrosamine Reduction in Plants
CAGCAGGGGTG
>LF131271.1 JP 2016508032-A/122: Tobacco Specific Nitrosamine Reduction in Plants
GCCATGGATGA
>LF131270.1 JP 2016508032-A/121: Tobacco Specific Nitrosamine Reduction in Plants
TTGAGCTAACA
>LF131269.1 JP 2016508032-A/120: Tobacco Specific Nitrosamine Reduction in Plants
GCGTCATATTT
>LF131268.1 JP 2016508032-A/119: Tobacco Specific Nitrosamine Reduction in Plants
CCGTTCTGGGA
>LF131267.1 JP 2016508032-A/118: Tobacco Specific Nitrosamine Reduction in Plants
CAGGGCTGTAT
>LF131266.1 JP 2016508032-A/117: Tobacco Specific Nitrosamine Reduction in Plants
TGAGAGAGAAA
>LF131265.1 JP 2016508032-A/116: Tobacco Specific Nitrosamine Reduction in Plants
AGGAGTGGGAA
>LF131264.1 JP 2016508032-A/115: Tobacco Specific Nitrosamine Reduction in Plants
AGCCATGGATG
>LF131263.1 JP 2016508032-A/114: Tobacco Specific Nitrosamine Reduction in Plants
ATGCCAACCCG
>LF131261.1 JP 2016508032-A/112: Tobacco Specific Nitrosamine Reduction in Plants
TGCGGTTCTCG
>LF131258.1 JP 2016508032-A/109: Tobacco Specific Nitrosamine Reduction in Plants
CATCACTTTTG
>LF131257.1 JP 2016508032-A/108: Tobacco Specific Nitrosamine Reduction in Plants
AGCTTCCCTTA
>LF131256.1 JP 2016508032-A/107: Tobacco Specific Nitrosamine Reduction in Plants
GGTTCTCGGAG
>LF131254.1 JP 2016508032-A/105: Tobacco Specific Nitrosamine Reduction in Plants
CAGGGCTGTAT
>LF131252.1 JP 2016508032-A/103: Tobacco Specific Nitrosamine Reduction in Plants
CGGAGCAGCTT
>LF131251.1 JP 2016508032-A/102: Tobacco Specific Nitrosamine Reduction in Plants
CATCTGGTCTC
>LF131249.1 JP 2016508032-A/100: Tobacco Specific Nitrosamine Reduction in Plants
GGCCTGGAATT
>LF131248.1 JP 2016508032-A/99: Tobacco Specific Nitrosamine Reduction in Plants
CTACTGCTGCA
>LF131244.1 JP 2016508032-A/95: Tobacco Specific Nitrosamine Reduction in Plants
TCAGGCAGGTG
>LF131242.1 JP 2016508032-A/93: Tobacco Specific Nitrosamine Reduction in Plants
AGCTGAGAGGG
>LF131241.1 JP 2016508032-A/92: Tobacco Specific Nitrosamine Reduction in Plants
CCTTCTCTGCG
>LF131240.1 JP 2016508032-A/91: Tobacco Specific Nitrosamine Reduction in Plants
TTTGATAGCTG
>LF131235.1 JP 2016508032-A/86: Tobacco Specific Nitrosamine Reduction in Plants
CTGATGTAAAG
>LF131234.1 JP 2016508032-A/85: Tobacco Specific Nitrosamine Reduction in Plants
CTGGTGAGCTT
>LF131232.1 JP 2016508032-A/83: Tobacco Specific Nitrosamine Reduction in Plants
GAGTAGTGCCA
>LF131230.1 JP 2016508032-A/81: Tobacco Specific Nitrosamine Reduction in Plants
CTTCAACCTAA
>LF131229.1 JP 2016508032-A/80: Tobacco Specific Nitrosamine Reduction in Plants
TTCTCAAGAAA
>LF131227.1 JP 2016508032-A/78: Tobacco Specific Nitrosamine Reduction in Plants
GACTCATCACT
>LF131226.1 JP 2016508032-A/77: Tobacco Specific Nitrosamine Reduction in Plants
ATTGCATATTG
>LF131224.1 JP 2016508032-A/75: Tobacco Specific Nitrosamine Reduction in Plants
CATTGCCATGG
>LF131222.1 JP 2016508032-A/73: Tobacco Specific Nitrosamine Reduction in Plants
GAATCGCTTCT
>LF131220.1 JP 2016508032-A/71: Tobacco Specific Nitrosamine Reduction in Plants
AACTGGGAATT
>LF131219.1 JP 2016508032-A/70: Tobacco Specific Nitrosamine Reduction in Plants
TTGTGTCACAT
>LF131218.1 JP 2016508032-A/69: Tobacco Specific Nitrosamine Reduction in Plants
GACAATGGCCG
>LF131216.1 JP 2016508032-A/67: Tobacco Specific Nitrosamine Reduction in Plants
TTCATGAAATA
>LF131215.1 JP 2016508032-A/66: Tobacco Specific Nitrosamine Reduction in Plants
CCCTTGGTTAG
>LF131212.1 JP 2016508032-A/63: Tobacco Specific Nitrosamine Reduction in Plants
TGCGACAGCAG
>LF131209.1 JP 2016508032-A/60: Tobacco Specific Nitrosamine Reduction in Plants
ACCAGAAGGCC
>LF131207.1 JP 2016508032-A/58: Tobacco Specific Nitrosamine Reduction in Plants
TCAAGGCTGCT
>LF131206.1 JP 2016508032-A/57: Tobacco Specific Nitrosamine Reduction in Plants
GAGTACATTGG
>LF131203.1 JP 2016508032-A/54: Tobacco Specific Nitrosamine Reduction in Plants
GTATCCAGATA
>LF131202.1 JP 2016508032-A/53: Tobacco Specific Nitrosamine Reduction in Plants
CTGTCACTCAA
>LF131201.1 JP 2016508032-A/52: Tobacco Specific Nitrosamine Reduction in Plants
GGTCGTAGAAA
>LF131200.1 JP 2016508032-A/51: Tobacco Specific Nitrosamine Reduction in Plants
CGGTTTGGTAG
>LF131199.1 JP 2016508032-A/50: Tobacco Specific Nitrosamine Reduction in Plants
ACCAGCTTGTG
>LF131198.1 JP 2016508032-A/49: Tobacco Specific Nitrosamine Reduction in Plants
CCATATTATTC
>LF131197.1 JP 2016508032-A/48: Tobacco Specific Nitrosamine Reduction in Plants
CTGGTTTGTTC
>LF131195.1 JP 2016508032-A/46: Tobacco Specific Nitrosamine Reduction in Plants
GTGTCACATTA
>LF131193.1 JP 2016508032-A/44: Tobacco Specific Nitrosamine Reduction in Plants
GACAATGGCCG
>LF131192.1 JP 2016508032-A/43: Tobacco Specific Nitrosamine Reduction in Plants
TGGAATCGCTT
>LF131191.1 JP 2016508032-A/42: Tobacco Specific Nitrosamine Reduction in Plants
TGGATCAGCTG
>LF131190.1 JP 2016508032-A/41: Tobacco Specific Nitrosamine Reduction in Plants
TGGATCAGCTG
>LF131188.1 JP 2016508032-A/39: Tobacco Specific Nitrosamine Reduction in Plants
ATAAAGGTGGT
>LF131185.1 JP 2016508032-A/36: Tobacco Specific Nitrosamine Reduction in Plants
CCAAGGGAGTT
>LF131184.1 JP 2016508032-A/35: Tobacco Specific Nitrosamine Reduction in Plants
CGGTTTGGTAG
>LF131180.1 JP 2016508032-A/31: Tobacco Specific Nitrosamine Reduction in Plants
TTCTGGTTTGT
>LF131178.1 JP 2016508032-A/29: Tobacco Specific Nitrosamine Reduction in Plants
TATAATCTCGG
>LF131177.1 JP 2016508032-A/28: Tobacco Specific Nitrosamine Reduction in Plants
CAATAATACCG
>LF131176.1 JP 2016508032-A/27: Tobacco Specific Nitrosamine Reduction in Plants
CTTTGTTGGCC
>LF131175.1 JP 2016508032-A/26: Tobacco Specific Nitrosamine Reduction in Plants
AATCTCGGCTT
>LF131171.1 JP 2016508032-A/22: Tobacco Specific Nitrosamine Reduction in Plants
GCTTTGTTGGC
>LF131167.1 JP 2016508032-A/18: Tobacco Specific Nitrosamine Reduction in Plants
TATAATCTCGG
>LF131166.1 JP 2016508032-A/17: Tobacco Specific Nitrosamine Reduction in Plants
CAAAGTCGATA
>LF131159.1 JP 2016508032-A/10: Tobacco Specific Nitrosamine Reduction in Plants
AAGTTATCCCA
>LF131158.1 JP 2016508032-A/9: Tobacco Specific Nitrosamine Reduction in Plants
CTCTGCTCGAG
>LG108923.1 KR 1020150134350-A/2: EUGLENA SPP. MICROALGAE, POLYSACCHARIDE MANUFACTURING METHOD, AND ORGANIC COMPOUND MANUFACTURING METHOD
AAATCGGGCTG
>LG108356.1 KR 1020150131045-A/5: SYNTHETIC POLYMERS CONTAINING AMINO ACID SIDE CHAINS
AGTTGCACGTM
>LG108353.1 KR 1020150131045-A/2: SYNTHETIC POLYMERS CONTAINING AMINO ACID SIDE CHAINS
AGTTGCACGTM
>HZ772029.1 JP 2014240430-A/34: METHOD OF TREATING OVARIAN AND RENAL CANCER USING ANTIBODIES AGAINST T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 1 (TIM-1) ANTIGEN
TTACTATGATA
>LG135173.1 KR 1020150126739-A/35: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAACTCC
>LG135172.1 KR 1020150126739-A/34: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
GGAGTTTTCCA
>LG135171.1 KR 1020150126739-A/33: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAAACAC
>LG135170.1 KR 1020150126739-A/32: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAATCTCC
>LG135169.1 KR 1020150126739-A/31: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAATTTT
>LG135168.1 KR 1020150126739-A/30: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAGTTTT
>LG135167.1 KR 1020150126739-A/29: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAGTTCC
>LG135166.1 KR 1020150126739-A/28: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAGTTAC
>LG135165.1 KR 1020150126739-A/27: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAATTAC
>LG135163.1 KR 1020150126739-A/25: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAATTCTAT
>LG135162.1 KR 1020150126739-A/24: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
ATAGAATTCCA
>LG135161.1 KR 1020150126739-A/23: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAACTAC
>LG135160.1 KR 1020150126739-A/22: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
CGGAAAATCCC
>LG135159.1 KR 1020150126739-A/21: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
CGGAAAATACC
>LG135158.1 KR 1020150126739-A/20: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
CGGAAAAAACC
>LG135157.1 KR 1020150126739-A/19: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
AGGAAAATCAC
>LG135156.1 KR 1020150126739-A/18: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAATTTAC
>LG135155.1 KR 1020150126739-A/17: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAATATTAC
>LG135154.1 KR 1020150126739-A/16: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAATTAC
>LG135153.1 KR 1020150126739-A/15: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAATCAC
>LG135152.1 KR 1020150126739-A/14: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
CGGAAAATCAC
>LG135151.1 KR 1020150126739-A/13: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAATCAC
>LG135150.1 KR 1020150126739-A/12: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAAATTT
>LG135149.1 KR 1020150126739-A/11: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAAATAT
>LG135148.1 KR 1020150126739-A/10: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAAGTCC
>LG135147.1 KR 1020150126739-A/9: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAAATCAC
>LG135143.1 KR 1020150126739-A/5: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGGAAATTTGT
>LG135142.1 KR 1020150126739-A/4: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
HGGAAANNHNH
>LG135139.1 KR 1020150126739-A/1: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
HGGAAWNNHNH
>LG134227.1 KR 1020150132481-A/2: Nucleic Acid Amplification
GAGCAACCGTT
>LG134226.1 KR 1020150132481-A/1: Nucleic Acid Amplification
AACGGTTGCTC
>LG099627.1 KR 1020150127582-A/5: RIBONUCLEIC ACIDs WITH 4''-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS
GGGATCCTACC
>LG095700.1 KR 1020150105956-A/389: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS
CCNNNNNNNGG
>LG127197.1 KR 1020150132395-A/334: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>LG127196.1 KR 1020150132395-A/333: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>LG127177.1 KR 1020150132395-A/314: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
TCAACCGGTGG
>LG095012.1 KR 1020150125644-A/5: APTAMERS INHIBITING THE ENZYMATIC ACTIVITY OF TYROSINASE
CGCAATGGGCG
>LG094574.1 KR 1020150096451-A/167: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AGTGGGAAGTG
>LG094572.1 KR 1020150096451-A/165: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTGATGTAAAG
>LG094570.1 KR 1020150096451-A/163: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AATGAGAATGA
>LG094568.1 KR 1020150096451-A/161: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GGCTCCGCCAC
>LG094566.1 KR 1020150096451-A/159: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTTTGGTTCTC
>LG094565.1 KR 1020150096451-A/158: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GAACTCACCTT
>LG094564.1 KR 1020150096451-A/157: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
ATGAAGGAGTG
>LG094563.1 KR 1020150096451-A/156: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TCCCTGTCGTC
>LG094561.1 KR 1020150096451-A/154: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GTGGGAAGTGA
>LG094559.1 KR 1020150096451-A/152: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CCTTAATGAAA
>LG094558.1 KR 1020150096451-A/151: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CATGGATGAGA
>LG094554.1 KR 1020150096451-A/147: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TAACACAACCC
>LG094553.1 KR 1020150096451-A/146: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GCATCCCCTGA
>LG094550.1 KR 1020150096451-A/143: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGTGCCATCTG
>LG094545.1 KR 1020150096451-A/138: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTCTCCTTCTG
>LG094544.1 KR 1020150096451-A/137: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GATCTTATACA
>LG094542.1 KR 1020150096451-A/135: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTGTCCTGGCA
>LG094540.1 KR 1020150096451-A/133: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTCAATGAGAA
>LG094538.1 KR 1020150096451-A/131: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CAGCAGGGGTG
>LG094535.1 KR 1020150096451-A/128: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GCCATGGATGA
>LG094534.1 KR 1020150096451-A/127: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTGAGCTAACA
>LG094533.1 KR 1020150096451-A/126: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GCGTCATATTT
>LG094532.1 KR 1020150096451-A/125: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CCGTTCTGGGA
>LG094531.1 KR 1020150096451-A/124: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CAGGGCTGTAT
>LG094530.1 KR 1020150096451-A/123: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGAGAGAGAAA
>LG094529.1 KR 1020150096451-A/122: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AGGAGTGGGAA
>LG094528.1 KR 1020150096451-A/121: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AGCCATGGATG
>LG094527.1 KR 1020150096451-A/120: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
ATGCCAACCCG
>LG094525.1 KR 1020150096451-A/118: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGCGGTTCTCG
>LG094522.1 KR 1020150096451-A/115: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CATCACTTTTG
>LG094521.1 KR 1020150096451-A/114: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AGCTTCCCTTA
>LG094520.1 KR 1020150096451-A/113: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GGTTCTCGGAG
>LG094518.1 KR 1020150096451-A/111: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CAGGGCTGTAT
>LG094516.1 KR 1020150096451-A/109: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CGGAGCAGCTT
>LG094515.1 KR 1020150096451-A/108: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CATCTGGTCTC
>LG094513.1 KR 1020150096451-A/106: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GGCCTGGAATT
>LG094512.1 KR 1020150096451-A/105: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTACTGCTGCA
>LG094508.1 KR 1020150096451-A/101: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TCAGGCAGGTG
>LG094506.1 KR 1020150096451-A/99: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AGCTGAGAGGG
>LG094505.1 KR 1020150096451-A/98: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CCTTCTCTGCG
>LG094504.1 KR 1020150096451-A/97: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTTGATAGCTG
>LG094499.1 KR 1020150096451-A/92: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTGATGTAAAG
>LG094498.1 KR 1020150096451-A/91: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTGGTGAGCTT
>LG094496.1 KR 1020150096451-A/89: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GAGTAGTGCCA
>LG094494.1 KR 1020150096451-A/87: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTTCAACCTAA
>LG094493.1 KR 1020150096451-A/86: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTCTCAAGAAA
>LG094491.1 KR 1020150096451-A/84: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GACTCATCACT
>LG094490.1 KR 1020150096451-A/83: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
ATTGCATATTG
>LG094488.1 KR 1020150096451-A/81: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CATTGCCATGG
>LG094486.1 KR 1020150096451-A/79: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GAATCGCTTCT
>LG094484.1 KR 1020150096451-A/77: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AACTGGGAATT
>LG094483.1 KR 1020150096451-A/76: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTGTGTCACAT
>LG094482.1 KR 1020150096451-A/75: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GACAATGGCCG
>LG094480.1 KR 1020150096451-A/73: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTCATGAAATA
>LG094479.1 KR 1020150096451-A/72: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CCCTTGGTTAG
>LG094476.1 KR 1020150096451-A/69: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGCGACAGCAG
>LG094473.1 KR 1020150096451-A/66: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
ACCAGAAGGCC
>LG094471.1 KR 1020150096451-A/64: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TCAAGGCTGCT
>LG094470.1 KR 1020150096451-A/63: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GAGTACATTGG
>LG094467.1 KR 1020150096451-A/60: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GTATCCAGATA
>LG094466.1 KR 1020150096451-A/59: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTGTCACTCAA
>LG094465.1 KR 1020150096451-A/58: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GGTCGTAGAAA
>LG094464.1 KR 1020150096451-A/57: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CGGTTTGGTAG
>LG094463.1 KR 1020150096451-A/56: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
ACCAGCTTGTG
>LG094462.1 KR 1020150096451-A/55: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CCATATTATTC
>LG094461.1 KR 1020150096451-A/54: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTGGTTTGTTC
>LG094459.1 KR 1020150096451-A/52: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GTGTCACATTA
>LG094457.1 KR 1020150096451-A/50: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GACAATGGCCG
>LG094456.1 KR 1020150096451-A/49: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGGAATCGCTT
>LG094455.1 KR 1020150096451-A/48: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGGATCAGCTG
>LG094454.1 KR 1020150096451-A/47: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TGGATCAGCTG
>LG094452.1 KR 1020150096451-A/45: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
ATAAAGGTGGT
>LG094449.1 KR 1020150096451-A/42: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CCAAGGGAGTT
>LG094448.1 KR 1020150096451-A/41: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CGGTTTGGTAG
>LG094444.1 KR 1020150096451-A/37: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TTCTGGTTTGT
>LG094442.1 KR 1020150096451-A/35: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TATAATCTCGG
>LG094441.1 KR 1020150096451-A/34: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CAATAATACCG
>LG094440.1 KR 1020150096451-A/33: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTTTGTTGGCC
>LG094439.1 KR 1020150096451-A/32: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AATCTCGGCTT
>LG094435.1 KR 1020150096451-A/28: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
GCTTTGTTGGC
>LG094431.1 KR 1020150096451-A/24: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
TATAATCTCGG
>LG094430.1 KR 1020150096451-A/23: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CAAAGTCGATA
>LG094423.1 KR 1020150096451-A/16: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
AAGTTATCCCA
>LG094422.1 KR 1020150096451-A/15: TOBACCO SPECIFIC NITROSAMINE REDUCTION IN PLANTS
CTCTGCTCGAG
>LG126478.1 KR 1020150131251-A/2744: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>LG126477.1 KR 1020150131251-A/2743: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>LG126458.1 KR 1020150131251-A/2724: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
TCAACCGGTGG
>HZ787455.1 JP 2016504910-A/5: APTAMERS INHIBITING THE ENZYMATIC ACTIVITY OF TYROSINASE
CGCAATGGGCG
>HZ787429.1 JP 2016504307-A/21: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
CTAACCCTAAC
>HZ787424.1 JP 2016504307-A/16: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
GTTAGGGTTAG
>HZ787423.1 JP 2016504307-A/15: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
TAGGGTTAGAC
>HZ787415.1 JP 2016504307-A/7: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
GTGGAAGGCGG
>HZ783556.1 JP 2016041065-A/4: OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
TCTTGTTCTCC
>HZ783554.1 JP 2016041065-A/2: OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
GGAGAACAAGA
>HZ782948.1 JP 2016039810-A/7: DNA binding proteins using PPR motifs and use thereof
AATTTGTCGAT
>LG087011.1 KR 1020150091130-A/23: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
CTAACCCTAAC
>LG087004.1 KR 1020150091130-A/16: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
GTTAGGGTTAG
>LG087003.1 KR 1020150091130-A/15: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
TAGGGTTAGAC
>LG086995.1 KR 1020150091130-A/7: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
GTGGAAGGCGG
>HZ782336.1 JP 2016028585-A/35: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAACTCC
>HZ782335.1 JP 2016028585-A/34: Compositions and Methods for Regulating Cell Osmolarity
GGAGTTTTCCA
>HZ782334.1 JP 2016028585-A/33: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAACAC
>HZ782333.1 JP 2016028585-A/32: Compositions and Methods for Regulating Cell Osmolarity
TGGAAATCTCC
>HZ782332.1 JP 2016028585-A/31: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATTTT
>HZ782331.1 JP 2016028585-A/30: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAGTTTT
>HZ782330.1 JP 2016028585-A/29: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAGTTCC
>HZ782329.1 JP 2016028585-A/28: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAGTTAC
>HZ782328.1 JP 2016028585-A/27: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATTAC
>HZ782326.1 JP 2016028585-A/25: Compositions and Methods for Regulating Cell Osmolarity
TGGAATTCTAT
>HZ782325.1 JP 2016028585-A/24: Compositions and Methods for Regulating Cell Osmolarity
ATAGAATTCCA
>HZ782324.1 JP 2016028585-A/23: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAACTAC
>HZ782323.1 JP 2016028585-A/22: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAATCCC
>HZ782322.1 JP 2016028585-A/21: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAATACC
>HZ782321.1 JP 2016028585-A/20: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAAAACC
>HZ782320.1 JP 2016028585-A/19: Compositions and Methods for Regulating Cell Osmolarity
AGGAAAATCAC
>HZ782319.1 JP 2016028585-A/18: Compositions and Methods for Regulating Cell Osmolarity
TGGAAATTTAC
>HZ782318.1 JP 2016028585-A/17: Compositions and Methods for Regulating Cell Osmolarity
TGGAATATTAC
>HZ782317.1 JP 2016028585-A/16: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATTAC
>HZ782316.1 JP 2016028585-A/15: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATCAC
>HZ782315.1 JP 2016028585-A/14: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAATCAC
>HZ782314.1 JP 2016028585-A/13: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATCAC
>HZ782313.1 JP 2016028585-A/12: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAATTT
>HZ782312.1 JP 2016028585-A/11: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAATAT
>HZ782311.1 JP 2016028585-A/10: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAGTCC
>HZ782310.1 JP 2016028585-A/9: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATCAC
>HZ782306.1 JP 2016028585-A/5: Compositions and Methods for Regulating Cell Osmolarity
TGGAAATTTGT
>HZ782305.1 JP 2016028585-A/4: Compositions and Methods for Regulating Cell Osmolarity
HGGAAANNHNH
>HZ782302.1 JP 2016028585-A/1: Compositions and Methods for Regulating Cell Osmolarity
HGGAAWNNHNH
>HZ781734.1 JP 2016040246-A/273: Anti-DLL4 Antibodies and Uses Thereof
CTAACTGGGGA
>HZ779368.1 JP 2015096552-A/2: method for preparing pentamethylenediamine and method for preparing polyamide resin
ACCAAGCTGAT
>HZ774536.1 JP 2015025015-A/162: RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR
CTAACTGGGGA
>LG077548.1 KR 1020150070307-A/168: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCTTTAA
>LG077547.1 KR 1020150070307-A/167: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCTTAAT
>LG077546.1 KR 1020150070307-A/166: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCAATTT
>LG077545.1 KR 1020150070307-A/165: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTAATTTTT
>LG077544.1 KR 1020150070307-A/164: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTAAGCTTTTT
>LG077543.1 KR 1020150070307-A/163: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
AATTGCTTTTT
>LG077542.1 KR 1020150070307-A/162: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTAAAAATTT
>LG077541.1 KR 1020150070307-A/161: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCTTTTT
>LG077450.1 KR 1020150070307-A/70: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
AAAAAGCAAAA
>LG109903.1 KR 1020150126923-A/32: FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF
GGCCTCCCTAA
>LG109902.1 KR 1020150126923-A/31: FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF
CCGGTTAGGGA
>HZ539329.1 JP 2016500275-A/117: Methods and primer sets for high throughput PCR sequencing
TCTTCCGATCT
>HZ539297.1 JP 2016500275-A/85: Methods and primer sets for high throughput PCR sequencing
TCTTCCGATCT
>HZ492995.1 JP 2016019523-A/56: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
TCTTCGGAGTT
>HZ492988.1 JP 2016019523-A/49: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
TCTTCGGAGTT
>HZ492982.1 JP 2016019523-A/43: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GGATCTTATTT
>HZ492973.1 JP 2016019523-A/34: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CTACACAAATC
>HZ492966.1 JP 2016019523-A/27: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CAGCGATTTTT
>HZ492961.1 JP 2016019523-A/22: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GGATCTTATTT
>HZ492958.1 JP 2016019523-A/19: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CGGAGACAATG
>HZ492948.1 JP 2016019523-A/9: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GGATCTTATTT
>HZ492945.1 JP 2016019523-A/6: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GATTTCCATGT
>HZ492937.1 JP 2016027800-A/69: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
CAATCCCAATC
>HZ492913.1 JP 2016027800-A/45: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAACGGTGGAA
>HZ532837.1 JP 2016501531-A/361: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS
CCNNNNNNNGG
>HZ531322.1 JP 2016502527-A/44: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS
TGAGAGGCCGC
>HZ531320.1 JP 2016502527-A/42: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS
GCGACCGTAAC
>HZ531313.1 JP 2016502527-A/35: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS
TGAAGGGCTCT
>HZ531288.1 JP 2016502527-A/10: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS
CTTCCCTCCCA
>HZ479498.1 JP 2015535430-A/4: TERMINALLY MODIFIED RNA
AAAAAGCAAAA
>HZ479496.1 JP 2015535430-A/2: TERMINALLY MODIFIED RNA
TTTTGCTTTTT
>HZ475974.1 JP 2015536647-A/167: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCTTAAT
>HZ475970.1 JP 2015536647-A/163: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
AATTGCTTTTT
>HZ475975.1 JP 2015536647-A/168: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCTTTAA
>HZ475971.1 JP 2015536647-A/164: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTAAGCTTTTT
>HZ475972.1 JP 2015536647-A/165: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTAATTTTT
>HZ475968.1 JP 2015536647-A/161: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCTTTTT
>HZ475973.1 JP 2015536647-A/166: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTTGCAATTT
>HZ475969.1 JP 2015536647-A/162: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
TTTAAAAATTT
>HZ475877.1 JP 2015536647-A/70: PRODUCTION OF STABLE NON-POLYADENYLATED RNAS
AAAAAGCAAAA
>HZ470232.1 JP 2016013125-A/77: TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN
CTCCTTCCTCC
>HZ462883.1 WO 2015194520-A/116: Antisense Nucleic Acid
CGCCGCCATTT
>HZ462882.1 WO 2015194520-A/115: Antisense Nucleic Acid
TCTGTTAGCCA
>HZ458453.1 JP 2015221819-A/28: DIAGNOSIS OF PORCINE TORQUE TENO VIRUS INFECTION AND PORCINE TORQUE TENO VIRUS VACCINES
TATCGGGCAGG
>HZ458450.1 JP 2015221819-A/25: DIAGNOSIS OF PORCINE TORQUE TENO VIRUS INFECTION AND PORCINE TORQUE TENO VIRUS VACCINES
AACCAATCAGA
>HZ458449.1 JP 2015221819-A/24: DIAGNOSIS OF PORCINE TORQUE TENO VIRUS INFECTION AND PORCINE TORQUE TENO VIRUS VACCINES
AGTCCTCATTT
>HZ456833.1 JP 2015221036-A/322: RNAse H-Based Assays Utilizing Modified RNA Monomers
ACTGGACCTGA
>HZ458221.1 JP 2015221044-A/68: TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN
CTCCTTCCTCC
>LP131693.1 Sequence 111 from Patent EP2534163
TTTAACCCACT
>LQ007050.1 Sequence 6 from Patent EP2971033
AAAAAAAAAAT
>LQ006209.1 Sequence 32 from Patent EP2971122
TCACTGCTGAA
>LP722087.1 Sequence 46 from Patent EP2882859
WTCCAAGGGGG
>LQ005919.1 Sequence 24 from Patent EP2895627
TGAACAAGGCT
>LP721250.1 Sequence 45 from Patent EP2868747
ACGAGNAACAA
>LP719719.1 Sequence 5 from Patent EP2885433
GAGCCACCATG
>LQ113242.1 Sequence 5 from Patent EP2970362
AGTTGCACGTM
>LQ113239.1 Sequence 2 from Patent EP2970362
AGTTGCACGTM
>LQ000461.1 Sequence 11 from Patent WO2015105963
TTGGATATGGG
>LP061501.1 Sequence 6 from Patent WO2015032800
ATCGGGTCTCC
>LP638590.1 Sequence 4 from Patent WO2015040402
TAGCNTTAAAA
>LP638589.1 Sequence 3 from Patent WO2015040402
TTTTANNGCTA
>LP638587.1 Sequence 1 from Patent WO2015040402
TTTTAGAGCTA
>LQ069680.1 Sequence 4 from Patent EP2964234
AAAAAGCAAAA
>LQ069678.1 Sequence 2 from Patent EP2964234
TTTTGCTTTTT
>LQ131630.1 Sequence 2 from Patent EP2980205
AAATCGGGCTG
>LQ131398.1 Sequence 9 from Patent EP2924121
DYGGCARGGAR
>LQ131397.1 Sequence 8 from Patent EP2924121
DYGGCARGGAR
>LP636428.1 Sequence 132 from Patent WO2015037992
ACTGAGGACAG
>LP636427.1 Sequence 131 from Patent WO2015037992
ACCGAAGATTG
>LP636426.1 Sequence 130 from Patent WO2015037992
ACAGCTGACTC
>LP636425.1 Sequence 129 from Patent WO2015037992
ACCGAGGATAG
>LP636424.1 Sequence 128 from Patent WO2015037992
ACTGAAGACAG
>LP636423.1 Sequence 127 from Patent WO2015037992
ACTGAAGATAG
>LP636422.1 Sequence 126 from Patent WO2015037992
ACAGCAGATTC
>LP636421.1 Sequence 125 from Patent WO2015037992
ACAGAAGACTC
>LP636420.1 Sequence 124 from Patent WO2015037992
ACCGAAGACAG
>LP636419.1 Sequence 123 from Patent WO2015037992
ACAGCTGATTC
>LP636418.1 Sequence 122 from Patent WO2015037992
ACCGAAGATAG
>LP636417.1 Sequence 121 from Patent WO2015037992
ACAACGGACTC
>LP636416.1 Sequence 120 from Patent WO2015037992
ACAGAGGACAG
>LP636415.1 Sequence 119 from Patent WO2015037992
ACCGAAGAATC
>LP056880.1 Sequence 20 from Patent EP2837695
ATTGTATAGTT
>LP056878.1 Sequence 18 from Patent EP2837695
AACTATACAAC
>LP056877.1 Sequence 17 from Patent EP2837695
GTTGTATAGTT
>LP056876.1 Sequence 16 from Patent EP2837695
TGAGGTAGTAG
>LP056568.1 Sequence 2 from Patent EP2830595
GGGATCCTACC
>LP635121.1 Sequence 1339 from Patent WO2015036599
CCATCCTTGTC
>LP635119.1 Sequence 1337 from Patent WO2015036599
GAGGAGGCAGT
>LP055307.1 Sequence 604 from Patent EP2839005
TCTCCAAAAGG
>LP055296.1 Sequence 593 from Patent EP2839005
ACTCAAAATGG
>LP055295.1 Sequence 592 from Patent EP2839005
AATCACTAACC
>LP055290.1 Sequence 587 from Patent EP2839005
AGGGCTTAGCT
>LP055231.1 Sequence 528 from Patent EP2839005
ATGCATTCTCT
>LP055230.1 Sequence 527 from Patent EP2839005
ATGCATTCTGT
>LP055229.1 Sequence 526 from Patent EP2839005
AAGTATCCTTT
>LP055101.1 Sequence 398 from Patent EP2839005
CTGCAAACACT
>LP055100.1 Sequence 397 from Patent EP2839005
CAGAACACATT
>LP055099.1 Sequence 396 from Patent EP2839005
CAGCAAGCACT
>LP055026.1 Sequence 323 from Patent EP2839005
AGCGGGAAGGT
>LP054967.1 Sequence 264 from Patent EP2839005
TTCCCATTCTC
>LP054966.1 Sequence 263 from Patent EP2839005
TTCCCTTGCTC
>LP054965.1 Sequence 262 from Patent EP2839005
TCCCCTCTGTC
>LP054964.1 Sequence 261 from Patent EP2839005
TTCCCTATCTC
>LP054930.1 Sequence 227 from Patent EP2839005
TTTGTGCAAAT
